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Abstract 
Enzymes are increasingly applied to organic synthesis because of their high 
enantioselectivity, chemoselectivity, and environmental friendliness. Hydrolytic enzymes 
are the largest class used for biotransformations, and subtilisin is one of the commonly 
used serine proteases for organic synthesis. We hypothesized that we could expand the 
usefulness of subtilisin to hydrolyze unnatural substrates. The X-ray crystal structure of 
subtilisin shows that it has a large open active site. Previous workers focused on 
hydrolysis of natural substrates and close analogs, but the open active site suggests that 
subtilisin should accept bulky substrates that do not resemble peptides. 
The Diels-Alder reaction is important in organic synthesis because it has the 
potential to create several stereocenters in a single step. We resolved a bulky secondary 
alcohol ester of a spiro chiral auxiliary for the Diels-AIder reaction on a gram scale using 
subtilisin Carlsberg. The reaction proceeded with high enantioselectivity and yield. 
Cholesterol esterase showed high enantioselectivity but with the opposite 
enantiopreference, consistent with mirror image arrangement for the active sites of 
subtilisins and lipases/esterases. We also used molecular modeling to identify the 
molecular basis of enantioselectivity of subtilisin Carlsberg toward this secondary 
alcohol. 
Resolution of tertiary alcohol esters is difficult because they are also very bulky, 
but important because there are only a few synthetic and biocatalytic methods to prepare 
enantiopure tertiary a1cohols. We discovered several proteases that hydrolyze esters of 
tertiary alcohols, one of which was subtilisin Carlsberg. This is the first examination of 
protease hydrolysis of tertiary alcohol esters. Substrate studies and molecular modeling 
explained their reactivity and enantioselectivity. 
Sulfinamidies are also bulky substrates, but surprisingly subtilisin catalyzed a 
catalytic promiscuous reaction of N-acyl sulfinamides. Subtilisin Carlsberg-catalyzed 
hydrolysis of N-acyl sulfinamides favored cleavage ofthe sulfinamide (S(O)-N) bond 
with a minor amount of the expected carboxamide (C(O)-N) bond. The sulfinamide 
hydrolysis was enantioselective and confirmed by product isolation from the S-N 
sulfinamide cleavage. In contrast, the related subtilisins BPN' and E favored the C-N 
carboxamide hydrolysis. 
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Further examination using electrospray-mass spectrometry revealed a sulfinyl-
enzyme intermediate located at the active site, analogous to an acyl-enzyme. This 
suggested an analogous mechanism to the amide/ester hydrolysis. Substrate variation 
indicated a substrate reversaI was responsible for the change in reactivity by binding in 
the SI acyl pocket. Three mutations of subtilisin BPN' towards subtilisin Carl sb erg 
increased the S-N hydrolysis by 14-fold, indicating that only a few mutations were 
responsible for the catalytic promiscuity. The substrate specificity and mutagenesis were 
consistent with a reversed orientation for the sulfinyl hydrolysis reactions. 
The active site of subtilisin is indeed versatile for unnatural substrates and 
unnatural reactions. We expanded the applications of subtilisin to resolve bulky 
substrates, such as chiral auxiliaries and tertiary alcohol esters, and also to perform a new 
catalytic promiscuous sulfinamide S-N bond hydrolysis. Based on these results, 
subtilisin should prove useful for future resolutions of bulky substrates, and also in 
catalytic promiscuous reactions where unusual reactive centers are hydrolyzed. 
IV 
Résumé 
Les enzymes sont de plus en plus utilisées en synthèse organique du fait de leurs 
grandes énantio et chimiosélectivités ainsi que pour leur milieu réactionnel relativement 
doux. Les enzymes hydrolytiques représentent la classe d'enzyme la plus utilisée pour les 
biotransformations et la subtilisine est une des protéases à sérine le plus fréquemment 
utilisée en synthèse organique. Nous avons supposé la possibilité d'étendre l'utilisation 
de la subtilisine à l'hydrolyse de substrats non naturels. La structure tridimensionnelle 
déterminée par rayons X de la subtilisine a permis d'observer un site actif largement 
ouvert. Des travaux antérieurs portant sur l'hydrolyse de substrats naturels et de proches 
analogues ont été réalisés, cependant le site actif ouvert suggère que la subtilisine devrait 
être en mesure d'accepter des substrats encombrés ne ressemblant pas à des peptides. 
La réaction de Diels-Alder est importante en synthèse organique du fait de la 
possibilité de créer différents stéréocentres en une seule étape. Grâce à la réaction de 
Diels-Alder nous avons obtenu un ester d'alcool secondaire encombré à partir d'un 
auxiliaire chiral spirocylclique à l'échelle du gramme et ce en utilisant la subtilisine 
Carlsberg. La réaction est réalisée avec une haute énantiosélectivité et un fort rendement. 
La cholestérol estérase montre quant à elle toujours une haute énantiosélectivité mais 
avec une énantio-préférence inverse, cohérent des subtilisines et des lipases/estérases 
ayant des sites actifs image miroir l'un de l'autre. Nous avons donc utilisés la 
modélisation moléculaire afin d'identifier les bases moléculaires de l'énantiosélectivité 
de la subtilisine Carlsberg en ce qui concerne les alcools secondaires. 
L'obtention d'esters d'alcools tertiaires est difficile à cause de leur encombrement 
stérique mais importante du fait du peu de méthodes de synthèse et de biocatalyse 
permettant d'obtenir des alcools tertiaires énantiosélectivement purs. Nous avons 
découvert un grand nombre de protéases permettant l'hydrolyse d'esters d'alcools 
tertiaires parmi lesquelles la subtilisine Carlsberg. C'est la première étude portant sur 
l'hydrolyse d'esters d'alcools tertiaires grâce à une protéase. Les études de substrats et de 
modélisation moléculaire ont permis d'expliquer la réactivité et l'énantiosélectivité. 
Les sulfinamides sont aussi des substrats encombrés stériquement et de façon 
étonnante la subtilisine catalyse une réaction hétérogène des N-acyl sulfinamides. 
L 'hydrolyse de N-acyl sulfinamides catalysée par la subtilisine Carlsberg favorise le 
v 
clivage du lien sulfinamide (S(O)-N) par rapport à la rupture du lien carboxamide (S(O)-
N). L'hydrolyse de la sulfinamide est énantiosélective et est confirmée lors de l'isolation 
du produit après la rupture du lien sulfinamide S-N. De manière opposée, il a été montré 
que les subtilisines BPN' et E favorisaier quant à elles l'hydrolyse du lien carboxamide 
(C-N). 
De plus des études de spectrométrie de masse-Electrospray ont montré que 
l'intermédiaire sulfinyl-enzyme était situé au sein du site actif de manière analogue à 
l'acyl-enzyme. Ceci suggère un mécanisme similaire pour l'hydrolyse de l'amide/ester. 
Le changement de substrat indique qu'une inversion de substrat est responsable du 
changement de réactivité lors de la liaison dans la poche acyl SI. Trois mutations de la 
subtilisine BPN' dans le sens de la subtilisine Carlsberg augmentent l'hydrolyse S-N d'un 
facteur 14, ceci indiquant que peu de mutations sont responsables de l'hétérogénéité 
catalytique. La spécificité du substrat et la mutagénèse sont en accord avec une 
orientation inversée des réactions d'hydrolyse des groupements sulfinyl. 
Le site actif de la subtilisine est en effet flexible pour les substrats et les réactions 
non naturels. Nous avons étendu les applications de la subtilisine pour obtenir des 
substrats encombrés tels que les auxiliaires chiraux et les esters d'alcools tertiaires et 
ainsi améliorer une nouvelle catalyse hétérogène de l'hydrolyse des liens S-N 
sulfinamide. En se basant sur ces résultats, la subtilisine pourrait être utilisée de manière 
pratique pour de futures obtentions de substrats encombrés lors de réactions catalytiques 
hétérogènes où le centre réactif rare est hydrolysé. 
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1.1.1 Chirality 
Chapter 1 
General Introduction 
Any three non-linear points define a plane. Adding a fourth point off the plane 
creates three-dimensional shape, and another feature called chirality. Consider two 
cubes with four corners labeled (Figure 1). The mirror image of this cube is different -
it cannot be rotated to align the labeled corners. The word 'chiral', from the Greek for 
hand, was first introduced by Lord Kelvin (William Thomson), Professor ofNatural 
Philosophy at the University of Glasgow from 1846-1899: "1 cali any geometrical 
figure, or group of points, chiral, and say that it has chirality, if ifs image in a plane 
mirror, ideally realized, cannot be brought to coincide with itself.") Two objects that 
are non-superimposable mirror images are termed enantiomers, and in chemistry this 
arises from the three dimensional shape of chiral molecules. Pure enantiomers have 
equal physical properties, such as boiling point and density, with the exception of the 
direction in which they rotate plane polarized light, and equal chemical properties, 
except when interacting with a chiral environment. 
1 
1 
1 
... ------ --
1 
1 
1 
-- -------8 
\ 
\ 
\ 
Figure 1: A three-dimensional object with a non-superimposable mirror image; the 
two labeled cubes are enantiomers and cannot be overlaid by rotation. 
There are several real world examples of enantiomers. The standard example 
is the relationship between left and right hands (Figure 2, A). Cars are another 
example, with respect to the placement of the steering wheel (Figure 2, B). North 
American cars place the steering wheel on the left; the British drive the enantiomers 
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with the wheel on the right. An unoccupied (achiral) road can be driven down equaIly 
as weIl by either type of car. When other cars are present, however, the interaction of 
different types becomes increasingly important. For instance, with multiple cars a 
convention as to which side to drive on becomes necessary. That is, the major 
significance of chirality results when two chiral things interact to form diastereomers. 
A) 
)U) 
C:::l 
.!21~ a.. ..0 
......... 
00 
......... 
.... ..... 
~I~ 
B) 
Figure 2: Examples of enantiomers: (A) left and right hands, and (B) North 
American (left) and British (right) cars. The objects are aIl related by the mirror plane 
and are not superimposable with each other. A left hand cannot become a right by 
rotating it, or a North American car become a British car by turning it around or 
upside down. 
1.1.2 Diastereomers 
The joining of enantiomeric elements leads to diastereomers. A handshake 
combines chiral hands, and there are four possible ways for people A and B to shake 
hands; two sets of diastereomers. In this case the RightA + RightB and the LeftA + 
LeftB fit better for a handshake, while diastereomers LeftA + RightB and RightB + 
LeftA do not fit as weIl. 
2 
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In chemical interactions, the favourable and unfavourable interactions (or the 
"fit") of the diastereomers are thought of in terms of energy. Thus the combination of 
two chiral molecules produces diastereomers of different energy, and they also have 
different physical properties. In the same way, the interaction of enantiopure 
molecules with chirality from nature leads to interactions of different energy. This 
energy difference allows enantiomers to be separated when they interact with a 
resolving agent to form diastereomers. More importantly, it is also the basis for chiral 
pharmaceuticals. Enantiomers of a potential drug bind and inhibit a chiral target by 
forming diastereomers with different energy; the one bound more tightly is usually a 
better drug. Enantiomers may also cause unwanted si de reactions - one enantiomer 
may be an effective drug, while its enantiomer is toxic. Examples of enantiomers 
along with their differing biological effects are shown in Figure 3. 
The commercial market for single enantiomer drugs is valued at over 100 
billion, representing approximately 40% ofpharmaceuticals. 2 The US Food and Drug 
Administration (FDA) and its European counter part both recognize the different 
biological properties of enantiomers and require that each enantiomer of a drug be 
individually characterized? Racemic drugs may cause problems because of the 
differences in the pharmacokinetics of enantiomers. For instance the racemic form of 
Perhexiline, a drug used to treat abnormal heart rhythms, lead to several deaths after a 
buildup of the slowly metabolized enantiomer.4 Thus methods to prepare 
enantiomerically pure compounds for the pharmaceutical industry are increasingly 
important. 
3 
(RH -)-limonine 
orange 
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( R)-penieillamine 
toxie 
Me'N 
è9q 
OMe 
levomethorphan 
pote nt nareotie 
________________________________________________________________________ Mirror 
(S)-( + )-limonine 
lemon 
( S)-penieillamine 
antiarthritie 
~Me 
Me"N 
dextromethorphan 
eough su pressant 
Plane 
Figure 3: Enantiomers have very different biological properties. The (R)-
enantiomer of limonine has an orange smell, while the (S)-enantiomer smells of 
lemons. In pharmaceuticals, one enantiomer of penicillamine is used to treat arthritis, 
while the other is toxic. The cough suppressant dextromethorphan's enantiomer is a 
. 4 potent narcohc. 
1.1.3 Controlling chirality: everyone borrows from nature 
Chemists need to be able to control the stereochemistry of compounds that 
will interact with a fundamentally chiral nature. Chirality is important because the 
basic building blocks of nature are chiral. Sugars, amino acids, and other compounds 
combine to form larger chiral molecules such as DNA or enzymes. These in turn are 
involved in the synthesis of enantiopure natural products. It is a fundamental property 
that an asymmetric transformation requires a chiral influence, which must be 
borrowed from nature. Synthetic chemistry and biotransformations both take different 
parts of nature to perform stereoselective transformations. Synthetic chemistry uses 
small molecules from nature for chiral building blocks, ligands, and auxiliaries. 
Biotransformations use larger and more complex pieces: enzymes, and even who le-
cells. 
4 
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1.2.1 Chemical methods to enantiopure compounds 
Asymmetric chemistry uses one of three methods to prepare enantiopure 
compounds. Enantiopure compounds may be taken from the chiral pool, be obtained 
by a chemical resolution, or be prepared using chiral auxiliaries and catalysts. The 
first method, the chiral pool, refers to chiral materials such as carbohydrates, amino 
acids, lipids, terpenes and alkaloids from plant and animal sources. L-Serine was 
used as the only chiral material in the synthesis of the aikaloid (-)-deoxoprosophylline 
from the Prosopis afrikana plant (Scheme 1).5 The chiral pool is limited in the type 
and amount of compounds available, and often they are only readily available in one 
enantiomer, the natural one. 
L-serine 
~o ,Me o N 1 ~NBOC OMe • HO,,_("j HO~I\,A N C12H25 H 
(-)-Deoxoprosophylline 
Scheme 1: The alkaloid ( -)-deoxoprosophylline from L-serine, a member of the chiral 
pool. 
The second method to prepare single enantiomer compounds is a resolution, 
which separates enantiomers. A common method is separation of racemates through 
diastereomeric salt formation. For example, racemic mandelic acid treated with (-)-
(IR, 2S)-ephedrine produces diastereomeric salts with over lü-foid difference in 
aqueous solubility.6 The less soluble (-)-ephridine (-)-(2R)-mandelate salt is readily 
separated by filtration. Resolution by crystallization is highly empirical and often 
requires extensive testing to obtain solvent, resolving agent, and other conditions. 
Kinetic resolutions with chemical catalysts are also use fui to obtain 
enantiopure compounds. Like an enzymatic resolution, a chiral catalyst acts on a 
racemic mixture to preferentially transform one enantiomer. Modified cinchona 
alkaloids catalyze the enantioselective ring opening of urethane-protected amino 
acids (Scheme 2).7 The chiral Lewis base promotes a selective alcoholysis of only one 
enantiomer with high enantioselectivity (E = 114) and yield (48% for product and 
remaining starting material). A variety of natural and unnatural amino acids were 
resolved using this method. 
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o (DHQD)2AQN (10 mol%) /"'000. J 1 lo El EI~ ~ MeOH (0.55 eq) Ph·"\ '0 + Ph/"·r 'OMe H 0~6Y. " 
Ph 0 E 0 oC' ZN-J NHZ 0 ~ !J 0 H 
ZN-î 12 ,-60 \\ MeO r r ~ ~ 0 
o 0 "",,1 - l''.off 
51% conversion 97% e.e. 93% e.e. N ~!J N 
E = 114 48% yield 48% yield 
(DHOD)2AON 
Scheme 2: Chemical kinetic resolution ofurethane-protected amino acids catalyzed 
by cinchona alkaloid derivatives occurs with high enantioselectivity. 
The final method chemists employ to obtain chiral compounds is asymmetric 
synthesis using chiral auxiliaries or catalysts. A chiral auxiliary is a temporary 
stereocenter incorporated into a molecule to direct the asymmetric formation of 
further stereocenters before its removal. Chiral catalysts favour formation of one 
enantiomer from achiral starting materials but are employed in a catalytic amount. 
The production of L-Dopa, used in the treatment of Parkinson's disease, uses an 
asymmetric hydrogenation with quantitative yield and 95% enantiomeric excess 
(Scheme 3).8 The 2001 Nobel Prize in chemistry was awarded in part to Knowles for 
this first industrial catalytic asymmetric synthesis.9 
MeO~COOH 
~ NHAc AcO 
1. Rh(DiPAMP) 
H2 HO~COOH 
HO~ NH2 
L-DOPA (R, R)-DiPAMP 
Scheme 3: Key asymmetric hydrogenation in the synthesis of L-DOPA by Monsanto. 
1.2.2 Sulfinic acid derivatives 
Organosulfur compounds can be classified based on the coordination around 
the sulfur atom. Sorne examples of divalent sulfur species are thiols, thiol esters and 
episulfides. These have analogous oxygen compounds - alcohols, esters and 
epoxides. Tricoordinate sul fur compounds include sulfoxides, sulfites, sulfinates, and 
sulfinamides (Figure 4), while tetracoordinate species include sulfonic acids, 
sulfones, and sulfonamides. 
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0 0 0 0 
Il Il Il 
" R(S'R2 R1 0"" S'OR2 R(S'OR2 R(S'NHR2 
Sulfoxide Sulfite Sulfinate Sulfinamide 
Figure 4: Examples oftricoordinate sulfur compounds, which contain a stereocenter 
at the sulfur atom. 
Sulfoxides contain a stereogenic center and can be used as chiral auxiliaries. 
The pyramidal configuration at the sulfur atom (tetrahedral if the lone pair is 
inc1uded) has a high thermal stability of approximately 200 °C,1O allowing sulfoxides 
to be used as both chiral reagents and substrates. Several pharmaceuticals and natural 
products contain a stereogenic sulfinyl sufur atom. Omeprazole, marked by Astra 
Zeneca, is gastric proton pump inhibitor used as an antiulcer agent and now marketed 
as a single enantiomer, while the immunosupressor oxisurane also contains a chiral 
sulfoxide (Figure 5).11 
( S)-omeprazole ( S)-oxisurane 
Figure 5: Pharmaceuticals that contain chiral sulfinyl functionality; omeprazole is an 
antiulcer agent and oxisurane is an immunosupressor. 
1.2.3 Racemic synthesis of sulfinyl compounds 
Sulfinates and sulfinamides are readily prepared from sulfinic acids, thiols, 
disulfides, or sulfinyl phthalamides.12 Sulfinic acids are [Ifst converted to the 
corresponding halide using oxalyl chloride or thionyl chloride, and then condensed 
with the appropriate amine or alcohol. As only a few sulfinic acids are commercially 
available, sulfinyl chlorides can also be prepared from thiols or disulfides using 
chlorine or sulfuryl chloride, and acetic acid. 13 Sulfinyl chlorides are less stable than 
the corresponding sulfonyl chlorides and disproportionate into sulfonyl and sulfenyl 
chlorides. 14 
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To avoid the instability of sulfinyl chlorides, Harpp and coworkers developed 
sulfinyl phthalimides as stable sulfinyl transfer agents. 15 Preparation from thiols or 
disulfides first involves formation of a thiophthalimide, in itself an efficient sulfenyl 
transfer agent. 16 Thiophthalimides are then oxidized to the sulfinyl-phthalimide using 
m-chloroperbenzoic acid (m-CPBA) in excellent yield (80-100%). Displacement with 
amines or alcohols provides sulfinamides or sulfinates in 77-95% yield, and the 
insoluble phthalimide by-product is easily filtered. Both N-(aryl- and 
alkylsulfinyl)phthalimides are accessible using this method and serve as a stable 
equivalent to the sulfinyl chlorides. 
0 (COCI)2 0 Amine or Il 
" 
alcohol 0 
R ... S .... OH .. R ..... S .... CI " x= NHR' .. R ..... S'X (or SOCI2) =OR' 
CH3COOH 
soy l Amineor 
alcohol 
0 0 
RSH 1. S02CI2 m-CPBA q, ~ RSSR .. S-N~ 2. Phthalimide, .. S-N 1 ~ CHCI3 R ~ base R 
0 0 
thiophthalimide sulfinyl-phthalimide 
Scheme 4: Preparation of sulfinates and sulfinamides from sulfinic acids, thiols and 
disulfides via sulfinylchlorides or sulfinylphthalimides 
1.2.4 Asymmetric synthesis of sulfinyl compounds 
There are several strategies to prepare chiral compounds containing the 
sulfinyl functionality. The [Ifst method involves resolution of diasteromers formed by 
attaching a chiral auxiliary to give a sulfinate. The second also involves a chiral 
auxillary, but attached to give a sulfite or aminosulfite derivative (attached in two 
positions to the sulfur atom). The final method is asymmetric oxidation to give a 
chiral sulfur species. Emphasis is given to cases in which a heteroatom is attached to 
the sulfinyl center; these are possible targets for hydrolase chemistry. 
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Diastereomeric sulfinic esters are prepared by the reaction of a sulfinyl 
chloride with a chiral auxillary. The Anderson method is the most common, and is 
based on formation of (S)-menthylsulfinate diastereomers with menthol and pyridine, 
and separation by crystallization in acetone (Scheme 5). The resulting 
diastereomerically pure sulfinates react with Grignard reagents with inversion of 
configuration to give sulfoxides.17 The method was improved when crystallization in 
HCI/acetone catalyzed epimerization ofthe more soluble diastereomer to the 
crystalline diastereomer, with yields up to 90%.18 This method is limited to para-
substituted aryl sulfinates, as other aryl and alkyl sulfinates are liquids and difficult to 
separate. Similar strategies make use of compounds other than menthol as the 
resolving agent. The alcohol trans-2-phenylcyclohexanol provides access to sorne 
aliphatic sulfinates, 19 while the diacetone-D-glucose (DAG) methodology uses a 
protected sugar as the auxiliary.2o In aIl cases the resolved sulfinyl diastereomoers 
can be treated with a Grignard reagent to prepare enantiopure sulfoxides with 
inversion at the sulfur center. 
+ Pyridine 
• 
o 
:.," ... $ ..... 
,r Tol~ OMenthyl 
(-)-( S)-D-menthyl p -toluenesulfinate 
1 
crystallization in 
acetone/HGI 
o 
• IJ 
• """'S 
Menthyld ',r Toi 
(+)-(S)-D-menthyl p -toluenesulfinate 
Scheme 5: Synthesis of the Anderson reagent, (S)-menthyl-p-toluenesulfinate, by 
diastereomer formation with menthol and crystallization in acetone/HCl 
The Evans chiral sulfinyl transfer reagents make use of chiral oxazolidinones 
derived from ephedrine or phenylalanine?1 Preparation of N-sulfinyloxazolidinones 
involved either reaction of oxazolidinones with n-butyllithium, followed by a sulfinyl 
chloride, or altematively oxidation of N-sulfenamides. Both cases gave low 
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diastereomeric ratios (16-54%), but the resulting diastereomers were readily separated 
by chromatography. Treatment of the purified N-sulfinyloxazolidinones with 
Grignards provided sulfoxides in excellent yields (78-92%) and inversion with high 
enantiopurity (90-99%). 
a 
HNJl.a 
'----1 
Bn"" 
1. n-BuLi a a 
THF, -78°C Il Il a a Il Il 
• Ar"'··S't,('p + 
2. ArSaCI L-J 
Bn"· 
~S'NAa 
Ar '----1 
Bn'·· 
major (54% de) minor 
j MeMgBr 87% Yield 
a 
1\ 
Ar~S" 
Ar = Ph, ee = 90% 
Scheme 6: Evans' N-sulfinyloxazolidinone methodology for chiral sulfinyl transfer. 
Another strategy for chiral sulfinyl transfer uses sulfites or aminosulfites. 
Here the auxiliary is attached to the chiral sulfur in two positions, and can be 
displaced by two successive nucleophilic attacks to give sulfinamides and sulfoxides. 
The aminosulfite methodology reported recently by Senanayake22 improves upon 
previous reagents reported by Wudl and Lee (an aminosulfitei3 and Kagan (a sulfite, 
Figure 6).24 Wudl and Lee's reagent is limited because oflow reactivity and cannot 
prepare tert-butyl or diaryl sulfoxides. Kagan's reagent can accept many substrates, 
but has poor chemoselectivity in ring opening, and therefore low stereoselectivity. 
Senanayake's reagent overcomes the limitations of the previous reagents as it accepts 
a wide variety ofnucleophiles and has high selectivity. Thus, Senanayake's method 
can be used to make a wide range of sulfinamides, and possibly sulfoxides in the 
future. 
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Figure 6: Sulfite and aminosulfite derived chiral sulfinyl transfer reagents. 
To prepare Senanayake's reagent, thionyl chloride is reacted with the N-
sulfonyl-derived (IR, 2S)-aminoindanol to give primarily the endo product (97% d.e.) 
in 80% yield after crystallization (Scheme 7). The reagent can be prepared on the 
kilogram scale. The activating sulfonyl group on the nitrogen allows chemoselective 
attack to break the S-N bond before the S-O bond, with inversion of configuration, 
giving the sulfinate ester intermediate. A second attack allows production of various 
sulfinamides, including tert-buyl sulfinamide, in high enantiomeric excess. 
1. SOCI2 , 
3,5-lutidinefTHF 
-45 Oc 
• 
2. Crystallization 
(80%) 
~ LiNH2/NH3 
H2N,S'R2 • 
exo 
Scheme 7: Preparation ofSeyanayake's aminosulfite reagent. The N-sulfonyl group 
activates the nitrogen so that the S-N bond is cleaved chemoselectively by the 
Grignard reagent. 
The final method to prepare chiral sulfinyl compounds is by oxidation, and 
there are a plethora of methods for the asymmetric oxidation of sulfur. Most recently, 
Ellman developed the asymmetric oxidation of tert-butyl disulfide to prepare tert-
butyl sulfinamide.25 Using hydrogen peroxide, VO(acac)2, and a chiral ligand gave 
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(R)-tert-butanethiolsulfinate in 92% yield and 91 % ee on a 1 mole sc ale (Scheme 8). 
Reaction with Grignards and lithium amides provide enantiomerically pure sulfoxides 
and sulfinamides. The reaction is limited to the tert-butyl disulfide; smaller groups 
give racemization at the thiosulfinate stage. 
92% yield, 
91%ee 
55-98% yield 
Scheme 8: Enantioselective oxidation of tert-butyl disulfide for the preparation of 
sulfinamides and sulfoxides. 
The variety of methods to produce optically active sulfinyl compounds 
indicates their value. Enantiomerically pure sulfinamides are widely used as 
auxiliaries providing a chiral ammonia equivalent. Condensation of a sulfinamide 
with an aldehyde provides an N-sulfinyl imine, (or sulfinimine). The electron 
withdrawing N-sulfinyl group activates the C=N bond for nucleophilic addition and 
controls the stereochemistry ofthe newly formed stereocenter.26 Addition of 
Grignard reagents proceeds via a Zimmerman-Traxler transition state with the large 
RI (usually p-tolyl or tert-butyl) and R2 groups in the less hindered equatorial 
position, and the Mg coordinated to the oxygen of the sulfinyl group (Scheme 9).27 
Enantiopure amines such as a- and J3-amino acids28 and J3-hydroxy a-amino acids29 
were synthesized using this method. 
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. 0 
./', , 
R(:S'NH2 
sulfinamdie sulfinimine N-Alkyl sulfinamide amine 
L[R, .. l-N4RJt~ 
1 O-Mg· R3 J 
Zimmerman-Traxler ts 
Scheme 9: Nucleophilic Grignard addition to sulfmimines proceeds via a 
Zimmerman-Traxler transition state in the synthesis of enantiopure amine derivatives. 
Chapters four and five will focus on new ways to make chiral sulfinyl compounds 
using enzymatic hydrolysis of N-acyl sulfinamides. 
1.3.1 Biocatalysts 
Enzymes are also efficient catalysts for organic transformations. Enzymes are 
widely applied in food and pharmaceutical industries, and their use is expected to 
increase.30 Sorne of the advantages of enzyme-catalyzed reactions include their 
enantioselectivity, regioselectivity, large rate accelerations, environmentally 
friendliness, and mild reaction conditions. There are also enzymatic equivalents to 
many types of organic transformations such as oxidationlreduction, 
additionlelimination, hydrolysis, aldol reactions, and others.31 
An example of an enantioselective reduction is found in the synthesis of 
cholesterollowering statins, which inhibit the enzyme 3-hydroyl-3-methylglutaryl 
reductase and prevent the biosynthesis of cholesterol. AIl statins contain a common 
3,5-dihydroxy acid side chain, and enzymes have been extensively used in the 
stereoselective synthesis ofthis group. The reduction ofketone by the yeast Pichia 
angusta and regioselective acylation of the primary hydroxyl group provided the 
dihydroxy statin si de chain in high yield and diastereomeric purity (Scheme 10).32 
I3 
OH 0 0 
HO~OR 
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1. Pichia 
angusta OH OH 0 
----------. ACO~OR 
2. Chirazyme L2 
Vinyl aceatate 80%yield, 
>99 % d.e. 
F 
Scheme 10: The cholesterol-Iowering statins contain a common 3,5-
dihydroxy side chain, as found in Rosuvastatin. One synthetic method involves 
bioreduction of the ketone followed by regioselective acylation to produce a key 
intermediate. 
Carbon-carbon bond forming reactions are valuable in organic synthesis. 
Aldolases catalyze the formation of a C-C bond between an aldehyde and a ketone 
with stereochemical control. The dihydroxyacetone phospate (DHAP) aldolases 
catalyze a condensation between dihydroxyacetone phosphate and an aldehyde to 
create two stereocenters (Scheme Il ).33 The enantiomeric and diastereomeric 
products are also available by switching to one of the four complementary aldolases. 
0 OH 0 OH 
PO~ ~Po~o~ PO~R . R OH OH (38,4R) (3R,4S) 
+ 
0 OH / 0 ~A 0 OH PO~ H)lR PO~R . R 
OH OH 
(3S,4S) (3R,4R) 
Scheme 11: Carbon-carbon bond formation with four complementary DHAP-
dependant aldolases provides aIl of the four possible stereoisomers. P = P032-. 
Regioselectivity is another valuable feature of enzyme catalysis. An enzyme 
can selectively modify one of several functional groups within a molecule. 
Thermolysin reacts with only one of the carboxyl groups in aspartic acid when 
coupled with the methyl ester of phenylalanine to produce a precursor to aspartame, a 
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low-calorie sweetener (Scheme 12)?4 This avoids a protection step and the formation 
of the unwanted j3-isomer. 
CBZ ... HN'(COOH 
COOH 
+ f?~ o .....:;. Thermolysin J. 
.. CBZ .... 
HN) ~ COOMe 
HOOC 
Scheme 12: Regioselective amide bond formation by thermolysin to produce CBz-
protected aspartame. 
A limitation of resolutions is a maximum 50% yield. The recently developed 
dynamic kinetic resolutions (DRK) avoid this problem by racemization of the starting 
material, followed by an enantioselective enzymatic reaction. There are several 
requirements for an efficient dynamic resolution. The rate of racemization should be 
faster than the acylation step, that is, krac should be larger than kR or ks (especially the 
rate ofthe slow enantiomer, Figure 6). An enantioselective enzyme is necessary, and 
both the racemization catalyst and conditions must be compatible with the enzyme. 
kR 
R • P (major product) 
fast 
krac 
ks 
S .. Q 
slow 
Figure 6: R-selective dynamic kinetic resolution allows a theoretical yield of 100%. 
Rand S represent the two enantiomers of starting material; P and Q represent the two 
possible enantiomers of product. kR and ks are rate constants for each enantiomer in 
the enzymatic reaction, and krac is the racemization. The starting material is constantly 
racemized so the slow enantiomer, S, is eventually converted to P. 
Secondary alcohols have been successfully resolved using dynamic kinetic 
resolutions. A transition metal catalyst, such as the ruthenium complex in scheme 13, 
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is used to chemically oxidize and reduce the alcoholleading to racemization. 
Backvall and coworkers developed and efficient system using Candida antartica 
lipase B (Cal B) to give the resolved ester in good yield and excellent enantiopurity, 
scheme 13.35 To access the opposite enantiomer, an enantiocomplementary enzyme 
(see section 1.3.2 below) was used for the dynamic kinetic resolution. Subtilisin has 
the opposite stereopreference towards secondary alcohols, and thus gave an S-
selective resolution.36 
OH 
R~ 
R = aryl or alkyl 
Cal B 
p-chlorophenyl acetate 
Ru catalyst, 2 mol% 
tolene 
o 0 P~V~h 
R~ Ph p~h/:Ii/ Ph Ph 
78-92 % yield , Ru Ru. , 
>99% ee OC êo êoCO 
OAc 
Scheme 13: Dynamic kinetic resolution of secondary alcohols. The ruthenium 
complex constantly racemizes the starting alcohol, followed by an enantioselective 
acylation of the enzyme. This allows for yields greater than 50%. 
1.3.2 Enantiocomplementary enzymes 
An objection to the use of enzymes is that they are available in only one 
enatiomeric form, being made from L-amino acids. In asymmetric synthesis switching 
to the ligand or starting material with the opposite configuration yields the opposite 
enantiomer. The equivalent enzyme, prepared from D-amino acids, is not a practical 
solution, although sorne have been made by chemical synthesis. For example, the 99 
D-amino acid HIV -1 protease was prepared by peptide coupling, and displayed the 
opposite enantiopreference?7 Related examples include a 62 amino acid 
oxalocrotonate tautomerase from D-amino acids/8 and of a 49-mer ribozyme 
prepared from unnatural L-nucleotides that catalyzes a Diels-Alder cycloaddition 
reaction with opposite specificity from the natural D-nucleotide ribozyme.39 Although 
proven in principle, enantiomeric enzymes can only be prepared on a very small scale 
with great expense. Practical biocatalytic routes to enantiomeric products employ 
enantiocomplementary enzymes. 
Enantiocomplementary enzymes are pairs of enzymes from natural L-amino 
acids that catalyze mirror image (enantiomeric) biotransformations. The starting 
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materials are enantiomers or achiral, but the products of the transformations are 
enantiomers. The catalyst acts in a mirror image fashion, and the mechanism and type 
of transformation is the same. In princip le there are two types of 
enantiocomplementary enzymes based on the structural basis by which they produce 
opposite enantiomers (Table 1). The first involves a mirror image arrangement of the 
catalytic machinery to provide the opposite stereopreference. The second involves a 
reversaI of the substrate orientation relative to the catalytic machinery to reverse the 
enantioselectivity. For many practical synthetic examples of enantiocomplemtary 
enzymes there is no structural information available to determine the basis of 
reversai, but they likely function by one of the two methods. Knowledge of the crystal 
structure, binding sites and mechanism is necessary before the molecular basis of 
enantiocomplementary enzymes can be established. For sorne whole-cell catalysis, 
the active enzyme is not even determined. 
Table 1 Possible ways to create enantiocomplementary enzymes: moving the 
catalytic groups vs. moving the substrate binding pockets 
Cate 0 
Enantiomeric enzymes 
from D- vs. L- amino 
acids 
Type 1: 
Mirror image 
enantiocomplementary 
enzymes 
Type 2: 
Substrate reversaI 
enantiocomplementary 
enzymes 
Schematic Features 
Exact mirror 
image by D-
amino acids 
synthesis; 
impracticai 
Altered 
orientation of 
the catalytic 
machinery 
Altered 
orientation of 
the substrate-
binding pockets 
Exam les 
HIV protease, 
oxalocrotonate 
tautomerase, Diels-
AIder ribozyme 
Lipase/protease, 
methionine 
sulfoxide reductase 
Tropinone 
reductase 
phosphotriesterase 
mutants 
There are several examples of enantiocomplementary enzymes with mirror 
image catalytic machinery held in position by a different overall fold. Chemical 
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oxidation ofmethionine yields both epimers ofmethionine sulfoxide. To rectify this 
requires either a non-specific enzyme or two enzymes with opposite stereospecificity. 
In Escherichia coli, separate enantiocomplementary enzymes reduce the enantiomeric 
sulfoxide configurations in methionine sulfoxide epimers.40 In Neisseria 
gonorrhoeae, one protein containing mirror-image active sites in separate domains 
reduces these enantiomeric sulfoxide configurations, as shown by x-ray 
crystallography.41 
Another example of enantiocomplementary enzymes resulting from mirror 
image active sites is the opposite enantiopreference of lipases and proteases. Lipases 
and subtilisin, both serine hydrolases, contain a catalytic triad, an oxyanion hole, and 
followan acyl enzyme mechanism (see section 1.4.2). However, the three-
dimensional arrangement of the catalytic triad in subtilisin is the mirror image of that 
in lipases, even though the overall fold is not related.42 Folding the protein to 
assemble the catalytic machinery creates a pocket with restricted size, the 'M'or 
stereoselectivity pocket for lipases and the SI' pocket for subtilisin. The mirror image 
relationship places the catalytic histidine on opposite sides of this pocket in lipases 
and subtilisin (Figure 7).43 This difference likely accounts for the opposite 
enantiopreference. The dynamic kinetic resolution of secondary alcohols using 
Candida antartica lipase provided the R-alcohol, while subtilisin gave the S-alcohol 
(Section 1.3.1, above). The empirical secondary alcohol rules, developed from 
substrate preference, are also related to these differences in structure (section 1.4.6, 
below). There are several other examples of mirror image active sites. The active site 
ofD-amino acid oxidase is a mirror image ofthat in flavocytochrome-b2•44 Two 
mirror image hydratases catalyze addition of water from opposite sides of a double 
bond.45 Although not important to substrate chirality, mirror image active sites exist 
in disulfide reductases46 and carbonic anhydrase.47 
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,.\-H ~: 221Ser 
His64, V. 
~ O·=XO NW.:::;:::::-N- -H::, ~ "'" 
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CRL Subtilisin 
(R)-selective (S)-selective 
Figure 7: Lipases and subtilisin have mirror image catalytic machinery resulting in 
opposite enantiopreference towards secondary alcohols. (A) Candida rugosa lipase 
(PDB code lcrl), shown with catalytic residues Ser 209 and His 449, and two regions 
of the alcohol binding site: the large substituent binds in the large hydrophobie pocket 
(in yellow), while the small substituent binds in the medium pocket (in green). (B) 
Subtilisin (PDB code Isbn) has a mirror image arrangement; the catalytic residues Ser 
221 and His 64 are shown, along with the oxyanion stabilizing Asn 155. The SI' 
medium binding site (in green) positions the medium substituent, while the large 
substituent is oriented towards solvent. (C) Schematic oftetrahedral intermediates for 
the favoured secondary alcohols for lipase and subtilisin. 
In addition to mirrored active sites, enantiocomplementary enzymes may 
reorient the substrate to favour opposite enantiomers through a switch in binding 
pocket preference. A reverse binding can occur when two enantiocomplementary 
enzymes have both a high sequence homology and a conserved location of catalytic 
residues. Enzymes are unlikely to have major structural changes with very similar 
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sequences, and conserved catalytic residues eliminate mirror image machinery, so it 
is likely the preference for placement of substrate has reversed. 
There are several examples of complementary reductions. Two tropinone 
reductases, TR-I and TR-Il, from the plant species Datura stramonium give opposite 
configurations of the product hydroxyl group (Scheme 14).48 The two enzymes are 
260-274 amino acids in length and are 64% identical. In addition, crystal structures 
revealed the hydride donor (NADPH) binding site and catalytic residues are 
conserved. The configuration of the product is therefore dependant on the binding 
orientation of the tropinone to the enzyme. The two enzymes' substrate binding sites 
differ in a smaU number of charged amino acids, resulting in a reversed orientation 
for the tropinone and reduction from the opposite face. This was confirmed when 
only five amino acid substitutions in the binding site of either TR-I or TR-II switched 
the stereospecificity to the opposite enzyme. 49 
H3C'N H3C'N 
~ TR-I A\ TR-II • 
OH 0 
tropine tropinone "-V-tropine 
Scheme 14: Reduction oftropinone by two similar reductases, TR-I and TR-II, to 
give opposite hydroxyl configurations occurs by binding of the tropinone in a 
reversed orientation. Five mutations of either TR-I or TR-Il inverted their 
stereoselectivity to that of the opposite enzyme. 
As in the tropinone example, mutagenesis resulting in reversed 
enantioselectivity often involves modifying binding sites to reposition the substrate; 
the catalytic residues are seldom moved. Mutagenesis of the phosphotriesterase from 
Pseudomonas diminuta produced two enzymes that clearly demonstrate switching 
substrate orientation to reverse enantioselectivity. The phosphotriesterase has three 
binding sites with which it binds phosphotriesters, referred to as smaU, large, and 
leaving group subsites based on which part ofthe substrate occupies the site.50 The 
enantioselectivity was altered, and then reversed, by making changes to the size of the 
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small and large subsites. The wild type enzyme hydrolyzed the substrate ethyl phenyl 
p-nitrophenyl phosphate with an enantioselectivity of21 favouring the S-enantiomer. 
Mutation of the small subsite to reduce its size increased the enantioselectivity, E, 
from 21 to >1000, probably making it impossible for the large substituent of the slow 
enantiomer to bind. Enlargement of the small subsite decreased E from 21 to 1.3 
because now the large substituent can bind in either site. Simultaneously enlarging 
the small subsite while the large subsite was reduced in size gave a mutant that 
favoured the opposite R -enantiomer by a factor of 80. Thus binding the substrate in a 
reversed manner reverses the enantioselectivity. 
Other examples in this category inc1ude 8R- and 8S-lipoxygenases who se 
conserved active site and other essential residues suggest a substrate reversalleading 
to opposite selectivity, and not a mirror image active site.51 Likewise, two 
cyc100xygenase enzymes with 80% identity and conserved catalytic residues produce 
15R and 15S prostaglandins, due to a substrate reversaI. 52 Subtilisin and cholesterol 
esterase are enantiocomplementary enzymes in the resolution of a chiral auxiliary for 
the Diels-AIder reaction, discussed in chapter two ofthis thesis. 
1.3.3 Catalytic promiscuity: multiple enzyme functions 
Another frontier ofbiocatalysts is catalytic promiscuity, the ability of sorne 
enzyme active sites to catalyze two chemically distinct transformations.53 Catalytic 
promiscuity is important in enzyme evolution and developing new reactions for 
organic synthesis. The type of bond broken, or the reaction mechanism, or both, may 
change in the promiscuous function. Gene duplication followed by modification is 
thought to be responsible for the evolution ofnew activities.54 Adaptation ofnew 
functions is also important in understanding pesticide and drug resistance. 
Atrazine, a herbicide used since the 1950's, initially was not metabolized by 
microorganisms in the soiI. Recently, several groups discovered bacteria with the 
ability to degrade atrazine using a modified form of the enzyme melamine hydrolase. 
Melamine hydrolase shows low activity towards atrazine, but 9 ami no acid mutations 
produces a new enzyme, atrazine chlorohydrolase, which c1eaves the C-CI and not the 
original C-N bond (Figure 8).55 Interestingly, several groups independently 
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discovered the same chlorohydrolase in different types bacteria isolated from four 
continents, suggesting an evolutionary relationship between the two activities.56 
Melamine 
CI 
N~;= ,/'N~N~ 
H H 
Atrazine 
Figure 8: Mutation of nine amino acids in melamine hydrolase creates a new enzyme 
capable of C-CI bond cleavage to degrade the herbicide, atrazine. 
The hydrolysis of sulfite esters by the protease pepsin highlights a single 
active site that can hydrolyze two mechanistically different reactions. Pepsin is an 
aspartate protease active at low pH in the stomach. It also catalyzes the hydrolysis of 
sulfite esters rapidly, and with sorne stereoselectivity (Figure 9).57 The sulfur reaction 
center is trigional, unlike the natural Sp2 carbonyl of the amide bond. Therefore the 
reaction must proceed through transition state with a different shape. A catalytic 
promiscuous reaction of subtilisin is discussed in chapters four and five. 
peptides sulfite 
Figure 9: The protease pepsin hydrolyzes both amide and sulfite bonds. 
1.3.4 Enzymes accelerate reactions by stabilizing the transition state 
Enzymes are efficient catalysts that accelerate a reaction, sometimes by a 
factor as high as 1019.58 Many uncatalyzed reactions would occur on a time scale too 
long for biological processes. For example, peptide hydrolysis in water has a half-life 
of 450 years, highlighting the need for catalysis.59 As seen in Figure 10, enzymes 
decrease the activation energy the reaction compared to the uncatalyzed process. 
Pauling proposed that the lowering of the activation energy results from a preferential 
binding ofthe transition state over the substrate.60 Two kinds of enzyme-substrate 
interactions lead to a stronger binding of the transition state: electrostatic forces, such 
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as hydrogen bonding and dipole interactions, and van der Waals interactions. In 
addition to these effects, others have proposed entropic factors make a large 
contribution. Pre-organization to bring reacting groups together may assist catalysis. 
Bruice has proposed Near Attack Conformers (NAC), which are ground state 
conformers that closely resemble the transition state.61 These involve arranging the 
reacting groups so that distances and angles are similar to those in the transition state. 
Menger has proposed that holding the substrate in a reactive conformation contributes 
to the catalytic efficiency of enzymes.62 
E+S 
Transition 
Siaie 
Reaction Coordinate 
EP 
Figure 10: Energy diagram an enzyme catalyzed reaction. The energy of the enzyme 
catalyzed reaction, ~Gcat, is less than the uncatlyzed reaction, ~Gnon, while the overall 
energy of the transformation is unchanged, ~Grxn. 
1.3.5 Enzyme kinetics 
The kinetic behaviour for many enzymes, including the serine proteases, is 
described by Michaelis-Menten kinetics and refined further by Briggs and Haldane.63 
The enzyme (E) and substrate (S) combine in a rapid, reversible equilibriurn with no 
chemical changes taking place to form an enzyme-substrate (Michaelis) cornplex, ES, 
with rate constants ofkl and k.1• This complex can then react to give free enzyme and 
product (P) with rate constant kcat. 
kt 
E+S ES E+P 
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The reverse reaction, E + P, can be ignored because when measuring initial rates the 
concentration ofproduct is low.lt is also assumed that the concentration ofsubstrate 
is both constant (as in the initial stages of the reaction) and much greater than that of 
enzyme. The initial rate (v) of formation ofproduct with time is given by: 
1.1 
Initial rates are measured so that changes in substrate concentration are negligible. 
During the initial portion of the reaction, the reaction velocity is constant and the rate 
of formation of the ES complex is equal to its rate of destruction. The steady state 
assumption gives: 
1.2 
Rearranging this equation to group the rate constants provides: 
1.3 
The three rate constants can be redefined as one constant, KM' termed the Michaelis 
constant. 
K _ kcat + k_1 M- k] 1.4 
The enzyme may be either free enzyme [E] or in a bound form [ES], such that the 
total amount of enzyme [ET] less that which is bound to substrate gives the amount of 
free enzyme, 
[E] = [ET] - [ES]. 
Substituting equation 1.5 into 1.3 gives 
[ES] = [ET][S] 
[S]+KM 
Substitution of this expression for [ES] into 1.1 gives: 
v = --,k c=at (=--E...!...CT ]::..::..[ S-=-] 
KM + CS] 
1.5 
1.6 
1.7 
The maximum rate (vrnax) is achieved when the enzyme is saturated with substrate, 
such that aIl enzyme is in the ES form. This occurs at concentrations of CS] » KM, 
allowing cancellation in 1.7 to give, 
1.8 
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Substituting 1.8 into 1.7 gives the Michaelis-Menten equation, 
vmaJS] 
v = ---"==-- 1.9 KM + [S] 
Graphically a plot of v vs. [S] is a hyperbola, with an asymptote corresponding to 
vmax, representing the velocity at high substrate concentrations (Figure Il). The value 
KM corresponds to the concentration of substrate at which the velocity is half the 
maximum velocity. 
100 v max 
75 
> 
& 
~ 50 ~ _____ v max 
·ë 2 
25 
o+-~~---.---------.--------.--------,--------. 
10 20 30 40 50 
5ubstrate Concentration, [5J 
Figure 11: Plot of v vs. [S] illustrating Vmax and KM values. 
A competitive, reversible inhibitor (1) binds to the enzyme active site and prevents 
substrate binding. The affinity for the inhibitor (1) is defined by KI, the dissociation 
constant of the enzyme-inhibitor complex. 
k 1 
E+S 
El 
ES E+P 
Competitive inhibition does not affect the kcat value (at high substrate concentrations, 
an inhibitor will be displaced), but gives an apparent increase in the Michaelis 
constant, KM. The apparent KM value is increased by a factor of (1+[I]/K1).64 
v = v ma,JS] 1.10 
(1 + ;JKM + [S] 
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1.3.6 Kinetic resolution and enantioselectivity, E 5 
In a kinetic resolution, two enantiomeric substrates, A and B, compete for an 
enzyme's active site. 
(KM)A (kca0A 
E+A .. EA .. E+P 
(KM)B (kcat)B 
E+B .. EB .. E+Q 
The initial rate for each enantiomer is given by: 
VA = (kcat)A[EA] and vB = (kcat)B[EB]. 1.11 
When kcat is slow relative to the binding equilibrium, then the Michaelis constant, 
KM, simplifies to a true binding constant for each enantiomer is: 
(K ) = [E][A] and (K ) = [E][B] . 
M A [EA] M B [EB] 1.12 
Substituting 1.12 into rate equations 1.11 gives 
VA =(kcat ) [E][A] and vB =(kcat ) [E][B] 1.13 
KM A KM B 
The enantiomeric ratio, E (or, enantioselectivity), is defined the ratio between the 
rates of each enantiomer, 
1.14 
Integration of 1.14 gives the E value as a function of kcat and KM for each enantiomer, 
E = In([~A]J = (k;{Mt 
In([B]/ ) (kcat /) ' 
/[B]o /KM B 
1.15 
where [AJo and [BJo are initial concentrations for each enantiomer. The enantiomeric 
ratio measures the performance of an enzyme to produce enantiomerically pure 
compounds, making it important to quantitate for an enzyme catalyzed resolution. 
The enantioselectivity, E, is dimentionless and is dependant only on the ratio of 
constants and remains constant throughout an enzymatic resolution. Measuring initial 
rates and determining the necessary kinetic parameters for each pure enantiomer is 
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tedious. An alternate method employs the conversion of the reaction along with either 
the enantiopurity of the substrate or product; 
E = In[(I-c)(I-ees)]or E = In[l-c(l+ eep )) 1.16 
In[(1- c)(1 + ees )] In[l- c(l- eep )] 
where c is the conversion, ee = enantiomeric excess of substrate (ees) or product 
(eep). The conversion and enantiopurity are obtained by: 
A+B A-B 
c =1- ,ee=--. 
Ao +Bo A+B 
1.17 
Enantioselectivity values determined using conversion are generally less accurate due 
to experiential errors. Alternatively, the enantioselectivity is determined from the 
enantiomeric excess of substrate and product via: 
1.18 
Plots for three different enantioselectivities are shown in Figure 12, and illustrate the 
change in both ees and eep as a function of conversion. In the first plot, a low 
enantioselectivity of 5 demonstrates that the product cannot be obtained in high 
enantiopurity, while remaining starting material can be obtained in high enantiopurity 
only at conversions >80% (therefore with low yield). For synthetic purposes, an 
enantioselectivity of greater than 20 is considered useful, shown in the second plot. A 
reaction with E = 20 at 50% conversion gives an enantiomeric excess of 79% for the 
substrate (ees) and product (eep). Stopping the reaction at the midpoint maximizes 
the yield of the starting material and product. The final graph shows a high 
enantioselectivity (E=200), and at 50% conversion ees = eep = 97%. An 
enantioselectivy above 200 is difficult to measure accurately because of experimental 
errors. 
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Plot for SelectiVlIy E = 20 Plo!: for Setecüvîty E '" 200 
Figure 12: Enantiomeric excess of starting material (ees) and product (eep) as a 
function of conversion for enantioselectivity 5, 20, and 200. Produced using the 
computer program Selectivity.66 
1.3.7 Thermodynamic description of selectivity 
The success of a resolution depends on the energy difference at the transition 
state in the rate determining step( s). The enantioselectivity, a ratio of rates, is related 
to the energy difference, MG!, by: 
LiLiG! = LidR - LiG!s = -RTInE. 1.19 
The energy difference arises from the interaction of two enantiomers with a chiral 
environment, the enzyme. The resulting diastereomers, the enzyme-substrate 
complexes, have different energies (Figure 13). Surprisingly, the energy difference to 
obtain a high selectivity is not extremely large. For enantioselectivities of20 and 200, 
the energy difference in transition states is 1.7 and 3.1 kcal morl . For comparison a 
hydrogen bond contributes ~ 1 to 5 kcal mor l , while a peptide bond has a bond 
strength of ~96 kcal mor1.67 The relatively small energy difference is one reason why 
molecular modeling to quantitate enantioselectivity remains elusive. 
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E + P-- (ES] -=== E -=== [ERI _ E + Q 
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Figure 13: Enzyme (E) catalyzed enantioselective reaction has a difference in 
energy at the transition state (t) for the substrate enantiomers (R and S) reacting to 
product enantiomers (P and Q).31 
1.3.8 Molecular modeling to rationalize enantioselectivity 
Combining three dimensional protein structures and computer modeling 
allows an enhanced understanding of enzymatic reactions by predicting and 
explaining experimental results.68 Molecular mechanics (MM) uses empirically 
derived parameters to describe bon ding, where atoms are treated as balls and bonds 
are treated as springs. A force field is used to calculate the energy and geometry of a 
molecule. It is a collection of atom types, parameters such as bond lengths, bond 
angles, etc., and equations to calculate the energy of a molecule using these 
parameters. Amber is one common force field in MM calculations for large proteins 
and nucleotides. 
Modeling has several applications, such as docking or explaining 
experimental results. Docking plays an important role in drug discovery programs to 
identify potential drugs by predicting the conformation and orientation of a small 
molecule in a binding site. Inhibition of tyrosine kinase activity is important in the 
treatment ofleukemia. Peng and coworkers identified 15 inhibitors from a library of 
200000 by virtual screening, several ofwhich had ICso values of 10-200 J!M.69 
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Molecular modeling can also explain the behavior of an enzyme or suggest 
modifications to the substrate or enzyme for an improved reaction. For example HuIt 
and coworkers used molecular modeling to rationally design lipase mutants with 
improved enantioselectivity.70 Candida antarctica lipase B (CALB) has high 
enantioselectivity towards secondary alcohols (E = 200), but shows low 
enantioselectivity toward isosteric halohydrins such as I-bromo-2-octanol (E = 6.5) 
and l-chloro-2-octanol ((E = 14, Figure 14). Molecular modeling revealed an 
unfavourable interaction between the halogen of the fast reacting enantiomer and the 
medium size stereoselectivity pocket. Virtual mutation ofthree residues which define 
this pocket predicted amino acid substitutions with improved interactions. Based on 
this molecular modeling single point mutations were prepared and evaluated in 
kinetic resolutions. Replacing the electronegative serine in a Ser47Ala mutation 
doubled the enantioselectivity for both l-chloro and l-bromo-2-octano1. Another 
mutation, Tyrl04His, increased the size of the medium pocket so that it could now 
accommodate both the large and medium size substituents, and the enantioselectivity 
decreased as expected (E <2). Thus molecular modeling predicted steric and 
electrostatic interactions explaining enantioselectivity and predicting mutants for 
rational protein engineering. 
OH 
~x 
4 
vinyl butyrate 
n-hexane 
CALB 
a 
~O x= Br E=6.5 X = CI E= 14 
. x ~ x= CH3 E = 200 
Figure 14: Candida antarctica lipase B exhibits high enantioselectivity with 
secondary alcohols such as 3-nonanol, but low enantioselectivity with the isosteric 
halohydrins. 
Modeling with force fields is limited; it cannot study bond making and 
breaking processes or examine transition states. The combined quantum 
mechanical/molecular mechanics (QMIMM) overcomes this by treating the reactive 
portion at the active site with quantum mechanics, and the remaining unreactive 
portion with molecular mechanics. Altematively, a stable transition state analogue 
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can also be used to approximate the transition state. For instance, phosphonates serve 
to mimic the transition state in modeling of ester hydrolysis.71 
Finding the global minimum, rather than a local minimum, is another 
challenge, particularly in substrates with a large amount of flexibility. In these cases, 
molecular dynamics simulations use an increase in temperature to cause 
conformational changes and cross small energy barri ers. Another limitation is a 
quantative determination of an enzymes' enantioselectivity, which is currently not 
possible for any computational method because of the relatively small energies 
involved. 
1.4.1 Hydrolases 
Hydrolyases (E.e. 3.X) encompass a wide range of enzymes including lipases, 
esterases, and proteases. They are the largest class of enzymes used in applications 
such as food, dairy, detergent, and pharmaceutical industries, accounting for two-
thirds ofbiotransformations.72 Hydrolases are widely used because they are readily 
available, they do not require cofactors, and they are stable to the addition of organic 
co-solvents. Hydrolases catalyze the addition of water to cleave a bond, often in an 
amide or ester. They are also used in the reverse reaction to form esters and amides 
in solvents with low water content, or in transesterification reactions. 
1.4.2 Serine hydrolase mechanism 
The serine hydrolase mechanism is well understood. It was [IfSt reported for 
chymotrypsin, and later in many other hydrolases.73 The catalytic tri ad consists of a 
charge relay system between serine, histidine and aspartate group. The spatial 
arrangement of the catalytic tri ad is conserved among serine proteases despite a lack 
of sequence homology and differences in overall fold. The mechanism involves 
nucleophilic attack of the serine hydroxyl on the carbonyl carbon of an amide, or 
ester, of the non-covalently bound substrate to provide the [IfSt tetrahedral 
intermediate (Tdl, Scheme 15). The catalytic histidine forms a hydrogen bond to the 
catalytic serine during attack, reducing the pKa of the hydroxyl group, and then 
receives a proton from the serine hydroxyl. The imidazole, now with a positive 
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charge, is stabilized by the negatively chargee aspartate residue. The negative charge 
on the oxyanion of the tetrahedral intennediate is stabilized by hydrogen bonds. In 
subtilisin the backbone NH ofthe catalytic serine and the NH2 of aspargine 155 fonn 
the oxyanion hole to stabilize the oxyanion charge. Transfer of the histidine proton to 
the leaving group amine, or alcohol, releases the leaving group to give the acyl 
enzyme intennediate. Any enantioselectivity for amines or alcohols must have 
occurred by this point because the alcohol or amine is released from the enzyme. 
Attack of water on the acyl enzyme produces the second tetrahedral intennediate 
(T d2), with the catalytic histidine transferring a proton from the attacking water back 
to the serine. Release of the carboxylic acid regenerates free enzyme. For amide 
hydrolysis the acylation step is usually rate limiting, and for ester hydrolysis 
deacylation of the acyl enzyme intennediate is rate limiting.74 This agrees with 
amides being much less reactive than esters, but may not apply to amides such as 
reactive peptides and para-nitroanilides.75 
Asp32 
o=( 
-O-----"?N 
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Scheme 15: The catalytic mechanism for serine hydrolases. The catalytic triad 
is composed of Asp32, His64, and Ser221; the residues are numbered according to 
subtilisin. The mechanism involves attack by the catalytic serine on an ester or amide 
to produce the [Ifst tetrahedral intennediate, T dl, which breaks down to give an acyl 
enzyme. Hydrolysis by water through the second tetrahedral intennediate, Td2, 
completes the catalytic cycle. 
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Subtilisin was used to definitively determine the effect of each catalytic 
residue on the serine protease mechanism. Replacement of either of the active site 
residues Ser221, His64, and Asn155 with alanine decreases kcat by 104-106towards 
the peptide substrate, N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide?6 Removing active 
site residues was particularly difficult because subtilisin is synthesized containing a 
propeptide segment, usually processed by the active site. Active site mutants were co-
cultured with a small amount of wild-type enzyme to remove the propeptide. An 
additional Ser24Cys mutant away from the active site allowed separation of the 
mutants by binding to a thiol sepharose column. Even with the catalytic triad 
disabled, the mutant subtilisin hydrolyses the peptide substrate at a 103 higher rate 
than the uncatalyzed process. This residual activity may reflect contributions from the 
oxyanion hole, desolvation and binding. 
The existence of the acyl enzyme is also well established. If the substrate and 
reaction conditions favor fast acylation, but slow deacylation, an acyl enzyme 
accumulates and can be detected by spectroscopic techniques,77 mass spectrometry78 
and even x-ray crystallography.79 At low pH the histidine is protonated and prevents 
catalytic turnover of the enzyme. 
A recent paper suggested that the attack on inhibitor peptides at the carbonyl 
center occurs at approximately 90°, based on crystallographic, kinetic and mass 
spectrometry evidence with subtilisin BPN'. 80 This is significantly different from 
Bürgi-Dunitz trajectory of 105 ± 5° from small molecule crystallization and 
calculations.81 In this example, the attack angle for enzymatic peptide hydrolysis is 
not exactly analogous to nuc1eophilic attack on a carbonyl center, but it is not c1ear 
why the two are different. 
1.4.3 Screening to discover active enzymes 
Hydrolase screening is easily accompli shed using spectrophotometric 
methods. Hydrolysis of an ester produces a carboxylic acid and an alcohol (Figure 
15). Above the pKa of the carboxylic acid (typically 3-5), the acid is ionized to give a 
proton, which is detectable by a pH indicator, such as para-nitropheno1.82 When 
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protonated, the decrease in absorbance at 404 nm (yellow) with time gives the rate of 
hydrolysis. Sorne protons are lost to the buffer but small changes in pH give large 
changes in absorbance, and under the correct conditions the colour change is 
proportional to the number of protons released. The pKa of the indicator and the 
buffer are ideally within 0.1 units so that the relative amount of protonated buffer to 
protonated inhibitor stays constant as the pH shifts during the reaction, and gives 
improved linearity.83 The highest assay sensitivity is given with a low buffer 
concentration and high indicator concentration. Screening for enantioselectivity 
requires more in depth screening methods: Quick E84, chiral CG or HPLC, or 
deuterium labeled mass spectrometry85 are sorne options. 
enzyme 
.. + R'OH 
+ H+ 
02N-o-0-~ 02N-o-0H 
Yellow Colourless 
E = 18000 M-1cm-1 
Figure 15: Activity screening for hydrolysis with the pH indicator p-nitrophenol: 
protons released upon ester hydrolysis can protonate the highly coloured p-
nitrophenoxide to give a decrease in absorbance at 404 nm. 
1.4.4 Subtilisin 
Subtilisin (E.C. 3.4.21.62) is a 275 amino acid single chain protease that has 
several variants from various bacillus species: subtilisin E (Bacillus subtilis), 
subtilisin BPN' (Bacillus amyloliquefaciens), subtilisin Carl sb erg (Bacillus 
lichenformis), and subtilisin BL (Bacillus lentus). Subtilisins are produced as 
precursors, called preprosubtilisins. The pre-region, a signal peptide, is required for 
protein secretion. The pro-region, or the propeptide, is located between the signal 
peptide and the mature protein and functions as a chaperone for folding before 
undergoing autolysis. A schematic for the subtilisin BPN' plasmid with restriction 
sites, subtilisin gene, and resistance is shown in figure 16.86 Subtilisin-like motifs, 
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tenned subtilases, are found in other organisms, such as archaea, fungi and yeasts.87 
Due to its stability, wild-type or genetically modified enzyme is widely used in 
detergents for degrading peptide based stains.88 
BamHI 
Figure 16: Plasmid pS4 containing the subtilisin BPN' gene. Select 
restriction sites are shown (Eco RI, Barn HI and Sau 3a).86 Pre: Signal peptide, Pro: 
pro-peptide, pUB 110 ori: origin of repli cation, CA T: chloramphenicol 
acetyltransferase gene, pBR322 ori: origin of replication in E. coli. 
Protease specificity is described in a series ofbinding sites based on peptide 
binding, as described by Schechter and Berger.89 The substrate is divided into two at 
the scissile bond. Binding sites for the carboxy, or acyl, portion of the substrate are 
tenned SI, S2 etc., increasing away from the active site (Figure 17). The amino acids 
of the substrate are correspondingly PI, P2. Etc. The amino portion (or leaving group) 
of the substrate is denoted PI', P2', binding to the corresponding SI' and S2' binding 
sites of the protease. 
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Enzyme Binding Sites 
Cleavage 
Carboxyl 
--- terminus 
Figure 17: Protease active site nomenclature for peptide hydrolysis. An arrow 
indicates the position ofhydrolysis. Peptide residues on the acyl portion of the 
peptide (left) are numbered PI, P2 etc, with numbers increasing away from the 
cleavage site. Residues in the amino portion (leaving group) of the peptide are 
numbered PI " P2 " etc. The corresponding enzyme binding sites are S2, SI, SI' S2'. 
etc.89,90 
1.4.5 Structure 
The subtilisin BPN' crystal structure was first reported in 1969,91 and since 
then crystal structures of Carlsberg,92 E,93 and others in the subtilisin family have 
been reported. To prevent autodigestion subtilisin is crystallized in an inactive form, 
usually complexed with a small, non-covalent peptide inhibitor, or with the active site 
serine mutated to a cysteine. The overall folding is termed the a/f3-subtilase protein 
fold, which differs from other serine proteases such as chymotrypsin. The secondary 
structure consists of seven parallel f3-strands that form the core of the enzyme. These 
are surrounded by eight a-helices, figure 18. The active site residues are located 
within the secondary structure, Asp32 is located on the carboxyl terminal end of 13-
strand El, His64 is located on helix HC, and the catalytic Ser221 is positioned near 
the amino terminus ofhelix HF. In contrast the active site residues oflipases (a/f3-
hydrolase foId) are located in loop regions. The variety of reactions catalyzed by the 
a/f3-hydrolase fold family may reflect the flexibility of the se 100ps.94 
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HE 
Figure 18: Secondary structure of the a/j3-subtilase fold. a-Helices are shown as 
cylinders and j3-sheets strands as arrows, along with the position of the catalytic triad. 
(Adapted from Siezen et. a1.87) Ribbon diagram ofsubtilisin BPN' (PDB lSBN95) in 
which each of the structural elements are coloured differently. 
1.4.6 Substrate specificity 
The active site of subtilisin is on the surface of the enzyme so that it is easily 
accessible to degrade long peptides. Peptides bind to subtilisin in an extended 
conformation.96 The substrate makes several hydrogen bonds along the peptide 
channel in addition to specifie side chain - binding pocket interactions.97 Substrate 
specificity is generally broad. For small molecules, the SI acyl and SI' leaving group 
pockets are the most significant because they are close to the active site residues 
(Figure 19). 
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Figure 19: X-ray crystal structure of subtilisin BPN' with the non-covalent eglin-C 
inhibitor from the leech Hirudo medicianlis (PDB codel SBN).95 The inhibitor is 
shown in green binding along the peptide channel and sorne inhibitor residues not in 
direct contact with the enzyme are removed for clarity. The catalytic triad of Asp32, 
His64, and Ser221, alongwith the oxyanion stabilizing Asn155, is shown as sticks, 
while the remained of the enzyme is spacefill. The location of the scissile bond is 
shown with a dashed line. Occupying the SI acyl site is an arginine (PI) of the 
inhibitor, and in the SI' site is an aspartate residue (PI ') ofthe inhibitor. 
The SI site, or the acyl-binding site, can distinguish many types of acyl 
groups. For peptide substrates, subtilisin generally prefers large, nonpolar amino 
acids such as phenylalanine, tyrosine or leucine. For example, BPN' cleaves the 
peptide succinyl-Ala-Ala-Pro-Phe-p-nitroanilide peptide with a kcat/Km value of 0.36 
s-lmM-I(kcat = 50 S-I, Km = 0.14 M).98 The analogous peptide with alanine is cleaved 
25-fold slower; succinyl-Ala-Ala-Pro-Ala-p-nitroanilide reacts with a kcat/Km value of 
0.014 S-lmM-1 (kcat = 1.9 S-I, Km = 0.15 M). In a similar way, hydrolysis ofphenyl 
acetate vs. phenyl hippurate occurs with a 20-fold higher kcat/Km value, highlighting 
the preference for non-polar groups in the acyl portion.99 
The SI' poeket binds the leaving group of the substrate, usually an amine or 
alcohol. The enantioselectivity is determined by the first step in the reaetion -
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fonnation of the first tetrahedral intennediate. Empirical mies predict the 
enantiopreference for subtilisin reactions of secondary alcohols and primary amines 
in organic solvent and water based on the sizes of the substituents at the stereocenter 
(Figure 20).100 These are similar to mIes developed for lipases/esterases to predict the 
fast reacting enantiomer of secondary alcohols.lOl For lipases, the mie successfully 
predicted the fast reacting enantiomer of over 130 esters of secondary alcohols with ~ 
95% accuracy. As noted in the enantiocomplementary enzyme section (Section 1.3.2), 
lipases have an approximate mirror image arrangement of the catalytic machinery, 
and thus show the opposite stereopreference to subtilisin. The mIe for subtilisin is 
slightly less accurate, and predicted the correct enantiomer approximately 85% of the 
time. It is reliable for reactions in organic solvent, but sometimes predicts the 
incorrect enantiomer for small substrates in water. 
A. B. 
OH 
~~ 
OH 
e~ 
Lipase/Esterase Subtilisin Amines 
Figure 20: Empirical mIes to predict the fast reacting enantiomer of secondary 
alcohols base on substituent sized where L is the large substituent and M is the 
medium substituent. A. Lipases/esterases favour opposite enantiomers of secondary 
alcohols than subtilisin. B. The mie can also be extended to primary amines and 
subtilisin. 
Subtilisin typically shows low to moderate enantioselectivity towards simple 
substrates when compared with lipases and esterases. Lipases have two pockets of 
different size with which they bind both substituents of a secondary alcohol. 
Subtilisin has only one pocket, the SI' pocket, which binds one portion of the 
secondary alcohol, while the other portion is orientated towards the solvent. 
Therefore both substituent size and solvation can contribute to enantioselectivity. The 
open SI' binding pocket also accounts for the inaccuracy of the mIe in solvents of 
differing polarity. For example, the R-enantiomer of esters of sec-phenethyl alcohol 
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reacts faster in water (against the rule), while in organic solvent the S-enantiomer 
reacts faster. 102 The SI' site is hydrophobie, and will bind the larger, non-polar phenyl 
group in a polar solvent such as water, while the medium methyl group is oriented 
towards the solvent. In a non-polar organic solvent, this hydrophobie effect is 
diminished, and steric interactions dominate to give the opposite enantiomer. 
Altering the polarity of the substrate has a similar effect. Adding charged residues in 
the para-position makes it favourable to orient the aryl group toward a polar solvent, 
while the highly polar sulfinamides react with high enantioselectivity.103 Solvation 
effects disappear with groups larger than para-substituted aryl groups because they 
are too large to fit in the SI' pocket and the S-enantiomer is favoured. 
1.4.7 Mutation of subtilisin 
Extensive mutation of subtilisin has modified almost aIl its properties. 
Altering over half of the 275 amino acids has improved various features. 104 Subtilisin 
is a model system for mutation studies because the mechanism and crystal structure 
are weIl known, and the enzyme is easily cloned, expressed and purified. Mutations 
of the specifie sites, the entire enzyme, or residues close to the active site have aIl 
been used to improve performance. Generally, global effects that are poorly 
understood, such as thermostabilty, are best solved with the irrational approach of 
mutation of the entire enzyme. Problems in which sorne structure/function 
information is known (such as the binding site of a substrate) are most efficiently 
treated with a "cl oser is better" approach - that is, mutations close to the active site 
have a larger effect than those distant from the active site. 105 
In detergent applications, bleach inactivates subtilisin by oxidizing the 
Met222 residue, adjacent to the active site in the SI' pocket.106 Site directed 
mutagenesis replaced position 222 with aIl other amino acids, and subsequent tests 
revealed both Met222Ser and Met222Ala were resistant to peroxide oxidation. 107 In 
another study, modification of the SI acyl site by replacing the small glycine 166 
residue at the bottom of the SI site with 12 larger amino acids changed the substrate 
specificity.108 Wild-type subtilisin generally prefers large, non-polar groups in the PI 
position, but the catalytic efficiency of the enzyme increased up to 16-fold towards 
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small, non-polar substrates, due to improved binding in the now smaller SI pocket. 
Engineering of subtilisin has also provided mutants with improved thermostability,109 
calcium ion stability, Il 0 pH stability, III substrate specificity, 1I2 and organic solvent 
tolerance. 113 
1.5.1 Thesis outline: Expanding the use of enzymes to new substrates and 
reactions 
This thesis contains new applications of enzymes, in particular subtilisin, to 
perform novel chemical transformations. The large open active site of subtilisin 
suggests it may accommodate sterically hindered substrates. In chapter two 
enantiocomplementary enzymes hydrolyzed a bulky spiro chiral auxiliary for the 
Diels-Alder reaction with high, opposite enantioselectivity. The molecular basis of 
subtilisin was examined with molecular modeling. In chapter three we examined the 
application of proteases to hydrolyze sterically demanding esters tertiary alcohols, 
along with the molecular basis for the reactivity and enantioselectivity. In chapter 
four a new catalytically promiscuous reaction was discovered with the protease 
subtilisin Carlsberg. The bulky N-acyl sulfinamides are typically hydrolyzed at the C-
N bond by related subtilisins, but subtilisin Carlsberg hydrolyses the S-N bond. In 
chapter five the mechanism ofthis S-N reaction was explored and determined to 
proceed through a sulfinyl enzyme intermediate at the active site. Substrate variation 
indicated that a substrate reversaI was responsible for the altemate bond hydrolysis. 
Mutations aiso demonstrated the basis for C-N vs. S-N selectivity differences 
between the subtilisins. 
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Expanding the role ofbiocatalysts provides altemate, environmentally 
friendly, routes to enantiopure compounds. Subtilisin is a well-known protease used 
in detergents and commonly in organic synthesis for resolution of amines and alco-
hols, and carboxylic acids. We hypothesized that the large open active site of subtil-
isin could accommodate sterically hindered substrates. 
Enantiocomp1ementary enzymes (section 1.3.2) are two enzymes that favor 
opposite enantiomers. In this chapter, we describe two enantiocomplementary en-
zymes, subtilisin and cholesterol esterase, found by screening an enzyme library. The 
enzymes hydrolyze different enantiomers of a bulky secondary alcohol Diels-Alder 
chiral auxiliary with high enantioselectivity. The opposite enantiopreference was in 
agreement with the secondary alcohol rules for proteases and lipases/esterases. We 
used subtilisin to resolve the auxiliary on a gram scale. Molecular modeling using the 
crystal structure of subtilisin revealed that the slow enantiomer bumps into the cata-
lytically essential residues. 
This chapter is a published article and is reprinted from ChemBiochem, 2004, 5, 980-
987, P. F. Mugford, S. M. Lait, B. A. Keay. R. J. Kazlauskas, "Enantiocomplemen-
tary Enzymatic Resolution of the Chiral Auxiliary 
cis, cis-6-(2,2-Dimethylpropanamido)spiro[4.4]nonan-l-01 and the Molecular Basis 
for the High Enantioselectivity of Subtilisin Carlsberg" Copyright 2004, with permis-
sion from Wiley-VCH, Weinheim, Germany. 
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Enantiocomplementary Enzymatic Resolution of the Chiral 
Auxiliary 
cis, cis-6-(2,2-Dimethylpropanamido )spiro[4.4]nonan-l-ol 
and the Molecular Basis for the High Enantioselectivity of 
Subtilisin Carlsberg 
Paul F. Mugford,[a] Susan M. Lait,[b] Brian A. Keay,[b] and Romas J. Kazlauskas*[a] 
[a] Paul F. Mugford, Dr. Romas J. Kazlauskas, McGill University, Department of 
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Abstract: cis, cis-( ± )-6-(2,2-Dimethylpropanamido) spiro[ 4.4 ]nonan-l-ol, 1, 
a chiral auxiliary for the Diels-Alder additions, was resolved by enzyme-catalyzed 
hydrolysis of the corresponding butyrate and acrylate esters. Subtilisin Carlsberg 
protease and bovine cholesterol esterase both showed high enantioselectivity (E 
>200), but favored opposite enantiomers. Subtilisin Carlsberg favored esters of(lS, 
5S, 6S)-1, while bovine cholesterol esterase favored esters of (IR, 5R, 6R)-1, 
consistent with the approximately mirror-image arrangement of the active sites of 
subtilisins and lipases/esterases. A gram-scale resolution of 1-acrylate with subtilisin 
yielded (IS, 5S, 6S)-1 (LI g, 46% yield, 99% ee) and (IR, 5R, 6R)-1-acrylate (1.3 g, 
44% yield, 99% ee) although the reaction was slow. The high enantioselectivity 
combined with the conformational rigidity of the substrate made this an ideal example 
to identify the molecular basis of enantioselectivity of subtilisin Carlsberg toward 
secondary alcohols. The favored (IS, 5S, 6S) enantiomer adopted a catalytically 
productive conformation with two longer-than-expected hydrogen bonds, consistent 
with the slow reaction. The slow-reacting (IR, 5R, 6R) alcohol moiety encountered 
severe steric interactions with catalytically essential residues. It either distorted the 
catalytic histidine position or encountered severe steric strain with Asn155, an 
oxyanion-stabilizing residue. 
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Introduction 
The enantiomer preference (which enantiomer is favored) is a key 
characteristic of enantioselective catalysts. For asymmetric syntheses, 
desymmetrizations, and dynamic kinetic resolutions, the enantiomer preference of 
the catalyst determines which enantiomer forms. Since most applications (e.g. 
preparation of a pharmaceutical or pharmaceutical precursor) require onlyone 
enantiomer, it is important that the enantiomer formed be the desired one. Although 
kinetic resolutions yield both enantiomers, the enantiomer preference still determines 
which enantiomer will be the unreacted starting material and which will be product 
of the reaction. This choice can simplify the next synthetic steps or, in a moderately 
enantioselective kinetic resolution, give higher enantiomer purity because the 
remaining starting material can be recovered in higher enantiomeric purity than the 
product.1 
To reverse the enantiomer preference of a chemical catalyst, one uses the 
enantiomeric catalyst; for example, a D-tartrate-derived epoxidation catalyst in place 
of an L-tartrate-derived catalyst. For enzymes, the switch to an enantiomeric form is 
possible, but not practical because it requires chemical synthesis of the enzyme from 
D-amino acids.z The practical solution for enzyme-catalyzed reactions is to use an 
enantiocomplementary enzyme, that is, one that favors the opposite enantiomer. 
Enantiocomplementary enzymes favor opposite enantiomers because either the 
substrate or the active site machinery orients differently. 
Researchers have discovered many examples of enantiocomplementary 
enzymes. For example, dehydrogenases as weIl as yeast reductases with opposite 
stereopreferences are common?·4 In Escherichia coli, separate enantiocomplementary 
enzymes reduce the enantiomeric sulfoxide configurations in methionine sulfoxide 
epimers.5 In Neisseria gonorrhoeae, one prote in containing mirror-image active sites 
in separate domains, reduces these enantiomeric sulfoxide configurations.6 In an 
oxidation example, the active site of D-amino acid oxidase is a mirror image of that in 
flavocytochrome-b2• Both enzymes catalyze amino acid oxidation, but with opposite 
enantiomer preference.7 Toluene dioxygenase (TDO) and naphthalene dioxygenase 
(NDO) are enantiocomplementary.8 Researchers reported diastereocomplementary 
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aldolases9 and enantiocomplementary aldolase catalytic antibodies. lo 
Enantiocomplemtary pinene synthases cyclize geranyl diphosphate to give either (+)-
(3R,5R)-a-pinene or (-)-(3S,5S)-a-pinene.11 Researchers have also used protein 
engineering to reverse the enantioselectivity of enzymes. 12 
Enantiocomplementary hydrolases include esterases, lipases and proteases,13 
epoxide hydrolases,14 hydantoinases,15 and lactamases.16 Serine proteases and lipases 
have approximately mirror image active sites and thus usually prefer opposite 
enantiomers of secondary alcohols and primary amines, Figure 1.17 In this paper, we 
report an enantiocomplementary resolution of a secondary alcohol useful as a chiral 
auxiliary using subtilisin or cholesterol esterase. 
OH 
CS~ 
protease 
(-)-(18, 58, 68)-1 
HO 
~~ 
lipase/este rase 
o 
HO HN~-BU 
6$ 
(+)-(1R, 5R, 6R)-1 
Figure 1: Empirical mIe to predict the fast reacting enantiomer in hydrolysis reac-
tions. M represents a medium-size substituent - in 1 this corresponds to the methyl-
ene (C2). L represents a large substituent - in 1 this corresponds to the spiro center 
(C5). 
The cis,cis 1,3-amino alcoholl is an excellent chiral auxiliary for the Diels-
AIder reaction because it shows excellent stereocontrol, high reactivity, and is easily 
removed. The acrylate of 1 forms a Diels-Alder adduct with cyclopentadiene in >98% 
de with an endo:exo ratio of>99:1, Scheme 1.18 In addition, it reacts with the less 
reactive dienes isoprene, furan, l-vinylcyclopentene, and l-vinylcyclohexane with 
good diastereoselectivities and yields. Removal of auxiliaries linked via an amide 
bond can be difficult, but the ester link of this auxiliary cleaves readily by 
saponification. 
52 
Chapter 2 
(1 R, 5R, 6R)-1-acrylate 84% yield, > 98% de 
> 99:1 endo:exo 
Scheme 1: Highly diastereoselective Diels-AIder addition ofcyclopentadiene to (IR, 
5R, 6R)-I-acrylate. 
The synthesis of racemic 1 controls the relative configuration of the three 
stereocenters to give the cis,cis stereoisomer.18 Fractional crystallization of the amine 
precursor of 1 (lacking the N-pivaloyl group) as the mandelate salt provided pure 
enantiomers with a yield of only 28% for each enantiomer, plus 28% recovered 
starting material. Here we report a kinetic resolution of (± )-1 by two 
enantiocomplementary enzymes, both with an enantioselectivity greater than 200. 
Results 
We screened approximately one hundred commercially available hydrolases 
for their ability to catalyze hydrolysis ofracemic l-acetate. For the initial screen, we 
used p-nitrophenol as the pH indicator to detect proton release upon hydrolysis. 19 At 
the second stage, we monitored 1-5-mg sc ale reactions using gas chromatography. 
This screening identified only two hydrolases that catalyzed hydrolysis of l-acetate -
subtilisin Carlsberg (also called protease from Baci/lus licheniformis) and proteinase 
N from Bacillus subtilis, Table 1. Even these two hydrolases were inefficient catalysts 
as the mass of enzyme required was 12-19 times higher than the mass of substrate. 
Subtilisin Carlsberg was approximately four times faster than proteinase N. The slow 
reaction with these two hydrolases and the inability of most hydrolases to catalyze 
hydrolysis of l-acetate is likely due to the rigid and hindered nature ofthis substrate. 
Even though it showed no activity in the initial screen, we also checked the 
ability of bovine cholesterol esterase (CE) to catalyze hydrolysis of l-acetate because 
this esterase previously resolved several spiro compounds.20 We expected the 
reaction, ifany, to be slow. Indeed, the reaction was very slow - with a 14-fold 
greater mass of esterase over substrate, the reaction reached 36% conversion after 30 
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h. Even after 110 h it did not proceed beyond 38% conversion. It is possible that our 
screen missed other slow reacting enzymes. Thus, we identified three hydrolases that 
could catalyze hydrolysis of this unnatural substrate. 
AlI three hydrolases showed excellent enantioselectivity, Table 1. We 
calculated the enantioselectivity of the candidate enzymes from the enantiomeric 
purity measured by gas chromatography on a chiral stationary phase. For l-acetate, 
subtilisin Carlsberg gave an E greater than 200 while proteinase N gave an E of 100. 
CE was also highly enantioselective towards l-acetate with E greater than 200. The 
absolute configuration of the favored enantiomer was determined by comparison with 
a sample of 1 with known configuration. 18, 21 The two proteases favored esters of (1 S, 
5S, 6S)-1, while CE favored esters of(IR, 5R, 6R)-1. This opposite enantiopreference 
is consistent with the secondary alcohol rules for proteases and lipases/esterases, 
Figure 1 above. The two proteases and CE are enantiocomplementary enzymes and 
aIl show high enantioselectivity. 
We tested resolution of I-butyrate ester since separation of 1 and I-butyrate 
by column chromatography is easier than for the acetate and also tested resolution of 
l-acrylate since this yields the reactant for the Diels-Alder addition directly, Table 1. 
Upon changing the acetate to a butyrate or acrylate, the enantioselectivity remained 
unchanged. The rate for the acetate and butyrate/acrylate reactions in Table 1 should 
not be compared as these reactions were under different conditions. Butyrate 
reactions were carried out on a slightly larger 20 mg scale and the relative amount of 
enzyme was reduced. Again we found that a high conversion could not be obtained 
using CE and the reaction temperature of37 oC was crucial for any reaction with this 
enzyme. In contrast the subtilisin-catalyzed hydrolysis of I-butyrate proceeded to 
47% conversion in 24 h at room temperature. 
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Table 1. Enzymatic resolution of esters of(±)-1 
Conv. 
Enzyme Ester Time Ratio ees [b, c) eep[b) %[1] pg,h) 
(h) enzyme/ ester1aJ (yieldidJ (~ieId)[e) 
Subtilisin Carlsberg Acetate!i] 48 liB 37 99 27 >200 (8) 
From Butyrate!i] 24 l.7 89 99 47 >200 (8) 
Baeil/us lieheniformis Acrylate 48 1.5 99 (44%) 99 (46 %) 50 >200 (S) 
Proteinase N from Acetate 46 19(j] 20 98 17 100 (8) 
Bacillus subtilis Butyrate 96 3.9 69 96 42 102 (8) 
Cholesterol Acetate 30 14(j] 55 99 36 >200 (R) 
Esterase Butyrate 24!k] 2.6 61 98 38 >200(R) 
[a] Ratio ofmass of enzyme to mass of ester of (±)-l. [b] Determined by GC. [cl ees for 
the butyrate determined after column chromatography and hydrolysis to the alcoholl. rd] 
Isolated yield ofl-acrylate. [el Isolated yield of 1. [i] Conversion % was determined 
from ees and eep by the formula c = (ees)/( ees + eep). [g] The enantiomeric ratio E meas-
ures the relative rate ofhydrolysis of the fast enantiomer as compared to the slow enanti-
omer E = ln[ eep(l - ees)/( eep + ees]/ln[ eep(l + ees)/( eep + ees] as defined by SihP2] [h] 
Absolute configuration was determined by comparison to an authentic sample of (IR, 5R, 
6R)_lys,21] ri] The rate for l-acetate should not be compared with the butyrate/acrylate as 
the reactions were under different conditions. [j] When the amount of enzyme is more 
than twice the weight of substrate, Michaelis-Menten kinetics and the equations used to 
calculate enantioselectivity may not be valid because the molar amount of enzyme is no 
longer negligible compared to the amount of substrate. Nevertheless, the high enanti-
omeric purity of the product and experiments with smaller amounts of enzyme clearly in-
dicate that the enantioselectivity is high. [k] CE butyrate reaction at 37 oC; other butyrate 
reactions at 25 oC. 
For a practical resolution, we chose the subtilisin-catalyzed hydrolysis of 1-
acrylate, Scheme 2. Subtilisin Carlsberg is stable and inexpensive and this reaction 
directly yields the reactant needed for the subsequent Diels-AIder reaction. A 2.6-
gram resolution using subtilisin Carlsberg (4.3 g) in approx 600 mL ofbuffer reached 
50% conversion after 48 h at room temperature. Isolation and separation by colurnn 
chromatography yielded unreacted (IR, 5R, 6R)-1-acrylate in 44% yield and 99% ee 
and product (18, 58, 6S)-1 in 46% yield and 99 % ee. 
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VLo HN~-BU 
CiD + 
o 
t-Bu~m OH $6 
(1 R, 5R, 6R)-1-aerylate (15, 55,65)-1 
1.3 9 (44% yield) 1.1 9 (46% yield) 
99% ee 99%ee 
Scheme 2: Preparative-scale resolution of l-acrylate using subtilisin Carlsberg. 
Molecular Basis for High Enantioselectivity of Subtilisin Toward I-butyrate. 
Starting with the X-ray crystal structure of subtilisÏn Carl sb erg, we added I-butyrate 
to the active site using computer modeling?3 We further replaced the reacting ester 
carbonyl of I-butyrate with a phosphonate to mimic the transition state, Figure 2a, 
and linked this phosphonate to the catalytic serine. The chiral alcohol moiety has only 
a few accessible conformations because it has only three rotatable bonds and its large 
size excludes many conformations within the active site pocket. We manually 
searched conformations by rotating the phosphorus-oxygen bond, the oxygen-CI 
bond, and the C6-N bond. Catalytically productive structures were those that 
contained aIl five catalytically essential hydrogen bonds,24 Figure 2b, and avoided 
steric clashes with the protein. 
(15, 55, 65)-1 
(a) 
81' 
Aleohol Binding Poeket 
Leu217~Asn218 
( I~H:t \8er221 
L-I NHR 
His64YNH:----OX : __ ----1:I2Ny Asn155 
HNd - ____ ()~\_O- ° 
°lé~+ -0 "") 8
1 
Asp32 ~AeYI Binding Poeket 
(b) 
Figure 2: Phosphonate transition state analog for hydrolysis of I-butanoate. a) 
Analog containing the fast reacting (18,58,65)-1. b) Key hydrogen bonds between 
the phosphonate and the catalytic residues of subtilisin Carlsberg. 
The phosphonate mimicking hydrolysis ofthe fast reacting (18,58,65) 
enantiomer adopted a catalytically productive orientation, Figure 2b, but the alcohol 
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substituents made Httle contact with the substrate binding site. The alcohol moiety 
rested above the active site with the medium substituent (C2 methylene, Figure 1) 
slightly above the right side of the shallow SI' binding site (defined by Met222, 
yellow, at the bottom, Leu217, red, on the left, and the backbone of Asn218, green, 
on the right), Figure 3(1). The large substituent (CS spiro center and ring, Figure 1) 
was unbound and pointed toward the solvent and to the left in Figure 3,(1). The 
closest contact between the medium substituent and the SI' binding site was longer 
than the van der Waals contact distance (4.52 A between C3 of the 1 moiety and the 
sulfur of Met 222 vs. 4.09 A,[A] for a van der Waals contact). But this distance is 
close enough to exclude water and create a favorable hydrophobic interaction. Thus, 
the substituents in the alcohol moiety were only partly in the substrate-binding site. 
Two of the catalytically essential hydrogen bonds were longer than expected. 
The alcohol orientation pointed the alcohol oxygen toward the catalytic histidine to 
form a hydrogen bond. This bond was longer than expected: NE2 to 0 distance 3.33 
A, N-H-O angle 135° while normal limit for a hydrogen bond is ~3.1 A and an angle 
greater than 120°. Of the remaining four catalytically essential hydrogen bonds, Table 
2, the hydrogen bond from the catalytic histidine 64 NE2 to the catalytic serine 221 
Of was also longer than expected: 3.42 A (N-H-O angle 133°). These two long 
hydrogen bonds may explain the very slow reaction for this substrate. (Bl 
We examined three different conformations for the slow reacting (IR, SR, 6R) 
enantiomer, but they either lacked key hydrogen bonds or encountered severe steric 
clash with the protein. The flfst conformation for the (IR, SR, 6R) enantiomer (Figure 
3, II, Conformation A) had a severely distorted histidine orientation. It placed the 
medium substituent of 1 into (deeper than the fast -reacting enantiomer) the left side 
A Estimated from the C-H bond length (1.09 A) and van der Waals radii for sulfur 
(1.80 A) and hydrogen (1.20 A) from A. Bondi, J. Phys. Chem, 1964, 68,441-451. 
B Although nonproductive orientations may also exist for the fast enantiomer we did 
not consider them because only productive orientations lead to product. Nonproduc-
tive orientations only slow the rate of reaction. Nonproductive orientations alter keat 
and KM in a compensating manner so that kea/KM and the enantioselectivity are unaf-
fected (A. Fersht, Structure and Mechanism in Protein Science, Freeman Freeman, 
New York, 1999, pp. 114-117). 
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of the shallow SI' pocket; the distance from C3 to the sulfur of Met222 was 4.20 Â. 
The large substituent pointed directly out of the active site and toward the solvent. 
The different absolute configuration of the alcohol stereocenter pointed the alcohol 
oxygen away from the catalytic histidine. In addition, the medium substituent hit the 
catalytic histidine causing the plane of the imidazole ring to rotate by 60° down into 
the active site as compared with the fast enantiomer. The resulting distance between 
C2 of the substrate and the NE2 of His 64 was 3.44 Â. This shift severely disrupted all 
three of the catalytically essential hydrogen bonds involving the catalytic histidine, 
Table 2. The distance from the catalytic histidine 64 NE2 to the catalytic serine 221 
Oy was too long form a hydrogen bond (4.04 Â, N-H-O angle 124°) as was the 
distance and to the alcohol oxygen (5.17 A, N-H-O angle 96°). Although the distance 
between aspartate 32 Oô and histidine 64 Nôl remained close (2.95 A), the O-H-N 
angle decreased to 66°, which is too acute to form a hydrogen bond. These 
disruptions of the catalytic hydrogen bond network make it extremely unlikely that 
the slow enantiomer could react via this Conformation A. 
58 
Chapter 2 
Il 
III IV 
Figure 3: Geometry optimized conformations of the tetrahedral intermediates 
for hydrolysis of 1-butyrate in the active site of subtilisin Carlsberg. Residues 
defining the SI' site are: Met222 in yellow, Leu217 in red, and Asn218 in green. (I) 
Catalytically productive conformation of the fast-reacting enantiomer (18, 58, 68)-1-
butyrate. Three non-productive conformations of the slow-reacting enantiomer (IR, 
5R, 6R)-1-butyrate: (II) Conformation A is missing key hydrogen bonds because of 
the distorted histidine orientation, (III) Conformation B has several distorted bond 
angles as a result ofsteric interactions with AsnI55, and (IV) Conformation Chas a 
syn-pentane like interaction and several other distorted bond angles. 
In the second slow reacting (IR, 5R, 6R) conformation, conformation B, the 
alcohol moiety rotated clockwise along the P-O bond, to relieve the histidine 
distortion and restore the catalytically essential hydrogen bonds (Table 2). This 
rotation placed the medium substituent above the left si de of the SI' pocket and the 
closest distance was significantly longer than the van der Waals contact distance 
(5.06 A between C3 of the alcohol moiety and sul fur of Met 222). This rotation also 
pointed the large group to the right (Figure 3, III) where its bulky pivalamide group 
hit the si de ofthe active site at AsnI55. AsnI55 also has a catalytic role - the Na-H 
stabilizes the oxyanion of the transition state by forming a hydrogen bond. The 
pivalamide carbonyl group made hydrogen bonds to the NH2 (Nô2) of Asn 155 (2.92 
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A N-O distance, O-H-N angle of 163°) and to the backbone NH (Na)(3.07 A, N-H-O 
angle of 125°) as weIl as a close steric contact with the ~-carbon (3.27 A). This 
pivalamide-Asn 15 5 contact also distorted bond angles in the alcohol moiety: P-O-C 1 
angle 128° vs. 120° in the ideal case and the O-Cl-C5 angle was 116° vs. 109° (Table 
3). Restoring these two angles to their ideal values dramatically increased the steric 
interactions between the pivalamide carbonyl andAsn 155: Nô2-0 = 2.29 A, Na-O = 
3.04 A, and CfI-O = 2.54 A. To confirm that conformation Bis a strained 
conformation, we calculated its energy (AMI, heat of formation) after removal from 
subtilisin to be 16 kcallmol higher than the conformation for the fast-reacting 
enantiomer. In summary, although conformation B contains the catalytically essential 
hydrogen bonds, steric clash between the pivalamide carbonyl and Asn155 make this 
a highly strained conformation. 
Table 2. Catalytic Essential Hydrogen Bond Distances and Angles[a1 
(IS, 5S, 6S) (1R, 5R, 6R) 
Confonnation A Confonnation B Confonnation C 
Hbond distance, A (angle) 
His64-0a1c 3.33 (135°) 5.17 (96°) 3.30 (146°) 3.30 (147°) 
His64- 3.42 (133°) 4.04 (124°) 3.36 (137°) 3.39 (138°) 
Oser221 
Oxyanion-NH 2.80 (154°) 2.72 (159°) 2.86 (149°) 2.85 (151°) 
Ser221 
Oxyanion- 2.79 (164°) 2.78 (129°) 2.76 (128°) 2.75 (140°) 
NH2Asn155 
Asp32-His64 2.76 (162°) 2.95 (66°) 2.78 (173°) 2.78 (174°) 
Productive confor- Key hydrogen bonds High energy struc- syn-pentane 
mation ture interaction mlssmg 
[a]Bold font indicates distances that are too long to form a hydrogen bond. 
Rotation of the pivalamide group along the C6-N bond to avoid the steric 
clashes with Asnl55 yields conformation C. Unfortunately, this rotation creates a 
new steric strain - a syn-pentane like interaction between the oxygen atom of the 
pivalamide and the spiro stereocenter: O-C5 distance = 3.00 A (Figure 3, IV). 
Typically a syn-pentane interaction increases the energy by -3.6 kcallmol.2s The main 
close contact with the enzyme was the pivalamide NH to the NH2 of Asn 155: 3.16 A. 
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The significantly distorted angles in this structure were: the N-C6-C5 angle (117°), 
the P-O-Cl angle (128°), and the O-Cl-C5 angle (116°), Table 3. Restoring these 
angles to their ideal values dramatically shortened the distance from the NH of the 
pivalamide to the NH2 of Asn 155: 2.51 Â. The calculated energy of the transition 
state analogue removed from the protein was 17 kcal/mol higher than the fast reacting 
enantiomer, indicating that this conformation is highly strained. 
Table 3: Energy of substrate and substrate angles for tetrahedral intermediates 
(IS, 5S, 6S) (IR, 5R, 6R) 
Conformation A Conformation B Conformation C 
Heat of Formation[a] o kcal/mol + 2 kcallmol + 16 kcal/mol + 17 kcal/mol 
CI-C5-C4 102° 103° 100° 99° 
CI-C5-C6 116° 116° 117° 119° 
CI-C5-C9 113° 113° 116° 117° 
N-C6-C5 112° 110° 110° 117° 
O-CI-C5[b] 109° 109° 116° 116° 
p_O_CI[b] 122° 123° 127° 128° 
[a] AMI heat offormation of the substrate removed from subtilisin. Bold font indicates bond angles 
distorted from their ideal values.[b] Restoring the angles in bold font to their ideal values in Conforma-
tion B and C gave severe steric clashes with the Asn155. 
Discussion 
Two enantiocomplementary enzymes - subtilisin and cholesterol esterase - show 
high enantioselectivity toward esters of(±)-l. The favored enantiomer forboth 
follows the secondary alcohol rules developed to predict the enantioselectivity of 
serine hydrolases. 17 Kim and coworkers also recently used subtilisin and lipases as 
enantiocomplementary enzymes in the dynamic kinetic resolution of secondary 
alcohols.26 
The gram-scale resolution of l-acrylate with subtilisin gave high yield and 
enantiomeric purity, but was very slow. We used 1.7 times higher mass of subtilisin 
than of substrate. Nevertheless, this resolution is a practical procedure because 
subtilisin Carlsberg is inexpensive enzyme (US $12/gram from Sigma). In addition, 
subtilisin is stable and could be reused. Given the bulky nature of this substrate, it is 
not surprising that it might react slowly. Other bulky substrates such as esters of u-
branched amino acids also reacted slowly with subtilisin.27 The advantage ofthis 
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resolution over resolution by crystallization ofthe amine precursor as the mandelate 
salt is that this kinetic resolution yields the desired acrylate ester directly. 
Subtilisin usually shows only Iow to moderate enantioselectivity toward 
secondary alcohols, but in this case the enantioselectivity is very high. Moiecular 
modeling revealed the molecular basis for this high enantioselectivity. The fast-
reacting (1 S, 5S, 6S) enantiomer fits in the active and makes aIl five catalytically 
essentiai hydrogen bonds, although two ofthese are longer than normal, likely 
reflecting the Iow reactivity for the substrate. On the other hand, the slow-reacting 
(IR, 5R, 6R) alcohoi moiety encounters severe steric interactions with catalytically 
essential residues. These interactions either distort the catalytic histidine position or 
cause severe steric strain with Asn155, an oxyanion-stabilizing residue. 
Erna and coworkers proposed an alternative explanation for the 
enantioselectivity of lipases28 and subtilisin29 toward secondary alcohols. They 
suggest that the fast reacting enantiomer adopts a conformation where 
stereoelectronic effects favor reaction, while the slow enantiomers cannot adopt this 
conformation. Thus, the fast enantiomer shouid adopt a gauche (g- for proteases) 
conformation aiong the Ca1cohol-Oa1cohol-CC=O-Oy dihedral, allowing overlap of the 
antiperiplanar lone-pair orbital of Oalcohol with the 0* orbital of the breaking C-Oy 
bond. They propose that the slow reacting enantiomer cannot adopt this favorable 
orientation because the large substituent would hit the catalytic histidine. 
Our modeling does not support this proposaI because the fast reacting 
enantiomer cannot adopt a gauche orientation along the CaJcohol-Oa1cohol-CC=O-Oy 
dihedral. The fast-reacting enantiomer adopted an anti conformation aiong this bond 
( -172 0) in order to make the catalytically essential hydrogen bonds. Imposing a 
gauche conformation (-60°) along this dihedral caused a severe steric clash between 
the medium substituent (C2) and His 64 (1.78 A, with the Cl hydrogen syn to the 
oxyanion). The slow-reacting enantiomer, predicted to adopt an anti conformation by 
the stereoelectronic effects model, indeed adopted the anti conformation in 
conformations B (151°) and C (159°); however, because this orientation is also anti 
for the fast-reacting enantiomer, it cannot contribute to enantioselectivity. 
Conformation A of the slow enantiomer adopted a gauche conformation, ((63 O)g+, 
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rather than g-,) but still hit the catalytic His 64. Thus, we find no evidence to support 
the notion that stereoelectronic effects along the Calcohol-Oalcohol-CC=O-Oy dihedral 
contribute to the enantioselectivity of subtilisin toward alcoholl. 
Previous X-ray crystal structures of phosphonate transition state analogs 
containing secondary alcohols also do not support the notion that stereoelectronic 
effects along the Calcohol-Oalcohol-CC=O-Oy dihedral contribute to enantioselectivity. The 
fast reacting enantiomer of menthol bound to lipase from Candida rugosa did not 
adopt the predicted gauche conformation (130°).30 On the other hand, the slow 
reacting enantiomer did adopt a gauche conformation (71°), again contrary to 
predictions. 
The X-ray crystal structures of bovine cholesterol esterase are only of inactive 
forms,31 so we did not model their interactions with alcoholl. 
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Experimental Section 
General 
Chemicals were purchased from Sigma-Aldrich (Oakville, ON) and were used with-
out further purification. Subtilisin from Bacillus licheniformis (E.C. 3.4.21.62, catalog 
no. P5459) was obtained from Sigma (Oakville, ON) and Proteinase N from Bacillus 
subtilis (catalog no. 82458) was obtained from Fluka (Oakville, ON). Cholesterol es-
terase from beef pancreas (EC 3.1.1.13, catalog no. 1081) was obtained from Gen-
zyme (Cambridge, MA). 
Synthesis 
The alcohol1 and the acrylate ester were synthesized according to a previous 
method. 18 The l-acetate and I-butyrate were made by a similar method. 
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(±)-l-Acetate 
(±)-l (62.0 mg, 0.259 mmol) and LHMDS (100 mg, 0.598 mmol) were dissolved in 
THF (6 ml) and stirred for 1 h to give a gold-colored suspension. Acetic anhydride 
(60 Jll, 0.64 mmol) was added, and the solution was stirred for 16 h. The resulting 
gold solution was quenched with water (10 ml) then HCI(aq) (4 M, 10 ml), extracted 
with CH2Ch (3x20 ml), washed with saturated Na2C03(aq) (20 ml) and dried over 
MgS04. Concentration in vacua followed by flash column chromatography (silica, 4 : 
1 hexanes : EtOAc) gave (±)-I-Acetate (47.6 mg, 0.169 mmol, 65.3%) as a white 
solid: mp 122-123 oC; [a]D22 -47.2 (c 1.08, CHCh); IR (film) /..max 3328 (N-H), 2956 
(C-H), 2873 (C-H), 1727 (ester C=O), 1625 (amide C=O), 1538 (C=C), 1373, 1245, 
1100, 1016 cm-I; IH NMR (400 MHz, CDCh): Ô 6.00 (br d, IH, HN), 5.02-4.96 (m, 
IH, Hl), 4.28-4.20 (m, IH, H6), 2.03 (s, 3H, HI4), 2.05-1.45 (m, 12H, H2-H4, H7-
H9), 1.16 (s, 9H, HI2); I3C NMR (100 MHz, CDCb): Ô 177.4 (C, CIO), 170.4 (C, 
C13), 81.2 (CH, Cl), 56.2 (CH, C6), 56.1 (C, C5), 38.7 (C, CIl), 34.8 (CH2), 34.7 
(CH2), 32.2 (CH2), 31.8 (CH2), 27.5 (CH3, CI2), 21.5 (CH3, CI4), 21.1 (CH2), 20.2 
(CH2); MS: m/z 281 (6, M+), 238 (12, [M-CH3COt), 196 (30, [M-(CH3)3CCOt), 121 
(64, [M-{(CH3)3CCONH2+CH3COÛt), 120 (100, [M-
{(CH3)3CCONH2+CH3C02H} t), 102 (75, [(CH3)3CCONH3t), 57 (86); HRMS calcd 
for CI6H27N03 281.19909, found 281.20062. 
(±)-l-Butyrate 
(±)-l (810 mg, 3.38 mmol) and LHMDS·OEt2 (1.72 g, 7.12 mmol) were dissolved in 
THF (40 ml) and stirred for 1 h to give a gold-colored suspension. Butyryl chloride 
(750 JlI, 7.22 mmol) was added, and the solution was stirred for 1 h. The resulting 
clear yellow solution was quenched with water (20 ml) then HCI(aq) (4 M,50 ml), ex-
tracted with CH2Ch (3x50 ml), washed with saturated Na2C03(aq) (50 ml) and dried 
over MgS04. Concentration in vacua followed by flash column chromatography (sil-
ica,4: 1 hexanes: EtOAc) gave (±)-l-butyrate (901 mg, 2.91 mmol, 86.1%) as a 
white solid: mp 107-108 oC; [a]D22 -44.6 (c 1.01, CHCh); IR (film) /..max 3339 (N-H), 
2962 (C-H), 2872 (C-H), 1730 (ester C=O), 1632 (amide C=O), 1537 (C=C), 1453, 
1435,1416, 1394, 1367, 1305, 1203, 1186, 1100,994,945 cm-I; IH NMR (400 MHz, 
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CDCh): ô 6.04 (br d, 1H, RN), 5.01 (dd, J= 5.5,2.5 Hz, 1H, Hl), 4.26-4.18 (m, 1H, 
H6), 2.26 (t, J= 7.5 Hz, 2H, HI4), 2.08-1.45 (m, 14H, H2-H4, H7-H9, H15), 1.16 (s, 
9H, HI2), 0.94 (t, J= 7.4 Hz, 3H, H16); J3C NMR (100 MHz, CDCh): ô 177.5 (C, 
CIO), 172.9 (C, C13), 81.0 (CH, Cl), 56.4 (CH, C6), 55.8 (C, C5), 38.7 (C, CIl), 
36.6 (CH2), 35.0 (CH2), 34.9 (CH2), 32.4 (CH2), 31.7 (CH2), 27.6 (CH3, CI2), 21.1 
(CH2), 20.2 (CH2), 18.4 (CH2), 13.7 (CH3, C16); MS: m/z 309 (4, M+), 238 (15, [M-
C3H7COt), 224 (35, [M-(CH3)3CCOt), 121 (64, [M-
{(CH3)3CCONH2+C3H7C02} t), 120 (100, [M-{(CH3)3CCONH2+C3H7C02H} t), 
102 (82, [(CH3)3CCONH3t), 57 (78); HRMS calcd for C1sH31N03 309.23039, found 
309.23114. 
Identifying the active hydrolases. An enzyme library of commercial hydrolases was 
prepared as previously described. [19] Hydrolase solutions (20 ilL welr') were placed 
in a 96 weIl microplate followed by addition of assay solution (80 ilL weIl- I ). The fi-
nal concentrations were l-acetate (5.1 mM), BES (N,N-Bis(2-hydroxyethyl)-2-
aminoethanesulfonic acid, 3.6 mM), 4-nitrophenol (0.36 mM), and acetonitrile (8%). 
The plate was then placed in the microplate reader and shaken for lOs to ensure 
complete mixing, and the decrease in absorbance at 404 nm was monitored at 25 oC 
every Il s for 30 min. Each hydrolysis was carried out in triplicate and averaged. The 
normalized initial decrease in absorbance for the interval20-300 s was -13 s-' for 
subtilisin from Bacil/us licheniformis (initial hydrolase solution of 22 mg mL-1) and -
6 S-l for Proteinase N (initial hydrolase solution of 60 mg mL-l). These enzymes were 
then tested for enantioselectivity in small-scale reactions. 
Measuring hydrolase enantioselectivity. BES buffer (450 ilL, 50 mM, pH 7.2) and 
l-acetate (50 ilL, 76 mM in MeCN) were placed in a 1.5 mL centrifuge tube along 
with 12-19 mg ofenzyme. Reactions were shaken at 600 rpm and 37 oC for 12 h in an 
EppendorfThermomixer R, extracted with EtOAc (0.5 mL), dried with MgS04, and 
analyzed by gas chromatography on a Chrompack Chirasil-DEX CB column (25 m x 
0.25 mm) using He as a carrier gas (120 oC for 5 min, 2.5 oC min-l, 195 oC, 10 psi): 1-
acetate: k'i = 15.94 (S), a =1.01; 1: k'i = 17.10 (R), a = 1.02. Both l-acetate and 1 
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showed similar retention on thin layer chromatography (silica gel): Rf 0.65 and 0.57 
respectively in 1: 1 hexanes: ethyl acetate. To measure enantiomeric purity of reac-
tions involving I-butyrate, the remaining I-butyrate and product 1 were separated by 
TLC (Rf 0.81 and 0.57, respectively in 1: 1 hexanes: ethyl acetate). The product 1 as 
analyzed by GC as above, but enantiomers of I-butyrate did not separate under these 
conditions, so it was hydrolyzed to 1 with NaOH (1 mL, 6 M) in MeOH (4 mL), ex-
tracted with EtOAc (2 mL)and dried. To measure enantiomeric purity ofreactions 
involving l-acrylate, the remaining l-acrylate and product 1 were separated by 
chromatography (l-acrylate Rf 0.77 in 1: 1 hexanes: ethyl acetate) and analyzed by 
gas chromatography (130 oC, 0.5 oC min-l, 185 oC, 10 psi): l-acrylate: k') = 34.71 (S), 
a =1.01; 1: k') = 34.62 (R), a = 1.04, where k)' is the capacity factor given by k)' = 
(tRT-tM)/(tM) where tRTis the retenti on time of the sample and tM is the dead time. ais 
the selectivity factor given by the ratio of the Rand S capacity factors). For l-acetate 
the (S, S, S) enantiomer elutes first while for the alcoholl the (R, R ,R) enantiomer 
elutes first. Separation of l-acrylate and 1 was needed because they overlap in the 
GC. Enantioselectivity was calculated from the measured eep and ees according to E = 
In[eep(1 - ees)/(eep+ ees]/ln[eep(1 + ees)/(eep+ ees] as defined by Sih.22 
Resolution of l-Acrylate. Protease from Bacil/us licheniformis (60 mL aqueous pro-
pylene glycol solution, 73 mg mL-), 9.1 J1 mg-)) was placed in BES buffer (2 mM, 
560 mL) and MeCN (25 mL) and adjusted to pH 7.2 using a pH stat. l-Acrylate (2.88 
g, 98.2 mmol) in MeCN (25 mL) was then added and the pH was maintained at 7.2 by 
the addition ofNaOH (0.1 M). At 50% conversion the reaction was extracted with 
EtOAc (3 x 200 mL), washed with water (200 mL), brine (200 mL), dried over 
MgS04, and the solvent removed under reduced pressure. Chromatographie separa-
tion (5:1 hexanes : EtOAc) yielded (lS, 5S, 6S)-1 (1.07 g, 44.7 mmol, 46 %,99% ee) 
as a white solid: mp 102-104 oC and (IR, 5R, 6R)-I-acrylate (1.27 g, 43.3 mmol, 44 
%,99% ee) as a white solid: mp 126-127 oc. 
Computer Modeling. Molecular modeling was performed using the BiosymIMSI 
InsightIl97.0/Discover software (San Diego, CA) using the Amber32 95.0 force field. 
66 
Chapter 2 
A distant-dependent dielectric constant of 4.0 was used and 1-4 van der Waals inter-
actions were scaled by 50%. The starting subtilisin Carlsberg structure was obtained 
from the Brookhaven protein data bank33 (lcse).23 The eglin c inhibitor was removed 
and hydrogens were added to correspond to a pH of 7.0 and the catalytic histidine 
(His64) was protonated. Initial relaxation of the enzyme was performed with a simple 
phosphonate transition state analogue. With the backbone constrained, 200 iterations 
of steepest descent algorithm were preformed followed by 200 iterations of conjugate 
gradients algorithm with the backbone tethered by a 10 kcal morlA-1 force constant 
and finally the 200 iterations without any constraints. The substrate was then added 
and minimizations were preformed in an analogous manner. Crystallographic water 
molecules were inc1uded in aIl minimizations. Final minimization was continued until 
the RMS value was less than 0.0001 kcallmoI. 
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In the previous chapter we described the enantiocomplementary resolution of 
a bulky secondary a1cohol ester of a chiral auxiliary for the Diels-Alder reaction. 
Molecular modeling revealed the basis for the high enantioselectivity of subtilisin 
towards this auxiliary. 
In this chapter, we expand the hydrolysis to new bulky substrates - tertiary 
alcohol esters. Subtilisin was one of the principal enzymes, along with other common 
proteases, in this frrst investigation of the protease-catalyzed resolution of tertiary 
a1cohol esters. Tertiary a1cohols are found in many natural products, but currently 
there are only a few synthetic and biocatalytic methods to prepare enantiopure tertiary 
a1cohols. Substrate studies and molecular modeling were also used to further 
understand the reaction. 
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Abstract 
Currently there are only a few synthetic and biocatalytic methods to prepare 
enantiopure tertiary alcohols. We discovered several prote as es that hydrolyze esters 
of tertiary alcohols. The initial discovery was the subtilisin Carlsberg catalyzed 
hydrolysis of the ester bond of N-(phenylsulfinyl)-tert-buylglycine to release tert-
butanol and resolve the remote sulfinyl stereocenter with high enantioselectivity (E = 
116). Further testing revealed six different proteases that catalyzed the hydrolysis of 
a-trifluoromethyl-a-acetylenic ester with different acyl groups. Aspergillus melleus 
protease reacted slowly with the dihydrocinnamoyl derivative, but showed good 
reactivity (38% conversion) and enantioselectivity with the acetate (E = 14). In 
general proteases showed good reactivity but 10w enantioselectivity. Further, 
subtilisin Carlsberg and a-chymotrypsin also catalyzed the hydrolysis of more 
sterically demanding allylic and alkyl tertiary alcohol esters, which are not 
hydrolyzed by lipases. Molecular modeling suggests their reactivity is limited to 
tertiary alcohols with a methyl or smaller small substituent because this substituent 
must adopt an unfavorable syn-pentane-like orientation with the oxyanion of the first 
tetrahedral intermediate, creating internaI strain within the substrate. The 
enantioselectivity is low because the medium-sized substituent and the large 
substituent compete for the SI' leaving group pocket, where binding of the methyl 
group avoids sorne steric interactions and binding of the phenyl group adds a good 
hydrophobic interaction. 
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Introduction 
Tertiary alcohol functionalities are found in many natural products. For 
instance the flavor compounds such as a-terpineol and linalool contain the tertiary 
alcohol functionality. The preparation ofthis bulky functional group in enantiopure 
form is challenging for both enzymes and synthetic organic chemistry. 
Enzymatic resolution of sterically crowded stereocenters is challenging. There 
are many examples for the resolution of smaller racemic esters of chiral primary 
alcohols, secondary alcohols, and carboxylic esters, but resolution of quatemary 
stereocenters are rare. Examples include a,a-disubstituted carboxylic acid esters, l a-
fluorinated malonate diesters2 and N-acylamino acids,3 Figure 1. 
lipase OF 
R = Et, E= 10 
R = n-Pr, E = 20 
Me, F EtO~OEt 
~O 0 
Candida cylindracea 
lipase, ee 91 % 
porcine kidney acylase 
R1 =aryl, E=15 
Figure 1: Resolution of sterically demanding substrates containing a quatemary 
stereocenter. The reaction site is indicated with an arrow. 
There are several approaches to tertiary alcohol ester hydrolysis. One 
approach is to attach a linker to place the sterically hindered portion of the tertiary 
alcohol further from the reactive center. Substrates in which the reactive center was 
moved by two bonds in the acyl portion gave low enantioselectivity (E = 7 or 9.7, 
Figure 2).4 A distant chiral center reduces the potential for a highly enantioselective 
reaction. The tertiary a1cohol can also be modified to include an adjacent primary 
alcohol. Acylation occurred with an improved enantioselectivity (E = 12-70), but this 
approach is limited in substrate range, as the tertiary alcohol must contain an adjacent 
primary a1cohol.5 
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PPL, E = 7 CRL, E = 9.7 PFL (liPXaSeCAIK)B' E
I
= 12-70 
hydrolysis alcoholysis with n-butanol a~yl~tio~ 
Figure 2: Resolution ofremote tertiary alcohol stereocenters by reaction at a less 
hindered remote site. The reactive center is indicated with an arrow. 
Another approach is screening of enzyme libraries to identify those that accept 
hindered alcohols esters. A library of over 100 yeast strains was screened for 
hydrolysis ofracemic linalyl acetate.6 Twelve were found with activity, the best with 
an enantioselectivity offive. In another example, Candida cylindracea (rugosa) 
lipase (CRL) resolved several tertiary acetylenic acetate esters with low to moderate 
enantioselectivity7 and several lipases resolved l-bicyclo[ 4.1.0]-heptyl acetate and 
chloroacetate with moderate enantioselectivity.8 The only practical resolution was a 
Candida antarctica A (CAL-A) transesterfication of 2-phenylbut-3-yn-2-01 with vinyl 
acetate.9 
OH -CH Ph0'C~ 
?HO .. ~F3 CH3 .' E=2.5 # Ph OH ~CH 
CRL Ph~~:g~3 
OH 
~ 
yeast cultures E>20 CRL E -4, 
E = 5 abs. config. assumed 
CRL, RML 
E= 13-38 
OH 
~ 
CAL-A, E=65 
Figure 3: Screening revealed lipases that resolve tertiary alcohol stereocenters. 
Bornscheuer and coworkers noted lipases such as CRL that hydrolyze tertiary 
alcohol esters contain a GGGX sequence motif at the active center. IO In contrast, most 
commercial lipases have a GX motif at the active site. 1 1 Structural analysis revealed 
that the alcohol binding pocket was wider in the CRL than in other lipases, possibly 
aIIowing the tertiary alcohol to bind. The extra glycines in the GGGX motif provide 
more space for the bulky substrate. Database searching for hydrolases containing the 
GGGX motif identified four esterases that later showed activity towards three model 
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tertiary a1cohol acetates (linalyl acetate, methyl-l-pentin-l-yl acetate, 2phenyl-3-
butin-2-yl acetate). However, recent unpublished work suggests that the GGGX motif 
may be only part of the story because adding this motif to an esterase by site-directed 
mutagenesis did not enable it to hydrolyze esters of tertiary alcohols. Thus, 
researchers have not found a good solution of the problem of resolution of tertiary 
a1cohols. 
There are also only a few chemical methods to prepare enantiopure tertiary 
alcohols. The simplest approach is the enantioselective addition of organometallic 
reagents to a ketone. 12 The high reactivity of organolithium and Grignard reagents 
require at least one equivalent of chiral ligand, making them impractical. Using less 
than one equivalent allows reaction ofuncoordinated ketone, giving lower 
enantiomeric excess. To reduce the amount of chiral ligand, an organometallic 
reagent with lower nuc1eophilic character is used, supplemented by activation ofthe 
carbonyl or nuc1eophile. The low nuc1eophilic character of organozinc reagents 
makes them ideal for this type of reaction. In a noncoordinating solvent, for instance, 
they will not add to aldehydes, but with a chiral promoter organozinc reagents add to 
aldehydes with excellent enantioselectivity. Extending this addition to ketones proved 
difficult because of the lower reactivity of ketones prevented reaction even with 
promoters or at high temperature. The solution to the low reactivity was a more 
reactive diphenyl zinc (instead of a dialkyl zinc reagent) along with methanol, which 
exchanges for one ofthe phenyl groups to increase reactivity.13 Thus, addition of a 
large excess of diphenylzinc to ketones promoted by 3-exo-
(dimethylamino )isobomeol in the presence of methanol provides phenyl chiral benzyl 
a1cohols in 71-91 % enantiomeric excess (Scheme 1). Further improved reagents 
allowed addition of alkyl and alkynyl reagents to ketones. 14 In general the 
methodology is limited because large amounts of chiral ligand (10-20%) and 
organozinc reagents are required, and activated ketones are often necessary. 
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PhMe,48 h 
MeOH (150 mol%) 
~~~ 
15 mol% 
ç?C HO Ph ac W ~ .& 
Br 
yield 91%, yield 58%, yield 76%, 
91%ee 72%ee 75%ee 
Scheme 1: Addition of diphenylzinc to ketones with the chiral ligand 
3-exo-( dimethy lamino )isobomeol. 
We discovered an unexpected subtilisin catalyzed hydrolysis of a tertiary 
alcohol ester while testing for S-N sulfinamide cleavage. We made la to test 
hydrolysis of the S-N sulfinamide bond,15 and expected no hydrolysis of the tert-butyl 
ester because there were no known examples of subtilisin hydrolysis of tertiary 
alcohols esters. HPLC analysis revealed an enantioselective disappearance of starting 
material, but attempts to isolate expected products, sulfinic acid and tert-butyl glycine 
resulting from sulfinamide hydrolysis, were not successful. Following the reaction 
using NMR in D20 revealed that a different reaction occurred. The enzyme cleaved 
the ester bond to produce tert-butanol, and gave only a small amount of chemical S-N 
hydrolysis (Scheme 2). The reaction proceeded with high enantioselectivity, E = 116. 
The related substrates N-(methylsulfinyl)- and N-(benzylsulfinyl)-tert-butylglycine 
reacted with lower enantioselectivity, E = 12 and 6, presumably through ester 
hydrolysis as weIl. Thus subtilisin can resolve a remote sulfinyl stereocenter and, 
more surprisingly, hydrolyze a tertiary alcohol ester. 
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o 0 
Il ' R;"s'N~Ot-Bu Subtilisin VS'N~OH Il --_. 1 H Il + HO-t-Bu 
H 0 ~ 0 
1a R = Ph 
1b R = Me 
1c R = Bn 
1a c =36%, E= 116 
Scheme 2: NMR demonstrates subtilisin Carlsberg resolves a remote sulfinyl 
stereocenter by hydrolysis oftertiary alcohol ester, and not the sulfinamide bond. 
Encouraged by this result, we investigated the reactivity of several 
commercial proteases toward a-trifluoromethyl-a-acetylenic esters 2a-b (Table 1). 
This tertiary alcohol ester is an ideal substrate because the CF 3 group helps to reduce 
chemical hydrolysis via alkyl oxygen cleavage.7 AlI proteases tested, except 
Aspergillus oryzae protease, catalyzed the hydrolysis of the dihydrocinnamoyl ester 
2a with moderate to high conversion. The dihydrocinnamoyl derivative 2a showed 
less than 1 % chemical hydrolysis in buffered solutions after 48 h. The reactivity and 
enantioselectivity of Aspergillus oryzae protease and Aspergillus mel/eus protease 
improved upon using acetate 2b. The enantioselectivity of Aspergillus mel/eus 
increased to a moderate E = 14. The reactivity of subtilisin Carlsberg, subtilisin BL 
and Streptomyces griseus protease also improved, but there was no significant change 
in their enantioselectivity. a-Chymotrypsin did not react with 2b, which is not 
surprising considering its specificity for large non-polar acyl groupS.16 
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Table 1. Reactivity and enantiose1ectivity of proteases toward dihydrocinnamate 2a 
and acetate 2b.o 
FC~rO FC~r FC~rO 3 protease 3 3 
Ph O~R1 • Ph OH + Ph O~R1 
H20 
2a R1 = CH2C6Hs 
2b R1 = H 
2a 2b 
Protease %Co Ebc , %c Ebc , 
Aspergillus mel/eus 3 2.0 (R) 38 14 (R) 
protease 
Aspergillus oryzae n.T. d n.T. 15 6.4 (R) 
protease 
Subtilisin BL 15 1.5 (R) 46 2.7 (R) 
Subtilisin Carlsberg 27 1.3 (S) 84 2.5 (R) 
a-Chymotrypsin 51 1.9 (S) <1 
Streptomyces griseus 7 2.4(S) 14 2.4 (R) 
Erotease 
°Conversion: reaction for 48 h. ~nantioselectivity: the enantiomeric ratio E measures 
the relative rate ofhydrolysis of the fast enantiomer as compared to the slow 
enantiomer as defined by Sih (Chen, C.S.; Fujimoto, Y.; Girdaukas, G.; Sih, c.J. J. 
Am. Chem. Soc. 1982, 104, 7294-7299). The enantioselectivity was determined using 
the enantiomeric excess of substrate and product, which were determined by GC 
analysis on a column. CFast reacting enantiomer (enantiopreference) in parenthesis. 
The absolute configuration was determined by Candida rugosa lipase (CRL)-
catalyzed hydrolysis of2b, which gives (R)-2 (O'Hagan, D.; Zaidi, N. A. 
Tetrahedron: Asymmetry 1994, 5, 1111-1118). "No reaction. 
The dihydrocinnamoyl group was chosen for further study because it is stable 
to chemical hydrolysis. Even though the acetate 2b showed the highest overall 
activity and enantioselectivity, it readily hydrolyzes for other tertiary alcohols without 
an electron-withdrawing group, such as CF3, on the alcohol portion.7 Attempted 
resolution of Sb (the acetate equivalent of 5a, table 2) with Aspergillus oryzae and 
Aspergillus mel/eus proteases resulted in >50% chemical hydrolysis. These proteases 
favour the acetate «3% conversion with the dihydrocinnamoyl group, Table 1) and 
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may be useful for resolving tertiary a1cohols that form stable acetate esters. It is 
unclear why the acetate esters are unstable while the dihydrocinnamate esters are 
stable in aqueous solutions because both are unactivated. Not surprisingly the 
activated chloroacetyl esters were not stable in water and could not be tested. 
To establish the substrate range and decipher the molecular basis for protease 
reactivity and enantioselectivity toward tertiary a1cohol esters, we used subtilisin 
Carlsberg and a-chymotrypsin to resolve a variety of tertiary alcohols with the 
aqueous-stable dihydrocinnamoyl group. Subtilisin Carlsberg and a-chymotrypsin 
showed high reactivity, but with low enantioselectivity, toward tertiary acetylenic 
dihydrocinnamoyl esters 2a-3a. Subtilisin Carlsberg showed its highest 
enantioselectivity with 3a (E = 2.8) to give (R)-3 and a-chymotrypsin showed its 
highest enantioselectivity with 5a (E = 3.0). As weIl, subtilisin Carlsberg and a-
chymotrypsin catalyzed the hydrolysis of the allylic derivative 4a and alkyl derivative 
5a - sterically hindered substrates that show no activity with lipases. 17 Subtilisin 
Carlsberg showed moderate-Iow reactivity toward 4a (c ~5%) and low reactivity 
toward 5a (c <1 %). Decomposition of the allylic aIcohol product from 4a prevented 
accurate determination of conversion and E. a-Chymotrypsin showed moderate 
reactivity toward 4a (c ~ 25%) and low reactivity toward 5a (c ~ 1 %). The increased 
size of 6a over 5a (ethyl to isopropyl) prevented any reaction from occurring. 
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Table 2. Reactivity and enantioselectivity of subtilisin Carlsberg and a-chymotrypsin 
toward 2a-6a. a 
R2R3~ protease R2 R3 R2R3~ A Bn R70H Ao Bn R1 0 • + R1 H20 
SubtiIisin Carlsberg a-Chymotrypsin 
0/0 ca ees eep E,d %ca ees eep E,d 
(%)b (%)b (%) (%) 
b b 
~o '-':: o~Bn 27 4 Il 
2a 10-
l.3(S) 51 23 22 1.9(S') 
~o "'" o~Bn 22 12 42 
3a 1 .0 
2.8 (It) 94 61 4 1.6(It) 
do '-':: o~Bn ~5 n.d.h n.d. i n.d. ~25 n.d.h n.d. i n.d. 
4a 1 .0 
do-LB" 1 1 64 4.& 1 1 50 3.01 
Sa 1 .0 
~~"" k n.L n.L n.L n.L n.L n.L n.L n.L 6a 1 .0 
aConversion after reaction for 48 h. bEnantiomeric excess: enantiomeric excess of 
substrate and product were determined by GC analysis on a chiral column. 
CEnantioselectivity: the enantiomeric ratio E measures the relative rate of hydrolysis 
of the fast enantiomer as compared to the slow enantiomer as defined by Sih (Chen, 
C.S.; Fujimoto, Y.; Girdaukas, G.; Sih, C.J. J. Am. Chem. Soc. 1982,104, 7294-
7299). dEnantiopreference in parenthesis. eThe absolute configuration was determined 
by Candida rngosa (CRL)-catalyzed hydrolysis of2b, which gives (R)-2 (O'Hagan, 
D.; Zaidi, N. A. Tetrahedron: Asymmetry 1994, 5, 1111-1118)JThe absolute 
configuration was determined by Candida antarctica lipase A (CAL-A)-catalyzed 
acylation of 3 with vinyl acetate, which proceeds with R-selectivity (Krishna, S. H.; 
Persson, M.; Bomscheuer, U. T. Tetrahedron: Asymmetry 2002, 13,2693-2696). gNot 
determined. hThe enantiomers could not be separated by GC or HPLC.iNo product 
allylic alcohol was detected as it readily decomposed in aqueous solutions. However, 
we observed loss of substrate in the presence of enzyme. jThe enantioselectivity may 
be inaccurate because of low conversion. kNo reaction. 
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Tertiary alcohols react slower than secondary alcohols because they fonn a 
syn-pentane-like interaction with the oxyanion hole in the first tetrahedral 
intennediate. For secondary alcohols, the orientation within the enzyme places the 
smallest group (hydrogen) in a syn-pentane-like orientation to the oxyanion (Figure 
4a). A hydrogen fits in this orientation easily, but in a tertiary alcohoI the hydrogen is 
replaced with a larger group creating significant steric strain. For instance, a 
methyl/methyl syn-pentane interaction destabilizes a confonnation by -3.6 
kcal/mol. l8 Previous work by O'Hagan and coworkers with lipases suggests that 
acetylene occupies the syn-pentane-like position in tertiary alcohols such as 3a based 
on absolute configuration. 17 Tertiary alcohols where the smallest substituent was 
larger than an acetylene did not react. While subtilisin Carlsberg and a-chymotrypsin 
show high reactivity toward the secondary alcoholl-phenethyl dihydrocinnamate,19 
and tertiary acetylenic ester 3a, the conversion decreases with more sterically 
hindered tertiary alcohols. The allylic ester 4a reacts two- to five-fold slower, the 
sterically demanding tertiary alkyl ester Sa reacts approximately fifty-fold slower, 
and there is no reaction with 6a. Molecular mechanics calculations suggest a 
methyl/oxyanion syn-pentane-like interaction is -2.5 kcal/mol higher in energy than 
an acetylene/oxyanion syn-pentane-like interaction (Figures 4b and 4c). Thus 
replacing hydrogen of a secondary alcohol with anything larger reduces activity. 
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(c) 
S1~ Me)(08 . )l kO-senne 
Ph 0- 1 
R 
ca. 2 kcal/mol higher in energy 
(b) S1r III 0 8 
\. Me)l *O-serine 
Ph R 0- 1 
(d) R 
S1r-::: III 08 
\. Ph)l *O-serine 
Mes 0- 1 
R 
Figure 4. Sehematie representation of the proposed conformation of the fIfst 
tetrahedral intermediate ofprotease-eatalyzed ester hydrolysis. (a) For a seeondary 
alcohol, the hYdrogen orients to form a syn-pentane-like orientation with oxyanion. 
(b) For a tertiary aeetylenie ester, the smaIIest substituent (acetylene) forms the syn-
pentane-like interaction with oxyanion. The fast-reaeting (R)-enantiomer binds with 
the medium-sized methyl group in the SI' poeket and the larger phenyl group open to 
solvent (e) When the substituent forming the syn-pentane-like interaction with 
oxyanion is methyl or larger the transition state is destabilized and the reaetion is 
slow. (d) The slow-reacting (5)-enantiomer binds with the large phenyl group in the 
SI' poeket and the medium-sized methyl group open to solvent. 
If the aeetylene susbtituent of3a oeeupies the syn-pentane-like position, then 
the placement of the two other susbtituents determines the enantioseleetivity of 
subtilisin Carisberg. Previous modeling of seeondary alcohol resolution with 
subtilisin reveal one poeket - the SI' poeket - that binds one substituent of the alcohol 
portion of an ester, while the other points towards solvent.20 This poeket is narrow 
and ean aeeommodate substituents approximately the size of a phenyl group. In 3a 
either the phenyl or the methyl substituent ean oeeupy the SI' aleohol poeket. 
Moleeular modeling of the fIfst tetrahedral intermediate for subtilisin Carlsberg-
eatalyzed hydrolysis of 3a reveals that (R)-3a places the methyl group in the SI' 
poeket, while (5)-3a places the phenyl group in this poeket (Figure 5). In both cases 
the other substituent is orientated towards the solvent, and the acetylene group forms 
the syn-pentane-like orientation with oxyanion. Placing the methyl group of (R)-3a in 
the SI' poeket avoids sorne sterie interactions between the poeket and the phenyl 
group. However, binding the phenyl group of (5)-3a has a favourable hydrophobie 
interaction with the poeket. The enantioseleetivity for the subtilisin eatalyzed 
resolution is low beeause of these eompeting hydrophobie interactions. A similar 
result was obtained for the resolution of the seeondary phenethyl alcohol, where there 
was no clear favourite between phenyl and methyl for binding in the SI' poeket and 
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the enantioselectivity was only 1.2.20b Other non-productive conformations (acetylene 
not in the syn-pentane like position) encountered severe steric clash with the active 
site residues of the protein. 
Figure 5. Catalytically productive orientation of the tetrahedral intermediates for the 
subtilisin Carlsberg catalyzed hydrolysis of (R)-3a (a) and (S)-3a (b) as identified by 
molecular modeling. The substrate atoms (green) and important residues are shown as 
sticks, and the remaining enzyme in spacefill (blue). The binding modes of a and b 
maintain all catalytically essential hydrogen bonds and the acyl dihydrocinnamoyl 
group was bound in the SI acyl site. The acetylene occupied the same site as 
hydrogen of a secondary alcohol, based on molecular mechanics calculations and 
substrate mapping experiments with 4-6. (a) In the fast-reacting enantiomer, (R)-3a, 
the methyl group is bound in the hydrophobic SI' pocket and the phenyl group is 
exposed to solvent, water. (b) In the slow-reacting enantiomer, (5)-3a, the phenyl 
group is bound in the hydrophobic SI' pocket and the methyl group is exposed to 
solvent, water. 
Consistent with this explanation for enantioselectivity, subtilisin-Carlsberg-
catalyzed hydrolysis of 3a increased from E = 2.8 in 90: 1 0 water-acetonitrile to E = 
4.2 in 40:60 water-acetonitrile. The high concentration of acetonitrile favors the 
phenyl group in the solvent; thus, the enantiomer preference shifts toward the (R)-
enantiomer, which orients with the methyl group in the SI' pocket and the phenyl 
group in solvent. This result suggests that the enantioselectivity for acylation of 
tertiary a1cohols in organic solvent would also be higher. Unfortunately, we did not 
detect any reverse reaction, possibly because binding predominately occurs in the 
acyl portion for proteases. 
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Discussion 
Here we report the protease-eatalyzed hydrolysis of tertiary aleohol esters, and 
also the resolution of a remote sulfinyl stereoeenter by subtilisin. The hydrolysis of 
tertiary alcohol esters by proteases is an unexplored area in bioeatalysis. Many of the 
proteases tested showed sorne aetivity, suggesting this may be a general reaetion. 
There is only one literature example of a protease-eatalyzed hydrolysis: thermitase 
eatalyzes the deproteetion of tert-butyl esters of several N-proteeted peptides.21 
The resolution of la demonstrates subtilisin's ability to resolve a remote 
sulfinyl stereoeenter. The stereocenter is three bonds from the reaeting earbonyl. In a 
related reaetion, a erude lipase preparation from Pseudonomas sp. resolved a three-
bond-distant sulfoxide with high enantioseleetivity.22 Chiral aldehyde inhibitors of 
subtilisin Carlsberg, with a stereoeenter three bonds from the earbonyt23 showed a 
4.8-fold preference for the R-enantiomer of the aldehyde when eomparing their 
inhibition constants (Figure 6, a). Moleeular modeling ofthese aldehydes revealed 
that the R-inhibitor was bound more deeply in the hydrophobie SI region than the S-
enantiomer. 
The substrate la also resembles the hippurate acyl group, an excellent acyl 
group for subtilisin. For example, the hydrolysis of the phenyl hippurate ester is 
approximately 200 times faster than the eorresponding phenyl aeetate (Figure 6, b).24 
Their KM values differ by 100-fold, indieating that better binding for the hippurate 
accounts for most of the increase in catalytic efficieney. The phenyl ring of the 
hippurate contributes to binding, as replaeing it leads to a 500-fold deerease in 
catalytie efficieney (Figure 6, e). Thus the ability of la to hydrolyze tertiary alcohol 
esters and resolve a remote stereoeenter may be due to an efficient acyl group. The 
methyl and benzyl compounds, lb-le, do not reaet with sueh a high 
enantioseleetivity, possibly due to weaker binding. 
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o 
.)lOPh 
KM = 12.5 mM, kcat = 0.78 S-1 
kea/KM = 62 mor1s-1 
o 
.)lN~oMe 
H 0 
kea/KM = 2.7 mor1s-1 
Figure 6: (a) Subtilisin Carlsberg has a 4.8 fold difference in the inhibition constants 
of chiral aldehyde inhibitors. The stereocenter in la is located in the same relative 
position. (b) Phenyl hippurate reacts 200 times more efficiently than the 
corresponding acetate. Most of the difference is in KM, indicating the hippurate binds 
preferentially to subtilisin. (c) The phenyl ring of the hippurate group contributes 
significantly to catalytic efficiency of the reaction, with a 500-fold greater kcaJKM 
value compared with the methyl analogue. 
It is interesting to note that only a few lipases catalyze hydrolysis of tertiary 
alcohol esters, whereas for serine proteases it appears to be a more general reaction. 
Lipases likely show low activity toward tertiary alcohols because of their restricted 
alcohol-binding site and weIl defined pockets. This may increase the internaI strain 
arising from the syn-pentane-like interaction. While lipases must bind substrate in a 
folded conformation for reaction,25 proteases bind substrate in an extended 
conformation.26 The active site is on the surface of the enzyme allowing it to 
accommodate polypeptides, making it more accessible to sterically hindered 
substrates such as tertiary alcohols.27 
Proteases may also use acyl group binding to anchor the substrate to the 
protease active site and help stabilize the transition state.28 This binding may help 
overcome the destabilizing syn-pentane-like interaction in tertiary alcohols. Enzymes 
often use an anchoring group to bind and orient a substrate for reaction. For example, 
orotidine 5' -monophosphate decarboxylase is an efficient catalyst.29 Although 
reaction occurs entirely in the orotic acid base, the ribosyl phosphate moiety is 
essential for activity. Orotic acid (2.5 x 10-5 M-1 S-I) alone shows twelve orders of 
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magnitude lower activity than orotidine 5'-monophosphate (6.3 x 107 M-1 s-I), even 
though orotic acid binds to the enzyme active site (Ki = 9.5 mM). In a few cases, 
researchers have used complementary anchor groups to enhance biocatalytic 
reactions. For example, the fungus Beauveria bassiana did not hydroxylate 
cyclopentanone, but did hydroxylate the N-benzoylspirooxazolidine derivative with 
moderate yield and diastereoselectivity.3o 
Although the enantioselectivities are low, the enantioselectivity of the reaction 
might be optimized using mutagenesis. For example, Reetz and coworkers expanded 
the range ofsubstrates accepted by the lipase fromPseudomonas aeruginosa. 31 The 
wild type lipase hydrolyzes esters of straight chain acids, but cannot hydrolyze more 
sterically demanding substrates. Mutation of residues spatially close to the active site 
and screening gave mutants with an increase in hydrolysis rate. One mutant could 
even hydrolyze a bulky adamantyl carboxyl acid ester with low activity. Thus protein 
engineering can increase an enzyme' s substrate acceptance and may be used in this 
case to improve reactivity and enantioselectivity for the protease catalyzed resolution 
of tertiary alcohol esters. Another method to improve the enantioselectivity is to use 
groups that are easily distinguished, unlike phenyl and methyl. Since only part of the 
alcohol binds in the active site and the rest remains in solution, the difference in 
hydrophobicity (or polarity) of the substituents contributes to enantioselectivity. The 
hydrophobicity, measured by LogP, is similar for phenyl (2.1) and methyl (LI) 
contributing to the low enanatioselectivity.32 Increasing the difference hydrophobicity 
increased the enantioselectivity of subtilisin towards secondary alcohols,2o and a 
similar approach may be successful here. 
Experimental section 
GenerallH- and I3C-NMR spectra were obtained as CDCh solutions at 300 MHz 
and 75 MHz, respectively. Chemical shifts are expressed in ppm (ô) and are 
referenced to tetramethylsilane or solvent signal. Coupling constants are reported in 
Hertz (Hz). GC analyses were performed on a 25 m x 0.25 mm Chrompack CP-
Chiralsil-Dex CB column (Varian Inc., Palo Alto, USA) with He as carrier gas using 
one of the three following temperature programs: A 17.5 psi, 50 oC, 5 oC min-l, 150 
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oc held for 5 min, 2.5 oC min-I; 175 oC held for 5 min, 5 oC min-l, 200 oC held for 30 
min); B 17.5 psi, 120 oC held for 10 min, 20 oC min-l, 200 oC held for 20 min. HPLC 
analyses were perfonned on a 4.6 x 250 mm Daicel Chiralcel OD column (Chiral 
Technologies, Exton, USA) and monitored at 254 nm. Flash chromatography with 
silica gel (35-75 mesh) was used to purify aIl intennediates and substrates. AlI 
reagents, buffers, starting materials and anhydrous solvents were purchased from 
Sigma-Aldrich (Milwaukee, USA) and used without purification. AlI air- and 
moisture-sensitive reactions were perfonned under Ar. Subtilisin Carlsberg, protease 
from Streptomyces griseus and a-chymotrypsin were purchased from Sigma-Aldrich 
(St. Louis, USA). Lipase from Candida rugosa (CRL), lipase A from Candida 
antarctica, protease from Aspergillus mel/eus and protease from Aspergillus oryzae 
were a generous gift from Altus Biologies (Cambridge, USA). 
o Synthesis of N-(suIfinyl)-
NEt3 JL ~Ot-Bu 
• R ~ g tert-butylglycines, la-le. 0, o~ 'S-N 1 + FI ~ 
o General procedure.33 The 
t-butyl ester of glycine (11 mmol, as HCL salt) was added dropwise to a solution of 
N-(sulfinyl)phthalimide (11 mmol) and NEh (18 mmol) in CH2Ch (50 mL) over 1 h. 
Stirring was continued for 5 h and the reaction mixture was filtered to remove 
phthalimide and washed with water (2 x 50 mL), sat. NaC03 (2 x 50 mL), brine (50 
mL), dried over MgS04 and the solvent evaporated under reduced pressure and 
purified by colurnn chromatography in EtOAc/hexanes. 
cr? N-(phenylsulfinyl)-tert-butylglycine, la Purification on silica 
r(YS'N~Ot-Bu V H 0 gel (20:80 hexaneslEtOAc/hexanes) gave a clear yellow liquid 
(1.36 g, 47 %); IH NMR: 1.35 (s, 9H), 3.15 (d, IH,J= 12),3.75 (d, IHJ= 11), 4.95( 
t, IH), 7.45 (m, 3H), 7.68 (m, 2H); BC NMR: Ô 28.3, 40.5,82.8, 126.2, 129.2, 131.2, 
143.5, 169.4; HR-EIMS m/z: M+ calcd for C 12H 17N03S 255.09292, found 
255.09230. HPLC: 95/5 HexaneslEthanol, flow 0.8 mL/min, la tR = 8.2 min, tR = 9.5 
min; 2-(p-nitrophenyl)-ethanol (internaI standard) tR = 16.6 min. 
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Ç! N-(methylsulfinyl)-tert-butylglycine, lb Purification on silica gel 
....... s, ~Ot-Bu ~ Il (25:75 hexaneslEtOAc/hexanes) gave a clear liquid (710 mg, 39%); 
o 
IH NMR: 1.37 (s, 9H), 2.73 (s, 3H), 3.15 (d, IH, J= 12),3.75 (d, IH, J= Il); 13C 
NMR (COCh, 75 MHz): Ô 28.1, 38.1, 40.5, 82.8,169.6; HR-EIMS m/z: M+ calcd for 
C7HISN03S 193.0773, found 193.0785. HPLC: 95/5 Hexanes/Ethanol, flow 0.8 
mL/min, lb tR = 7.6 min, tR = 8.8 min; 2(p-nitrophenyl)-ethanol (internai standard) tR 
= 16.6 min. 
r7) Ç? N-(benzylsulfinyl)-tert-butylglycine le Purification on silica 
~s, ~Ot-Bu ~ Il gel (25:75 hexanes/EtOAc/hexanes) gave a clear liquid (610 
o 
mg, 50%); IH NMR: 1.35 (s, 9H), 3.15 (d, IH, J= 12),3.75 (d, IH, J = 11),4.90 (d, 
IH, J = 12), 5.29 (d, IH, J = 12), 7.40 (m, 3H), 7.62 (m, 2H); 13C NMR: Ô 28.5,40.5, 
59.3,82.8, 128.4, 128.9, 130.5, 134.4, 169.4; HR-EIMS m/z: M+ calcd for 
C13H I9N03S 269.1086, found 269.1102. HPLC: 90/10 Hexanes/Ethanol, flow 1 
mL/min, le tR = 6.6 min, tR = 7.6 min; 2-(p-nitrophenyl)-ethanol (internaI standard) tR 
=12.6 min. 
NMR reaction IH NMR was used to determine the products ofthe subtilisin 
Carlsberg-catalyzed hydrolysis of la. Reactions conditions were as follows: 0 20 (1 
mL) containing phosphate buffer (20 mM, pH 7.4) and subtilisin Carlsberg (10 mg, 
Fluka 82518), d3-MeCN (100 ~), la (60 mM) and sodium 4,4-dimethyl-4-
silapentane-l-sulfonate,34 (DSS, 1 mM). The reaction was monitored over the course 
of 24 h using a 500 MHz instrument. Under these conditions the tert-butyl CH3 group 
has the following 500 MHz I H resonances relative to DSS: tert-butanol Ô = 1.228, 
tert-butylglycine Ô = 1.494, and la Ô = 1.349. The major product was tert-butanol 
from ester cleavage, while a small amount of tert-butylglycine from S-N cleavage 
(less than 5%) was detected. A blank reaction with no enzyme also showed a small 
amount of tert-butylglycine after 24 h. 
88 
Chapter 3 
Synthesis oftertiary alcohol substrates. We synthesized esters 2a-6a, and 2b by 
treating the corresponding tertiary alcohol with the appropriate acid chloride in the 
presence ofpyridine (Scheme 3a). We synthesized tertiary alkenyl alcohols via vinyl 
magnesium bromide addition to the appropriate ketone (Scheme 3b) and tertiary alkyl 
alcohols via modified alkyl addition of magnesium ate complexes derived from 
Grignard and alkyllithium reagents35 to the appropriate ketone (Scheme 3c). 
(b) 1 
PhAO 
(c) X 
Ph 0 
a R =CH2CsHs 
bR=H 
VinylMgBr ~ 
THF • Ph OH 
MeMgBr/MeLi =-Y 
THF • Ph OH 
2a Rl = Ph; R2 = CF3; R3 = CCH 
2b R l = Ph; R2 = CF3; R3 = CCH 
3a Rl = Ph; R2 = CH3; R3 = CCH 
4a Rl = Ph; R2 = CH3; R3 = CH=CH2 
5a Rl = Ph; R2 = CH3; R3 = CH2CH3 
5b R l = Ph; R2 = CH3; R3 = CH2CH3 
6a Rl = Ph; R2 = CH3; R3 = CH(CH3)2 
4 
6 
Scheme 3. Synthesis of esters 2a-6a, 2b, Sb, and tertiary alcohols 4 & 6. 
Pyridine 
Synthesis of racemic esters 2a-6a, 2b. 
General procedure. Dihydrocinnamoyl 
chloride (7.5 mmol) was added drop-wise to 
a stirred solution oftertiary alcohol (5 mmol) and pyridine (7.5 mmol) in CH2Ch (25 
mL) at 0 oc. The ice bath was removed and stirred until the reaction was complete by 
TLC (2-3 d). The reaction was quenched with the addition ofsat. NaHC03 (25 mL). 
The layers were separated and the aqueous layer was extracted with CH2Ch (2 x 
25mL). The combined organic layers were washed with sat. NaHC03 (2 x 25 mL), 
sat. NaCl (25 mL) and dried over MgS04. The organic layer was concentrated in 
vacua to give the crude ester. AlI substrates were purified on silica gel. The relevant 
analytical data are given below: 
F3C '1 0 ~'// 3-Dihydrocinnamic acid I-phenyl-l-trifluoromethyl-prop-2-I~ o~ b V 
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ynyl ester (2a). Purification on silica gel (1:1 hexanes/CHzClz) white solid (550 mg, 
43%): mp 71-72 oC; IH NMR Ô 2.81 (m, 2H), 2.89 (s, IH), 2.97 (t, J= 7.4, 2H), 7.30 
(m, 8H), 7.48 (d, J = 6.9 Hz, 2H); l3C NMR Ô 30.5, 36.0, 75.2, 78.9, 120.4, 124.1, 
126.6, 126.9, 128.5, 128.6, 128.7, 129.8, 132.3, 139.9, 168.9; HRMS calcd for 
Cl9HISF30zNa [M+Nat 355.0898. Found: 355.0921. The enantiomers were separated 
using GC (program A; (R)-2a, IR = 42.9 min; (5)-2a, IR = 43.1 min). 
~'11 Acetic acid I-phenyl-l-trifluoromethyl-prop-2-ynyl ester (2b).36 F3C '1 0 1: o~ Purification on silica gel (100% hexanes to 80:20 hexanes/acetone) to give a low melting white solid (288 mg, 51 %): 1 H NMR Ô 2.20 (s, 3H), 
2.93 (s, tH), 7.38-7.44 (m, 3H), 7.62-7.65 (m, 2H); l3C NMR Ô 21.3, 75.5 , 78.8, 
120.3, 124.1, 126.9,128.6, 129.9, 132.4, 166.9. The enantiomers were separated 
using GC (program B; (R)-2b, IR = 5.2 min; (5)-2b, tR = 5.5 min). 
_ ~ 0 3-Dihydrocinnamic acid I-methyl-l-phenyl-prop-2-ynyl 
(Y 'o~ ester (3a). Purification on silica gel (100% hexanes to 95:5 
hexanes/EtOAc) to give a clear liquid (927 mg, 67%): IH NMR 
Ô 1.85 (s, 3H), 2.65 (m, 2H), 2.79 (s, IH), 2.92 (t, J = 7.8, 2H), 7.15-7.34 (m, 8H), 
7.47-7.49 (m, 2H); l3C NMR Ô 30.8, 32.2, 36.5, 75.6, 75.8, 83.1, 124.9, 126.4, 128.0, 
128.5, 128.6, 140.6, 142.2, 170.6; HRMS calcd for CI9HlSOzNa [M+Nat 301.1224. 
F ound: 301.1204. The enantiomers were separated using GC (program A; (5)-2a, tR = 
46.7 min; (R)-2a, tR = 46.9 min). 
d o Dihydrocinnamic acid I-methyl-l-phenyl-aUyl ester (4a). l "" o~ Purification on si li ca gel (100% hexanes to 95:5 ~ V 
hexanes/EtOAc) to give a clear liquid (493 mg, 35%): IH NMR 
Ô 1.87 (S, 3H), 2.69 (m, 2H,), 2.97 (t, J = 7.5, 2H), 5.24 (dd, J = 0.9, 10.5, IH), 5.26 
(dd, J= 0.9,17.4, IH), 6.25 (dd, J= 10.8, 17.4, IH), 7.21-7.34 (m, IOH); 13C NMR Ô 
25.5,31.0,36.9,83.3, 114.5, 125.3, 126.3, 127.3, 128.3, 128.5, 128.6, 140.7, 141.5, 
143.7,171.2; HRMS calcd for CI9HzoOzNa [M+Nat 303.1373. Found: 303.1360. 
The enantiomers could not be separated using GC or HPLC. 
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Dihydrocinnamic acid I-methyl-l-phenyl-propyl ester (Sa). ~ ;:; o~ Purification on silica gel (1: 1 hexanes/CH2Ch) to give a clear cr' V liquid (1.13 g, 61%): IH NMR Ô 0.72 (t, J= 7.5, 3H), 1.76 (s, 
3H), 1.96 (q, J=7.2, 2H), 2.63 (t, J = 7.5, 2H), 2.92 (t, J= 7.8, 2H), 7.15-7.27 (m, 
IOH); 13C NMR Ô 8.3, 24.5,31.2,35.4,37.0,84.6, 124.9, 126.4, 127.0, 128.3, 128.6, 
128.7, 140.9, 145.0, 171.6; HRMS calcd for CI9H2202Na [M+Nat 305.1523. Found: 
305.1517. The enantiomers could not be separated using Ge. 
d o Acetic acid I-methyl-l-phenyl-propyl ester (Sb). Purification on '-":: o~ silica gel (100% hexanes to 95:5 hexaneslEtOAc) to give a clear 1 h liquid (518 mg, 54%): IH NMR Ô 0.78 (t, J= 7.2, 3H), 1.81 (s,3H), 
2.02 (q, J=7.5, 2H), 2.07 (s, 3H), 7.20-7.35 (m, 5H); BC NMR Ô 8.2, 22.3, 24.5, 
35.4,84.4, 124.7, 126.9, 128.2, 145.0, 169.8; HRMS calcd for C12H I60 2Na [M+Nat 
215.1049. Found: 215.1047. The enantiomers were separated using GC (program B; 
(S)-5b, tR = 6.6 min; (R)-5b, tR = 6.8 min). 
_ ..y Dihydrocinnamic acid 1,2-dimethyl-l-phenyl-propyl ester 
cr 'O~ (6.). Purification on sHica gel (100"10 hexanes to 90:10 
hexanes/EtOAc) to give a clear liquid (536 mg, 36%): I H NMR 
Ô 0.64 (d, J = 6.9), 0.91 (d, J = 6.9), 1.77 (s, 3H), 2.02 (sept, IH, J = 6.8),2.60 (t, J = 
7.5, 2H), 2.91 (t, J= 7.5, 2H), 7.10-7.28 (m, 10H); BC NMR Ô 17.2, 17.7, 19.0,31.1, 
37.0,39.8,85.6, 125.4, 126.4, 126.9, 128.0, 128.6, 128.7, 140.9, 144.1, 171.5, 171.5; 
HRMS calcd for C20H2402Na [M+Nat 319.1662. Found: 319.1673. The enantiomers 
could not be separated using Ge. 
Synthesis of racemic tertiary a-acetylenic alcohols 4 & 6. General procedure. 
Alkynyl magnesium bromide (0.5 M; 48 mL, 24 mmol) was added to a solution of the 
appropriate ketone (20 mmol) in THF (10 mL) and refluxed for 4 h or until complete 
by TLe. The solution was cooled to RT and quenched with dH20 (25 mL) and 
extracted with EtOAc (3 x 25 mL). The combined organic layers were washed with 
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sat. NaCI (25 mL) and dried over MgS04. The organie layer was eoneentrated in 
vacuo to give the erude tertiary alcohoL The relevant analytieal data are given below: 
d Synthesis of2-phenyl-but-3-en-2-ol (4).37 Vinyl magnesium bromide l "" OH (0.5 M; 48 mL, 24 mmol) was added to a solution of acetophenone (20 fi . 
mmol) in THF (10 mL) and refluxed for 4 h. The solution was eooled to 
RT and quenehed with dH20 (25 mL) and extraeted with EtOAe (3 x 25 mL). The 
eombined organic layers were washed with sat. NaCl (25 mL) and dried over MgS04. 
The organie layer was eoneentrated in vacuo to give a cIear liquid (2.67 g, 90%): I H 
NMR Ô 1.68 (s, 3H), 5.17 (dd,J= 0.9,10.5, 1H), 5.32 (dd, J= 1.2, 17.4, IH), 6.20 
(dd, J= 10.8, 17.4, 1H), 7.30-7.51 (m, 5H); 13C NMR Ô 29., 74.8, 112.4, 125.3, 
127.1, 128.3, 144., 146.6. The enantiomers were separated using HPLC (Chiralcel 
OD-H eolumn, 98:2 hexanes/i-PrOH, 1.0 mL/min, 254 nm; (R or S)-7, tR= 12.7 min; 
(R or S)-7, tR = 16.2 min). 
d: Synthesis of 3-methyl-2-phenyl-butan-2-ol (6).35 Methyllithium (1.5 M; l "" OH 50 mmol, 33 mL) was added to methylmagnesium bromide (3.0 M, 10 fi 
mL, 30 mmol) at -78 oC and stirred at this temperature for 1 h. A solution 
ofisobutyl acetophenone (3.70 g, 25 mmol) in THF «40 ml) was then added drop-
wise and stirred for 6 h at -78 oc. 35 The reaction was quenched with addition of sat. 
NH4Cl (100mL) and extracted with EhO (3 x 50 mL). The combined organic layers 
were washed with sat. NaCl (50 ml) and eoncentrated in vacuo to give give a cIear 
liquid (4.05 g, 96%): I H NMR Ô 0.82 (d, J= 6.9),0.91 (d, J= 6.9),1.55 (br s, IH), 
1.65 (s, 3H), 2.04 (sept, IH, J= 6.9), 7.22-7.45 (m, 5H); BC NMR Ô 17.3, 17.5, 38.7, 
125.4, 126.5, 127.9, 147.9. The enantiomers were separated using GC (program B; (R 
or S)-9, IR = 9.2 min; (R or S)-9, tR = 9.9 min). 
R2 R3 0 Protease-catalyzed 
+ R1X.O~R 
hydrolysis of esters 1a-6a, 
protease 
2b. Subtilisin BL, Aspergillus 
melleus protease, Aspergillus oryzae protease, subtilisin Carlsberg, a-ehymotrypsin 
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and protease from Streptomyces griseus in 50 mM BES buffer (10 mg/mL, pH 7.2, 
450 !-lL) and substrate (100 mM in CH3CN, 50 !-lL) were mixed in a 1.5 mL glass vial 
at 30 oC for 24 h to 48 h. The reaction was terminated with the addition of CH2Ch 
(500 !-lL). The phases were separated by centrifugation, and the organic layers were 
collected. The aqueous phase was extracted with CH2Ch (2 x 500 !-lL) and the 
combined organics were evaporated under a stream of air. The residue was diluted 
with EtOAc or EtOH (150 !-lL) and analyzed by GC or HPLC. The enantiomers were 
separated using the conditions described above. In cases where GC could not separate 
enantiomers of the substrate, it was purified using flash chromatography, hydrolyzed 
in ethanolic KOH and the enantiomeric excess was determined as the alcohol. 
~" cr 'OH subtilisin Carlsberg '< ~" 0 ~ " Attempted cr 'o~Bn + cr 'OH transesterification of 2-
phenyl-but-3-yn-2-01 with 
subtilisin Carlsberg. Subtilisin Carlsberg (50 mg), dihydrocinnamic vinyl ester (18 
mg, 100 !-lmol), 2-phenyl-but-3-yn-2-01 (73 mg, 500 !-lmol) and 4-A molecular sieves 
(100 mg) were added to a glass vial. Anhydrous dioxane (2 mL) was added and the 
mixture was stirred at 30 oC for at least 48 h. A small amount of the solution was 
removed, filtered through a 0.45 !-lm nylon filter and analyzed by GC. The 
enantiomers were separated using the conditions described above. 
Modeling of tetrahedral intermediates bound to subtilisin Carlsberg. AlI 
modeling was performed using lnsight 112000.1/ Discover (AcceIrys, San Diego, 
USA) on a SGI Octane UNIX workstation using the AMBER force field.38 We used a 
nonbonded cutoff distance of 8 A, a distance-dependent dielectric of 1.0 and scaled 
the 1-4 van der Waals interactions by 50%. Protein structures in Figure 5 were 
created using PyMOL (Delano Scientific, San Carlos, CA, USA). The X-ray crystal 
structure of subtilisin Carlsberg (entry 1 CSE)39 is from the Protein Data Bank. Using 
the Builder module of lnsight 11, we removed the inhibitor, Eglin C. The hydrogen 
atoms were added to correspond to pH 7.0. Histidines were uncharged, aspartates and 
glutamates were negatively charged, and arginines and lysines were positively 
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charged. The catalytic histidine (His64) was protonated. The positions of the water 
hydrogens and then the enzyme hydrogens were optimized using a consecutive series 
of short (1 ps) molecular dynamic fUllS and energy minimizations.40 This optimization 
was repeated until there was <2 kcallmol in the energy difference of the minimized 
structures. Thereafter, an iterative series of geometry optimizations were performed 
on the water hydrogens, enzyme hydrogens and full water molecules. Finally, the 
whole system was geometry optimized until the RMS was less than 1 kcallmol. 
The tetrahedral intermediates were built manually and covalently linked to 
Ser221. Nonstandard partial charges were calculated using a formaI charge of -1 for 
the substrate oxyanion. Energy minimization proceeded in three stages. First, 
minimization of substrate with only the protein constrained (25 kcal morl A-2); 
second, minimization with only the protein backbone constrained (25 kcal mor l A-2) 
and for the final stage the minimization was continued without constraints until the 
rms value was less than 0.0005 kcal mor l A-I. A catalytically productive complex 
required aIl five hydrogen bonds within the catalytic machinery. The limits for a 
hydrogen bond were a donor to acceptor atom distance of less than 3.1 A with a 
nearly linear arrangement (> 1200 angle) of donor atom, hydrogen, and acceptor atom. 
Structures lacking any of the five catalytically relevant hydrogen bonds or 
encountering severe steric clash with enzyme were deemed nonproductive. 
Modeling 3a with subtilisÏn Carlsberg gave one productive conformation for 
each enantiomer. The four other plausible conformations lost catalytically essential 
hydrogen bonds and/or encountered steric clash with the protein. Similar to previous 
modeling studies with secondary alcohols with subtilisin Carlsberg,41 the productive 
conformation ofthe (R)-3a binds with the methyl group in the leaving-group SI' 
pocket and the productive conformation of the (8)-3a has the phenyl group in this 
pocket. 
Productive conformer of (R)-3a. The acetylene group forms the syn-pentane-
like interaction with the oxyanion. (8)-3a fit weIl in the active site and SI' residues 
did not clash with the methyl group. 
Non-productive conformers of (R)-3a When the methyl group forms the syn-
pentane-like interaction with the oxyanion, the phenyl group of non-productive (R)-
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3a encounters a steric clash with Met222 (Cortho - Sdistance = 3.62 A, Cmeta - S 
distance = 3.88 A and Cmeta - CE distance = 3.78 A).42 When the phenyl group forms 
the syn-pentane-like interaction with the oxyanion, the phenyl group of non-
productive (R)-3a encounters a steric clash with the oxyanion hole Asn155 (Cortho-
Nô2 distance = 3.29 A, Cortho - Cy distance = 3.39 A, Cmeta - Nô2 distance = 3.73 A, 
Cmeta - Cydistance = 3.40 A) and G219 (Cmeta -Cadistance = 3.69 A).42 An essential 
hydrogen bond to His64 is lost in this conformer (NE2-0alc distance 3.21A). 
Productive conformer of (5)-3a. The acetylene group forms the syn-pentane-
like interaction with the oxyanion. (5)-3a fit weIl in the active site, but the phenyl 
group bumps Met222 (Cmeta - CE distance = 3.98 A) and His64 (Cmeta - Cô2 distance = 
3.72 A) in the SI' pocket. This tight fit suggests a favorable hydrophobic interaction 
between the phenyl group and SI' pocket residues. Consistent with this hypothesis, 
higher concentrations of organic co-solvent decreased this hydrophobie interaction 
and increased the enantioselectivity of subtilisin Carlsberg toward (R)-3a. 
Non-productive conformers of (5)-3a When the methyl group forms the syn-
pentane-like interaction with the oxyanion, the phenyl group of non-productive (5)-3a 
encounters a steric clash with catalytic His64 (Cortho - Nô2 distance = 3.64) and the 
methyl group bumps the oxyanion hole Asn155 (CH3 - Nô2 distance = 3.74 A). When 
the phenyl group formed the syn-pentane-like interaction with the oxyanion the 
phenyl group of non-productive (5)-3a encountered a steric clash with the oxyanion 
hole Asn155 (Cortho - N~ distance = 3.38 and Cmeta - Nô2 distance = 3.45 A and Cpara-
Nô2 distance = 3.51 A, Cpara - Cydistance = 3.42 A) and Gly219 (Cortho- Ca distance = 
3.53 and Cmeta - Ca distance = 3.63 A). 
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In the previous two chapters we described the reaction ofbulky substrates with 
subtilisin and several other enzymes. In the se examples the substrate range was 
broadened to include esters of a bulky secondary alcohol auxiliary and of tertiary 
alcohols. This agrees with the hypothesis that subtilisin has a large open active site 
capable of accepting unnatural sterically hindered molecules. 
Beyond substrate specificity is another frontier in biocatalysis - catalytic 
promiscuity (section 1.3.3). Catalytic promiscuity is the ability of a single active site to 
catalyze different chemical transformations. Expanding the substrate specificity modifies 
the substituent, but here the type ofreaction is changed so that atypical types of bonds are 
brokenlformed with different mechanisms. Catalytic promiscuity aids in understanding 
the evolution ofnew activities, and extends enzymes' usefulness in organic synthesis. 
Sulfinamides are commonly used as chiral auxiliaries for the preparation of chiral 
amines. In this chapter we describe a catalytic promiscuous reaction of subtilisin 
Carlsberg with N-acyl sulfinamides. These substrates contain both an amide (C-N) and 
sulfinamide (S-N) bond, but subtilisin hydrolyzes the unnatural S-N bond. Closely related 
subtilisins BPN' and E hydrolyzed the expected amide bond. Evidence is collected to 
confirm the unusual reaction of subtilisin Carlsberg. 
This chapter is a published article and is reprinted from J. Am. Chem. Soc, 2005, 127, 
6536-6537, P. F. Mugford, V. Magloire, . R. J. Kazlauskas, "Unexpected subtilisin-
catalyzed hydrolysis of a sulfinamide bond in preference to a carboxamide bond in N-
acyl sulfmamides" Copyright 2005, with permission from American Chemical Society. 
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Abstract 
Subtilisin Carlsberg-catalyzed hydrolysis of N-chloroacetyl p-toluenesulfinamide favored 
cleavage of the sulfinamide (S(O)-N) bond with a minor amount (~25%) of the expected 
carboxamide (C(O)-N) bond. The sulfinamide hydrolysis was enantioselective (E ~ 17) 
and yielded remaining starting material enriched in the (R)-enantiomer and achiral 
product - sulfinic acid and chloroacetamide as confirmed by mass spectra and NMR. In 
contrast, the related subtilisin BPN' and E favored the carboxamide hydrolysis. 
Hydrolysis of the pseudo-symmetrical N-p-toluoyl p-toluenesulfinamide, which contains 
a sulfinamide and a carboxamide in similar steric and electronic environments, gave only 
sulfinamide cleavage (> 10: 1) for subtilisin Carlsberg showing that sulfinamide cleavage 
is the preferred path even when a similar carboxamide is available. 
Introduction 
Catalytic promiscuity, the ability of an active site to catalyze more than one 
chemical transformation,l contributes to the natural evolution of new enzymes2 and can 
generate new useful catalysts for synthesis.3 We report a subtilisin-catalyzed hydrolysis 
of a sulfinamide S-N bond in an N-acyl sulfinamide. This reaction is the first example of 
an enzymatic sulfinamide hydrolysis and also the first example where the substrate 
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contains both the normal functional group (carboxamide) and the unnatural functional 
group (sulfinamide) in similar environments, but the enzyme favors the unnatural 
functional group. 
Proteases normally catalyze hydrolysis of the amide C-N bond, but can also 
catalyze hydrolysis of sulfite4 or sulfonate esters,5 phosphodiesters6 or organophosphate 
triesters 7 or the condensation of siloxanes.8 Peptides react via a tetrahedral intermediate 
while these analogs must involve altemate geometries. Catalytic promiscuity does not 
include irreversible inactivation of enzymes by phosphorous compounds,9 sulfonyl 
fluorides, 1 0 ~sultams, II or similar inhibitors because inactivation does not regenerate the 
starting enzyme. 
Chiral sulfinamides are versatile auxiliaries for the preparation of chiral amines. 12 
Previously, we reported the subtilisin E-catalyzed enantioselective hydrolysis of N-
chloroacetylp-toluenesulfmamide, 1, by cleavage of the carboxamide bond, path A in 
Figure la. l3 This highly (Rs)-enantioselective cleavage is a good synthetic route to 
enantiopure p-toluenesulfinamide. 
Results 
During this work, we discovered that a related subtilisin, subtilisin Carlsberg, 
which favored hydrolysis of the sulfmamide bond, path B, Figure 1. Mass spectrometry 
combined with IH-NMR unambiguously identified that hydrolysis of the sulfinamide 
bond in N-chloroacetyl p-toluenesulfinamide, 1, was the major reaction catalyzed by 
subtilisin Carlsberg. Mass spectrometry identified the sulfinic acid product, while IH_ 
NMR revealed formation of chloroacetamide from S-N hydrolysis, with a small amount 
of chloroacetic acid from C-N hydrolysis (1: 0.37 after 6 h), Figure 1 b, indicating 
approximately three times more substrate reacts via the S-N bond hydrolysis than by C-N 
bond hydrolysis. 
HPLC analysis confirmed that subtilisin Carlsberg favored the S-N bond 
hydrolysis by approximately fourfold over C-N bond hydrolysis and that both reactions 
were moderately enantioselective, Table 1. The disappearance of the starting compound 
N-chloroacetyl p-toluenesulfinamide, 1, revealed the sum of both reactions. The 
appearance of the product p-toluenesulfinamide revealed the amount of C-N hydrolysis 
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and the difference revealed the amount ofS-N hydrolysis. Control reactions without 
enzyme revealed ~ 7% spontaneous hydrolysis, mainly via S-N bond cleavage. For 
subtilisin Carlsberg (entry 2 in Table 1) approximately four times more substrate reacted 
via S-N bond hydrolysis than by C-N bond hydrolysis: 39% and 9% conversion, 
respectively after correcting for chemical hydrolysis. This agrees with the 
chloroacetamide and small amount of chloroacetic acid in the NMR and a 3-4 fold 
preference for the S-N reaction by Carlsberg. The S-N cleavage was moderately (Rs)-
enantioselective (E = 17) yielding the remaining starting material enriched in the (Ss)-
enantiomer. The products - sulfinic acid and chloroacetamide - are achiral. The C-N 
cleavage was moderately enantioselective (E = 6) and also favored the (Rs )-enantiomer. 
o o ~ p~hA ~ 
carboxamide ('Y 'NH, 
o 0 hYdrolY7 ~ Rs 
+ ~CI + (5sJ-1 
HO 
~s_ ~CI/subtilismBPN'orE 1 N ~ H ~ubtlhsm Carlsberg (±)·1 0 
path B " 
sulfinamide ~I '<::: S'OH 
hydrolysis 
o 
+ ~CI + (5sJ-1 
H,N 
b) lh ~2CIOf1 
---
3.5h 1\ __ IV '---_____ __ 
6h 1 A 
____ ~AJt~ ______ ~~ 
Chloroacetic acid 0=4_033 .L 
Chloro-. ÂO=4.137 
acetamide . _ 
~====== 
4.20 4.15 4.10 4.05 
C) <il 0 ~S'~R I N h H 
(±)-2 R ~ Bn 
(±)-a R = OMe 
Figure 1: a) Different subtilisins favor hydrolysis of different bonds in N-chloroacetyl p-
toluenesulfinamide, 1. b) Chemical shift of the methylene protons during subtilisin 
Carlsberg hydrolysis of 1 showing chloroacetamide as the major product. c) Substrates 2-
4. 
Two related subtilisins favored C-N hydrolysis in 1. Subtilisin E (from Bacil/us 
subtilis with 70% sequence identity to subtilisin Carlsberg) showed only a highly 
enantioselective hydrolysis via the C-N pathway (51 % conversion, E >75, entry 3) as 
reported previously.13 Subtilisin BPN' (from Bacil/us amyloliquefaciens with 70% 
sequence identity to subtilisin Carlsberg and 85% sequence identity to subtilisin E14) also 
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Table 1. Chemoselectivity and enantioselectivity of subtilisin-catalyzed hydrolysis of N-acyl-p-toluenesulfinamides, 1-4. 
Total Hydrolysisa.b Sulfinamide Hydrolysis Carboxamide Hydrolysis 
Substrate Subtilisin Conv. %b ees, %C Amounë %S_Ne eep Cal/ gg E!' %C_N i eep, 0/.) E,g·k E!',k 
1 None 7 0 0 5 0 N/Am 2 0 NIA 
2 1 Carlsberg' 55 85 (S) 6 44 (39) 72 (R) Il 17 Il (9) 59 (R) 4 6 
3 1 E 53 98 (S) 5 <3 NIA 53 (51) 91 (R) >75 >75 
4 1 BPN' 49 85 (S) 5 10 (5) 39 (37) 93 (R) 54 >75 
5 2 Carlsberg 57 83 (S) 6 30 69 (R) 7 7 27 57 (R) NIA 4 
6 2 BPN' 30 44 (S) 5 <3 28 94 (R) NIA 46 
7 3 None 21 0 0 20 0 NIA 0 NIA 
8 3 Carlsberg 49 27 (S) 6 39 (19) 16 (R) 1.5 2.2 10 80 (R) 10 18 
9 3 BPN' 27 13 (S) 5 17 (0) <3 NIA 10 90 (R) 20 >75 
10 4 Carlsberg 55 21 (S) 20 55 2 2 <3 
GAll reactions performed at 25 oC in BES buffer (50 mM, pH 7.2), Reaction times: 1::::: 6 h, 2 ::::: 24h, 3::::: 24 h, 4, ::::: 72 h. LProtal conversion 
determined from the disappearance ofl-4 using biphenyl as an internaI standard. Error ± ~2% conversion, based on standard deviation. 
cees ::::: enantiomeric excess of remaining starting material measured by HPLC. d Amount of enzyme (nmo!). eCalculated amount of the total 
conversion attributed to S-N bond hydrolysis, the value with the chemical reaction subtracted is in parenthesis. fCalculated enantiomeric 
excess for the portion ofl-4 that disappeared via the S-N cleavage path. gE' ::::: Observed enantioselectivity (uncorrected for spontaneous 
chemical hydrolysis) was calculated from conversion, c, and eep or ees according Sih. 15 hE::::: enantioselectivity, corrected for spontaneous 
chemical hydrolysis using the pro gram Selectivity KreSH 17. i%C_ N conversion - Percentage of C-N conversion based on formation of p-
toluenesulfinamide. JEnantiomeric excess of the C-N hydrolysis product, p-toluenesulfinamide, measured by HPLC. kSmall errors in 
conversion create large errors in E when E is high. For this reason, the E-values are given as lower limits; the E-values calculated from the 
data are higher in sorne cases. IThree different commercial samples of subtilisin Carlsberg gave similar values. mNot applicable. 
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favored the C-N pathway (37% conversion, E >75, entry 6) with a small amount of S-
N cleavage (5%, entry 6). 
Two experiments showed that both the C-N and S-N hydrolysis involved the 
active site. (Details in Supporting Information.) First, inhibition of subtilisin with an 
active-site-targeted inhibitor - phenylmethyl sulfonyl fluoride - eliminated both 
reactions. Second, 1 competitively inhibited the hydrolysis of the N-suc-AAPF-pNA 
peptide substratel7 with an inhibition constant (KÙ of 7 ± 2 mM, showing that 1 
bound to the active site of subtilisin Carlsberg. The affinity of 1 for other subtilisins 
was similar (subtilisin BPN': Ki = 8 ± 2 mM; subtilisin E: 12 ± 3 mM). 
Subtilisin Carlsberg also catalyzed sulfinamide hydrolysis in three other N-
acyl sulfinamides, 2-4. The N-dihydrocinnamoyl acyl group in 2 mimics 
phenylalanine's side chain. Subtilisin Carlsberg catalyzed approximately equal 
amounts of sulfinamide and carboxamide hydrolysis: 30% and 27% respectively. The 
N-methoxyacetyl compound 3 was a slow substrate for subtilisin Carlsberg and gave 
approximately twice as much sulfinamide hydrolysis as carboxamide hydrolysis: 39% 
S-N hydrolysis (including 20% chemical) and 10% C-N Hydrolysis, entry 8. In 
contrast, subtilisin BPN' showed only carboxamide hydrolysis with compounds 2 and 
3, entries 6 and 9. The N-p-toluoyl compound 4 is pseudo-symmetric since both 
sulfinyl and carbonyl substituents are p-tolyl to test the preference for sulfinamide vs. 
carboxamide hydrolysis in similar steric and electronic environments. Subtilisin 
Carlsberg catalyzed only sulfinamide cleavage (> 1 0: 1, no detected carboxamide 
hydrolysis) with low enantioselectivity (E = 2), entry 10, while subtilisin BPN' 
showed no reaction with compound 4. 
Sulfonyl compounds are irreversible inhibitors of serine proteases that form 
stable sulfonyl enzyme complexes, which have been characterized by x-ray 
crystallography.18 Peptides containing sulfinamide functionality were proposed as 
protease inhibitors, but synthesis was unsuccessful. l9 Sulfinamide hydrolysis by 
subtilisin Carlsberg may involve a sulfinyl serine intermediate, but we currently have 
no direct evidence for or against such an intermediate. Sulfatases catalyze the 
hydrolysis of sulfate group via a different mechanism. They contain an u-
formylglycine residue, not a serine, at the active site and react via a sulfate 
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hemiaceta1.2o Similarly, sulfamidase catalyzes the cleavage of the S-N bond in N-
sulfoglucosamine to give sulfate.21 
These results clearly demonstrate that subtilisin Carlsberg catalyzes the 
unnatural sulfinamide cleavage and that this cleavage can be the preferred path even 
when a carboxamide group is available. A related example involved inactivation of 
the serine protease eIastase with a j3-sultam (j3-lactam analog) where cleavage 
favored the strained sulfonamide over the unstrained carboxamide bond. 1 1 The 
structurally similar subtilisins BPN' and E do not cleave these sulfinamide groups, 
suggesting that a few amino acid substitutions may introduce this catalytic 
promiscuity . 
Acknowledgments. We thank the donors of the Petroleum Research Fund, 
administered by the American Chemical Society and the University of Minnesota for 
financial support, Dr. R. Bott (Genencor) for a plasmid encoding subtilisin BPN', Dr. 
S. L. Wong (U. Calgary) for the B. subtilis DB 104 ceIls, and Dr. F. Schendel and R. 
Dillingham (U. Minnesota) for the large-scale fermentation and purification of 
subtilisin BPN' and subtilisin E. 
Experimental 
Synthe sis of N-acyl-p-toluenesulfinamides. N-acyl-p-toluenesulfinamides22 were 
prepared by acylation of the corresponding p-toluenesulfinamide with 2 equivalents 
of n-butyllithium and addition of the appropriate anhydride23 to give the N-acyl 
sulfinamide, Scheme 2. 
+ 
R= CH2C1 
=CH2CH2Ph 
=CH~Me 
= p-tolyl 
1. n-BuUITHF 
.. 
2. Anhydride 
1, R=CH2C1 
2, R = CH2CH2Ph 
3, R=CH20Me 
4, R = p-tolyl 
Scheme 2: Synthesis of N-acyl-p-toluenesulfinamides. 
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N-Chloroacetyl-p-toluenesulfinamide, 1. White solid, 1.22 g (41 %), mp 115-117 oC 
(lit 119-121 °C24); IH NMR (300 MHz, CDCh ô): 2.43 (s, 3H), 4.29 (s, 2H), 7.31 (d, 
J = 8.1, 2H), 7.63 (d, J = 8.1, 2H); I3C NMR (CDCh, ô): 21.8, 42.5, 124.8, 130.6, 
139.9, 143.5, 167.2, HR-EIMS m/z: M+Na+ calcd for C9HlON02SNa 254.0023, found 
254.0013. 
N-Dihydrocinnamoyl-p-toluenesulfinamide, 2. White solid, 2.31 g (63%), mp 97-
99 oC (lit. 94-96 °C22); IH NMR (300 MHz, CDCh ô): 2.39 (s, 3H), 2.65 (m, 2H), 
2.96 (t, J= 7.5, 2H), 7.12-7.29 (m, 7H), 7.35 (d, J= 8.4, 2H), 8.39 (s, IH); BC NMR 
(CDCh, ô): 21.5, 30.9, 37.7, 124.8, 126.5, 128.5, 128.7, 130.1, 140.1, 140.2, 142.6, 
173.3, HR-EIMS m/z: M+Na+ calcd for CI6H17N02SNa 310.0883, found 310.0881. 
N-Methoxyacetyl-p-toluenesulfinamide, 3. White solid, 520 mg (21 %), mp 62-64 
oC (lit. 57-59 DC23); IH NMR (300 MHz, CDCh ô): ô 2.44 (s, 3H), 3.37 (s, 3H), 4.00 
(s, 2H), 7.39 (d, J = 8.4, 2H), 7.63 (d, J = 8.4 2H), 8.328 (s, 1 H) I3C NMR (CDCh, 
ô): 21.6, 59.3, 71.7, 124.7, 130.2, 140.4, 142.9, 170.6, HR-EIMS m/z: M+Na+ calcd 
for C IOH13N02SNa 250.0519, found 250.0504. 
N-p-toluoyl-p-toluenesulfinamide, 4. White solid, 1.50 g (43%), mp 124-125 oC, IH 
NMR (300 MHz, CDCh ô): 2.38 (s, 3H), 2.40 (s, 3H), 7.21 (d, J = 8.4, 2H), 7.29 (m, 
J = 8.4, 2H), 7.60 (d, J = 8.4, 2H), 7.72 (m, J = 8.4, 2H), 8.93 (s, 1 H) 13C NMR 
(CDCh, ô): 21.5, 21.7, 125.0, 128.2, 128.9, 129.5, 130.1, 140.7, 143.6, 144.1, 167.5, 
HR-EIMS m/z: M+Na + calcd for CIsHISN02SNa 296.0726, found 296.0734. 
Subtilisin Carlsberg. Three commercial samples of subtilisin Carlsberg were used: 
Fluka 82518 (11.7 V/mg), Sigma P5380 (11.4 V/mg), Sigma P8038 (9.2 V/mg), 
activity from the manufacturer (Sigma-Aldrich, St. Louis, MO). Electrospray 
ionization mass spectrometry (Q Star, Applied Biosystems, Foster City, CA) 
confrrmed that the commercial samples were indeed subtilisin Carlsberg. The 
phenylmethylsulfonyl fluoride-inhibited (PMSF) enzyme revealed a molecular weight 
of Fluka 82518: 27440 Da, Sigma P8038: 27441 Da, Sigma P5380: 27443 Da. This 
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agrees with the predicted value of 27,443 Da for subtilisin Carlsberg containing an 
added phenylmethylsulfonyl group. For comparison the predicted molecular weight 
for subtilisin BPN' is 246 mass units higher - 27,689 Da. Literature ESI 
measurements of non-inhibited subtilisin gave molecular weights of Carlsberg: 27289 
Da, and BPN': 27536 Da.25 The phenylmethylsulfonyl group adds a mass of 155 
g/mol, giving a total molecular weight ofCarlsberg: 27443 Da, and BPN': 27690 Da. 
Preparation of Subtilisin BPN' and Subtilisin E. Protease deficient B. subtilis 
DBI0426 was transformed with vectorpS4,27 which encodes for subtilisin BPN' and 
chloramphenicol resistance. Transformed cells were grown in 2XSG28 media (250 
mL) containing chloramphenicol (12.5 ~g/mL) with shaking overnight at 37 oc. This 
culture was used to inoculate 5 L bioreactor containing the same medium. After 47 
hours the culture was cooled and centrifuged at 7000 rpm/4 oC. Ammonium sulfate 
was added (473 g/L) and protein was precipitated by allowing the solutions to stand 
for 1-2 hours at 4 oc. The precipitate removed by filtration through Celite (Fisher 
C211) and then resuspended in buffer (20 mM Hepes-l mM calcium chloride, pH 
7.0) and filtered. Impurities in the filtrate were removed by adsorption unto Cellex-D 
anion exchange cellulose (at pH 7 subtilisin is not adsorbed) and re-filtered. The 
clarified solution placed in a 3.5 kDa cutoff dialysis membrane and dialyzed twice 
against buffer (20 mM Hepes-l mM calcium chloride, 6 L, pH 7.0) ovemight at 4 oC. 
The dialyzed protein solution was concentrated by passage through an 8 kDa cutoff 
ultra filtration cartridge and purified on a BioCad purification system using a Poros 
20HP2 (10 mm x 100 mm) column (Applied Biosystems, Foster City, CA). The 
sample was loaded and washed with 1.8 M N~S04 in 20 mM HEPES (pH 7.0) and 
then eluted with a linear gradient of 1.8 M to 0 M NH4S03 in 20 mM HEPES (pH 
7.0). SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel electrophoresis) gave 
one band corresponding to the mass of subtilisin. The activity of enzyme was 
determined using the synthetic peptide N-suc-AAPF-pNA29 (0.2 mM, pH = 7.2, 50 
mM BES buffer) and the absorbance monitored at 410 nm: BPN' 7.9 U/mg. Subtilisin 
E was prepared in a similar manner: 21 U/mg.3 For comparison, commercial samples 
of subtilisin Carlsberg, which has a 7 -fold higher kcaJKM value for this substrate,30 
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gave the following activities: Fluka 82518: 374 V/mg; Sigma P8038: 374 V/mg; 
Sigma P5380: 316 V/mg. Protein concentrations were determined by absorbance 
readings at 280 nm and subtilisin extinction coefficients31 or using the Bradford 
assay.32 Both gave similar values. 
General procedure for enzymatic reactions and analysis. Enzymatic reactions 
were performed under the following conditions: N,N-bis(2-hydroxyethyl)-2-
aminoethanesulfonic acid (BES) buffer (150 f.-lL, 50 mM, pH 7.2),1 (10 f.-lL, 63 mM 
in acetonitrile containing biphenyl (54 mM) as an internaI standard) and an enzyme 
solution (50 f.-lL typically 5-6 nmol subtilisin). After 6 h ofstirring at 25 oC, 
acetonitrile (1.0 mL) was added to precipitate protein and the reaction mixture was 
centrifuged. The conversion was determined by reverse phase chromatography ofthis 
solution on a Zorbax SB-CI8 column (4.6 mm x 250 mm, Agilent, Palo Alto, CA) 
with acetonitrile/water as the mobile phase, at 254 nm. A standard of known 
composition of p-toluenesulfmamidelbiphenyl was used to determine the moles of 
sulfinamide product. At 254 nm, equimolar p-toluenesulfinamidelbiphenyl gave an 
area ratio of 1: 1.94. For 1: 50/50 MeCNIH20, flow 0.6 mL/min for 9 min, then 
gradient to 80/20 over 0.5 min;p-toluenesulfinamide: tR = 5.6 min; 1: tR = 7.1 min; 
biphenyl: tR = 15.7 min. For 2: 60/40 MeCN/H20, flow 0.6 mL/min for 9 min, then 
gradient to 80/20 over 0.5 min; p-toluenesulfinamide tR = 5.1 min; 2, C = 8.9 min; 
biphenyl tR =18.1 min. Dihydrocinnamamide, tR = 5.0 min. overlaps withp-
toluenesulfinamide, but the absorbance at 254 nm, bandwidth 50, is negligible. 
Eluting with 25/75 MeCN/H20, flow 0.6 mL/min gives p-toluenesulfinamide tR = 
13.1 min and dihydrocinnamamide, tR = 13.4 min. Only subtilisin Carlsberg shows 
dihydrocinnamamide product; none was detected for subtilisin BPN'. For 3: 45/55 
MeCNIH20, flow 0.6 mL/min for 9 min, then gradient to 80/20 over 0.5 min; p-
toluenesulfinamide: tR = 5.8 min; 3: tR = 6.3 min; biphenyl: tR = 20.4 min. For 4: 
65/35 MeCN/H20, flow: 0.6 mL/min for 9 min, then gradient to 80/20 over 0.5 min; 
p-toluenesulfinamide and p-toluamide: tR = 4.6 min for both; 4: tR = 7.4 min; 
biphenyl: tR = 15.8 min. To separate p-toluenesulfmamide and p-toluamide: 25/75 
MeCN/H20, flow: 0.65 mL/min; p-toluamide: tR = 11.0 min; p-toluenesulfinamide: tR 
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= 11.9. There was no p-toluenesulfinamide detected for reaction with subtilsisin 
Carlsberg. To determine the enantiomeric excess the reaction was extracted with 
EtOAc (3 x 0.75 mL), dried with MgS04 and evaporated and analyzed using a chiral 
stationary phase: Chiralpak AD-H or Chiralcel OD columns (4.6 mm x 25 cm, Chiral 
Technologies, West Chester, PA) at 230 nm. An achiral Discovery Cyano column 
(4.6 mm x 25 cm, Supelco, Bellefonte, PA) was placed before the chiral column in 
cases where the sulfinamide and N-acyl sulfinamide enantiomers overlapped. For 1: 
80120 HexaneslEtOH, flow 0.75 ml/min, Cyano column and Chiralpak AD-H. p-
toluenesulfmamide, (S) tR = 20.5 min, (R) tR = 16.5 min; 1: (R) tR = 22.0 min, (S) tR = 
29.4 min. For 2: 90/10 Hexanes/EtOH, flow 1.0 mL/min, Chiralpak AD-H.p-
toluenesulfinamide, (S) tR = 13.0 min, (R) tR = 19.2 min; 2: (R) tR = 15.1 min, (S) tR = 
30.3 min; dihydrocinnamamide, tR = 10.9 min. For 3: 85/15 Hexanes/EtOH, flow 
0.75 mL/min, Cyano column and Chiralcel OD. p-toluenesulfinamide, (R) tR = 17.0 
min, (S) tR = 18.9 min; 3: (R) tR = 21.3 min, (S) IR = 23.9 min. For 4: 85/15 
HexaneslEtOH, flow 0.75 mL/min, Cyano column and Chiralpak AD-H. p-
toluenesulfinamide, (S) tR = 18.5 min, (R) tR = 23.4 min; 4: (S) tR = 27.5 min, (R) IR = 
36.4 min; p-toluamide: tR = 18.1 min. The p-toluamide overlaps with (R)-p-
toluenesulfinamide on this chiral column, but there is none present as determined by 
reversed phase HPLC. The Evalue was determined from the conversion and 
enantiomeric excess according to: 
E = In[l- c(l + eep)] or E = In[l- c(l-ees)] 
In[l- c(l- eep)J ln[l- c(l + ees)] 
where E is the enantioselectivity, c is the conversion, eep = enantiomeric excess of 
product and ees = enantiomeric excess of remaining starting materiaI. 33 The 
enantioselectivity for the C-N cIeavage was calculated from the enantiomeric purity 
of the product p-toluenesulfinamide and the conversion that corresponds to the C-N 
cIeavage reaction. The enantioselectivity for the S-N cIeavage was calculated from 
the enantiomeric purity of the remaining starting material, which was corrected for 
the amount of each enantiomer that reacted to yields p-toluenesulfinamide, and from 
the conversion that corresponds to the S-N cIeavage reaction. Both enantiomeric 
purities were corrected for the small amount of spontaneous hydrolysis. This 
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calculation is an approximation because both enantiose1ective steps act 
simultaneously upon the starting material. The Evalue is a lower limit of the 
theoretical value if one path could be suppressed. 
Inhibition of reaction with PMSF. Reactions of 1 carried out under the above 
conditions using enzyme treated with PMSF (phenylmethane sulfmyl fluoride34), (5 
flL, 120 mM in MeCN) gave reactions identical to those with no enzyme added. 
NMR reactioD. NMR was used to determine the products of the subtilisin Carlsberg 
reaction. Reactions conditions were as follows: D20 (1 mL) containing phosphate 
buffer (20 mM, pD 7.4, pH+O.4) and subtilisin Carlsberg (7.6 mg, Fluka 82518), d3-
MeCN (100 flL), (±)-l (160 mM) and sodium 4,4-dimethyl-4-silapentane-l-
sulfonate,35 (DSS, 1 mM). The reaction was monitored over the course of 6 h using a 
500 MHz instrument. Under these conditions the a-CH2Cl group has the following 
500 MHz lH resonances relative to DSS: Chloroacetic acid Ô = 4.033, 
chloroacetamide Ô = 4.137 and 1 Ô = 4.110. The major product was chloroacetamide 
(relative area = 1), while a small amount of chloroacetic acid (relative area = 0.37) 
was detected. A blank reaction with no enzyme showed no detectable change over 6 
h. Over the course of the reaction the pH changes slightly due to the acid produced. 
This causes a slight shift in the a-CH2CI group ofl as seen in Figure lb. For the 
enzymatic reaction at 1 h, Ô = 4.117.3.5 h ô = 4.121 and at 6 h Ô = 4.124. The 
chemical shift of the a-CH2Cl group of 1 as a function of pH is shown in Figure 2 
showing that the change in chemical shift in Figure 1 b is entirely due to the decrease 
in pH. 
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Figure 2: Effect ofpH on the chemical shift on the methylene of1 in D20. 
Isolation ofp-toluenesulfmic acid. Compound 1 (10 mg in 0.7 mL MeCN, 0.45 
mmol) in BES buffer (9.3 mL, 20 mM, pH 7.2) was stirred with subtilisin Carlsberg. 
After 6 hthe reaction was extracted with methylene chloride followed by 
acidification of the buffer layer with HCI (0.1 N). The aqueous layer was extracted 
with ether (2 x 15 mL), dried over MgS04 and concentrated to yield a white powder 
(2.1 mg, 6(010). TLC (90/1 0 CHChIHCOOH): Rf = 0.3; ) H NMR (400 MHz): Ô 2.45 
(s,3Hz), Ô 7.4 (d, J = 8.2 Hz), Ô 7.6 (d, J = 8.2 Hz); HRMS-EI (m/z): M+ caIcd for 
C7H g0 2S: 156.02450, found 156.02450. 
Kinetics and inhibition. The inhibition constant (KI) for the hydrolysis of the 
synthetic peptide N-suc-AAPF-pNA29 was measured for subtilisins Carlsberg, E, and 
BPN,.36 The inhibition constant for the hydrolysis of the peptide N-suc-AAPF-pNA 
by 1 was measured in a 96 weIl plate. In each weIl was placed enzyme solution (10 
f!L) and assay solution containing the peptide and 1 (90 f!L). The as say solution 
consisted ofbuffer (81 mL, 50 mM BES, pH 7.2), acetonitrile (8.2 f!L), and DMSO 
(0.8 f!L). The concentration of the peptide was varied from 0.1 mM to 1.6 mM, from 
a 200 mM stock in DMSO. The inhibitor, 1, was varied from 0 mM to 7.2 mM (the 
solubility limit). Each measurement was preformed in triplicate following the release 
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ofp-nitroanaline at 410 nm (E = 8800 M-tcm-t) over the first 0-35 s. Non-linear curve 
fitting was preformed on the rate vs. [S] plots using the OriginPro 7.5 software 
(OriginLab Corporation, Northampton, MA) to determine V max and KM (in set of 
Figures S-2 - S-4). A replot of inhibitor V maxlKM gave the KI values according to the 
equation: 
Where K Mapp is the apparent KM and slope (lis) is the slope of the reciprocal 
Lineweaver-Burk plot (llv vs. 1/[S]) for each inhibitor concentration. This plot gives 
the x-intercept as _KI•37 
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In the previous chapter. we examined the catalytic promiscuous reaction of 
subtilisin Carlsberg with N-acyl sulfinamides. Unexpectedly. subtilisin hydrolyzed the 
unnatural S-N sulfinamide bond rather than the C-N amide bond. 
In this chapter we continue this investigation into subtilisin Carlsberg' s catalytic 
promiscuous reaction with N-acyl sulfinamides. We identify an intermediate of the 
reaction and examine the pH dependence for subtilisin BPN' and CarIsberg. Further 
substrates. incIuding sulfinates are tested. and mutation reveals only a few amino acid 
substitutions are responsible for the promiscuity. 
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Abstract: 
N-acyl sulfinamides have two potential sites for hydrolysis - either the C-N amide bond 
or the S-N sulfinamide bond may be cleaved. Subtilisin, BPN' cataIyzes the natural C-N 
hydrolysis in these substrates. In contrast the protease subtilisin Carlsberg catalyzes an 
unexpected promiscuous reaction by hydrolyzing the S-N bond in N-acyl sulfinamides. 
Electrospray-mass spectrometry revealed a sulfinyl-enzyme intermediate Iocated at the 
active site, analogous to an acyl-enzyme. Substrate variation indicated a substrate 
reversaI was responsible for the change in reactivity by binding in the S) acyl pocket. 
The enzymatic hydrolysis of sulfinates supported this hypothesis. Three mutations of 
subtilisin BPN' towards subtilisin Carlsberg increased the S-N hydrolysis by 14-fold, 
indicating that only a few mutations were responsible for the catalytic promiscuity. The 
substrate specificity and mutagenesis were consistent with reversed orientation for 
sulfinyl reactions. 
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Introduction 
Catalytic promiscuity is the ability of an active site to catalyze more than one 
chemical transformation. l For example, proteases normally catalyze hydrolysis of the 
amide C-N bond, but can also catalyze hydrolysis of analogs. Pepsin, an aspartate 
protease, catalyzes hydrolysis of several sulfite esters.2 a-Chymotrypsin, a serine 
protease, catalyzes the hydrolysis of cyclic sulfonate esters,3 the aminopeptidase from 
Streptomyces grieus, a dizinc metalloenzyme, catalyzes the efficient hydrolysis of 
phosphodiesters.4 Two proline-specific proteases, manganese dependent enzymes, also 
hydrolyze organophosphate triesters, giving them flexibility to degrade highly toxic nerve 
agents and pesticides as a second function.5 These examples are unusual because 
peptides react via a tetrahedral intermediate while sulfites, sulfonates, phosphodiesters 
and phosphotriesters {or sulfur and phosphorous substrates} must have an alternate 
(trigonal bipyramidal) intermediate. Catalytic promiscuity does not include irreversible 
inactivation of enzymes by phosphorus compounds,6 sulfonyl fluorides/ ~sultams,8 and 
similar inhibitors because inactivation does not regenerate the starting enzyme. Catalytic 
promiscuity is important to understand the evolution of new enzymes9 and to generate 
new useful catalysts for synthesis. IO 
Sometimes an unmodified enzyme exhibits two functions, or a slightly modified 
enzyme may perform the promiscuous function. Often only a few mutations are 
necessary to introduce a new function in an enzyme. A typical ex ample is the evolution 
of melamine hydrolyase to an enzyme that degrades the pesticide atrazine with only 8 
amino acid substitutions. 1 1 Another example is a four amino acid modification of a fatty 
acid desaturase to produce an efficient hydroxylase.12 Adding four key catalytic 
mutations and an addition al a-helix modified a transport protein with no activity to a 
structurally related dehydratase with low activity. J3 Thus catalytic promiscuity is often 
introduced by a few mutations to a structurally related enzyme. 
The chiral sulfinyl group is a versatile chiral director in C-C and C-X bond 
formations. 14 Chiral sulfinamides are versatile auxiliaries for the preparation of chiral 
amines. 15 Chiral sulfoxides are common intermediates to control stereochemistry in the 
totally synthesis of many natural productS.16 The most frequent precursors to sulfoxides 
and sulfinamides are chiral sulfinates. There are few biocatalytic methods to prepare 
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chiral sulfinyl compounds. Oxidation of disulfies with cyc1ohexanone monooxygenase 
was generally gave low enantiomeric purity.17 Resolutions of several N-acyl sulfinamides 
by the protease subtilisin E gave sulfinames in high enantiopurity.J8 
Subtilisin (E.C. 3.4.21.62) is a common serine protease for which the structure, 
the mechanism, and the substrate preference are well understood. 19 Subtilisin is used in 
detergents and organic synthesis, in particular for organic solvent resolution of alcohols 
and amines.20 Protein engineering has modified many properties of subtilisin: 
thermostability, pH dependence, organic solvent stability and substrate specificity.21 
Previously we reported the subtilisin catalyzed sulfinamide (S-N) bond hydrolysis 
of N-chloroacetyl-p-toluenesulfinamide by subtilisin Carlsberg.22 In contrast, the related 
subtilisins E and BPN' hydrolyzed only the carboxamide (C-N) bond with high 
enantioselectivity (E> 100) to give p-toluene sulfinamide and enantioenriched starting 
material. 
pathA 
carboxamide 
hydrolysis 
subtilisin BPN' or E 
subtilisin Carlsberg 
o 0 path B 
sulfinamide 
hydrolysis ~S'N~CI 1 H ~s 
+ 
o 
HO~CI 
Figure 1: Different subtilisins hydrolyze different bonds in of N-chloroacetyl-p-
toluenesulfinamide 
In many cases the molecular basis for the promiscuous function is either not 
examined, or poorly understood. Sometimes the structure of the enzyme is unknown 
which prevents interpretation of the promiscuous reaction. This paper focuses on 
understanding the promiscuous Carlsberg reaction, and explaining the specific amino 
acid substitutions that cause subtilisins to catalyze different reactions. 
Results 
Subtilisin-catalyzed hydrolysis of carboxamide bonds involves an acyl enzyme 
intermediate. The active site serine attacks the carboxamide carbonyl group to form a 
tetrahedral intermediate, Figure 2. Next, this tetrahedral intermediate collapses as the 
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active site histidine protonates the leaving group nitrogen. This 10ss of the amine leaving 
group yields an acyl enzyme intermediate. Next, water attacks the acyl enzyme to form a 
second tetrahedral intermediate, which collapses by release of the acyl group as a 
carboxylic acid and leaves subtilisin ready for the next hydrolysis. 
Asp32 
o=( 
-O------H-N~N 
( 
His64 
Asp32 
o=( 
-o------H ~(J) HO 0-
-N N-H ~' 
( (0 R 
Ser221 His64 
Oxyanion HO 
hOle~ 
Asp32 
o=( 
-o------H ~(J) R1HN 0-
-N N-H ~ 
Oxyanion 
hole 
( (0 R 
His64 Ser221 
o 
oJlR ( 
Ser221 
acyl enzyme 
Figure 2. Mechanism of subtilisin-catalyzed hydrolysis of carboxamide bond involves an 
acyl enzyme intermidate. 
The simplest hypothesis for the subtilisin-catalyzed hydrolysis of the sulfinamide 
link in compound 1 is that it proceeds via a mechanism analogous to that for hydrolysis 
of the carboxamide link. This hypothesis predicts that the reaction should form a sulfinyl 
enzyme intermediate analogous to the acyl enzyme intermediate. 
Electrospray mass spectrometry can detect an acyl enzyme intermediate in 
subtilisin catalyzed hydrolysis of carboxamide links. Incubation of acryloyl imidazole 
with subtilisin at pH to 5 to slow hydrolysis of the cinnamoyl enzyme intermediate 
showed that ~ 90% of the substilisin was acylated.23 There are several other examples of 
acyl enzymes identified by ESI-MS. The serine f3-Iatamase forms an acyI enzyme with 
four different j>-lactam substrates at 10w pH?4 Acyl enzymes were directly observed for 
porcine pancreatic elastase and a heptapeptide susbtrate,25 u-chymotrypsin and isatoic 
anhydride.26 
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EIectrospray mass spectrometry revealed a similar sulfinyl subtilisin intermediate 
upon incubation of compound 1 with subtilisin Carlsberg at pH 7 followed by 
acidification to pH 1. The free enzyme (predicted mass 27,286 amu) appears at 27284 
amu, Figure 2a. Several sodium adducts were also present above this peak at 27,305 (+ 
21 amu) and 27,323 amu (+ 42 amu).a Another major peak occurs at 27,515 amu (M 
+231 amu), corresponding to subtilisin bound to substrate 1. This binding is likely an ion 
pair with the enzyme, see below. Two sm aller peaks occur at the predicted mass for a 
sulfinyl enzyme: a peak appears at 27,422 amu, which is 138 mass units above the free 
enzyme and as expected for the sulfmyl enzyme intermediate (+ 139 units for the p-
tolulenesulfin group, minus 1 unit for the serine proton). Another peak appears at 27653, 
which is a further 138 units above the non-specific binding peak. This peak corresponds 
to a sulfinylated enzyme with substrate non-specifically bound to it. 
Two control experiments confrrm this interpretation. First, subtilisin Carlsberg 
inhibited with PMSF (phenylmethane sulfonyl fluoride27) and then treated with 1 did not 
give a sulfinylated enzyme peak, Figure 2b. The substrate still bound in a non-specific 
fashion (M + 231), but 1 did not form sulfinyl-enzyme peaks (M + 138, or M + PMS + 
138). This demonstrates that the sulfinylation occurs at the active site; the inhibitor PMSF 
covalently modifies the catalytic serine in the active site. Secondly, using the phenyl 
substrate 210wered the sulfinyl-subtilisin peak by the expected 14 mass units as 
compared to the p-tolyl substrate 1. Thus subtilisin Carlsberg treated with 2 gave a 
phenylsulfinyl peak (M + 124). The mass spectral data provides strong evidence for a 
sulfinyl-subtilisin intermediate in the active site, but does not prove attachment at the 
serine or reveal the nature of the intermediate. 
a The expected mass of the sodium adduct is M + 22 due to a loss of hydrogen of mass 1 
and a gain of sodium ion of mass 23. The observed mass of M + 21 is likely due to errors 
in mass measurement. 
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Figure 3: Electrospray mass spectra of subtilisin Carlsberg treated with 1. (a) The peak at 
M+138 corresponds to the expected mass for ap-tolylsulfmyl-subtilisin intermediate; the 
peak at M+231 corresponds to the expected mass for an adduct of 1 with subtilisin; the 
peak at M+231 + 138 corresponds to an adduct of 1 and the p-tolylsulfinyl-subtilisin 
intermediate. (b) Control experiment with Carlsberg pretreated with the active-site 
targeted-inhibitor phenyimethane sulfonyI fluoride (PMSF). The peak at M+ 155 
corresponds to phenylmethane sulfonyl subtilisin; the peak at M+155+231 corresponds to 
an adduct of 1 with phenylmethane sulfonyl subtilisin. No p-tolylsulfinyl-subtilisin 
intermediate forms in this case because the inhibitor blocks the active site. 
The pH profiles for hydrolysis of 1 suggest similar mechanisms for hydrolysis of 
carboxarnide and sulfinarnide links. Subtilisin Carlsberg- and subtilisin BPN' favor 
hydrolysis of different links, but show similar bell-shaped pH rate profIles for 1 (Figure 
4, traces a and b). The conversion is low at pH below 4.5, rises to a maximum pH 6.5 and 
decreases to lessthan 10% conversion above pH 8.5 (Figure 4, a and b). This profIle 
suggests the reaction involves at least two ionizable groups and that they are in the 
correct protonation state near pH 6.5. We suggest that the decrease in activity of the 
subtilisins toward 1 above pH 6.5 is due to ionization of the substrate. The N-H proton is 
acidic (pK" = 6.5) and deprotonation gives a negatively charged species that is less likely 
to bind to subtilisin. The similar pH profIles for both the naturaI (C-N) and unnaturaI (S-
N) N-acyl sulfmarnide hydrolyses suggests similar mechanisms for the two reactions. 
Unlike typicaI amide or ester hydrolysis, the C-N and S-N hydrolysis still occurs pH 5 -6. 
Attempts to perform ESI-MS experiments below pH 5 did not give any sulfinyl enzyme 
intermediate. 
In contrast, a typicaI peptide substrate does not show a bell-shaped pH profile, but 
a plateau at high pH. For ex ample, the rate acceleration (kca/K". ) of subtilisin BPN'-
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catalyzed hydrolysis of N-succ-PFAA-pNP increases near pH 7 and reaches a plateau 
above pH 8.5 (Figure 4, trace c). The increase in rate near pH 7 is attributed to the 
deprotonation of the catalytic histidine (pKa = 7.17).28 
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Figure 4: Conversion as a fonction of pH for the hydrolysis of 1 by (a) +subtilisin 
Carlsberg (mainly S-N hydrolysis) and (b). Subtilisin BPN' (mainly C-N hydrolysis) 
(c) Subtilisin BPN' pH profile (,À.) for a typical peptide substrate N-succ-PFAA-pNP 
inc1uded for comparison.28 
Substrate orientation in the active site 
The catalytically productive orientation of carboxamides in the active site of 
subtilisin places the acyl moiety and the leaving group amine into specifie pockets. The 
acyl moiety binds in the SI site according to the protease binding site nomenc1ature,29 
while the leaving group binds in the SI' site, Figure Sa. This orientation positions the 
leaving group nitrogen near the active site histidine so that it can protonate the leaving 
group. The specificity of proteases for particular peptide links stems primarily from the 
SI site. Subtilisin favors amino acids with large, non-polar side chains such as 
phenylalanine as the acyl group. This preference is consistent with size and the nonpolar 
nature of the S, site in subtilisin. 
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(a) Leaving Group Acyl Group (b) Leaving Group Acyl Group Analogue 
.-----------" . -----, .-----------" , 
{c:J o~\ (jë~ 
Sl' Leaving Sl Acyl 
Group Site Group Site 
Figure 5. Proposed reversaI in substrate orientation to account for the subtlisin-cataIyzed 
hydrolysis of the carboxamide link and the sulfmamide link in compound 1. (a) Substrate 
positioned for C-N hydrolysis, with the conventionaI acyl and leaving group positioning 
(b) Corresponding orientation for the S-N hydrolysis, in which the substrate reverses to 
favor the altemate S-N hydrolysis. 
p-Toi '. 
"". 1 ° "8-
H~ + _-N'H Ser221 ~iNW- ~ 
HN--.!J -------ft~ \..0-
CI 
Tetrahedral intermediate 
positioned for CoN 51 Site 
hydrolysis 
Figure 6: Molecular model of the frrst tetrahedral intermediate for C-N hydrolysis of N-
cWoroacetyl-p-toluene sulfinamide 1 in the active site of subtilisin BPN (compare with 
the orientation in Figure la). The four positions selected for mutation in BPN' are 
indicated: Leu209Tyr indicates a mutation from the naturalleucine in BPN to tyrosine. 
Tyrosine is found at position 209 in subtilisin Carlsberg. Residues 217, 209, and 63 in the 
SI' leaving site, as well as residue 156 in the Slacyl site differ in subtilisins Carlsberg and 
BPN'. 
Formation of the sulfinyl enzyme intermediate from 1 by a mechanism similar to that for 
formation of an acyl enzyme intermediate requires that the sulfinamide 1 tum around in 
the active site, Figure 5b. Although simply sliding the substrate to the right in Figure 5a 
could position the sulfur near the active site serine, it would not position the leaving 
group nitrogen near the active site histidine to allow it to protonate the leaving group. 
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We hypothesize that the substrate reverses in the active site. Variation of the substrate 
structure changed the ratio of sulfinamide to carboxamide hydrolysis in ways that are 
consistent with a reversaI of orientation for two hydrolyses. 
We used a 2-phenylethyl substituent to vary the preferred substrate orientation in 
the active site. Subtilisin favors binding a 2-phenylethyl substituent in the SI acyl site 
because it mimics phenylalanine. We hypothesized that a 2-phenylethyI substituent on the 
sulfinyl group would favor a substrate orientation for sulfinamide hydrolysis. The ratio of 
sulfinamide to carboxamide hydrolysis for compounds 3 and 4 support this hypothesis. 
Compound 3, which contains a 2-phenylethyl substituent on the sulfinyl group, gave 
higher ratio of sulfinamide hydrolysis (4: 1) as compared to compound 4 (1: 1), which 
contains a p-tolyl substituent, Table 1. Both compounds 3 and 4 reacted at an 
intermediate rate. Compounds 5 and 6 also differ by a p-toluene and 2-phenylsulfinyl but 
reacted slowly and showed only sulfinamide hydrolysis (>10:1) so any difference in the 
ratio was outside the detection limit. Compounds 1 and 2 compared a phenyl vs. p-tolyl 
substitutent on the sulfinyl. Both compounds reacted quickly and showed the same 4: 1 
ratio of sulfinamide to carboxamide hydrolysis. 
To further test this hypothesis, we added the 2-phenylethyl substituent to the 
carbonyl group (corresponding to a dihydrocinnamoyl group) and predicted that it would 
favor carboxamide hydrolysis. We compared the ratio of sulfinamide to carboxamide 
hydrolysis in 1, 4 & 6-10, which aIl contain p-tolyl sulfinamide moiety and differing acyl 
groups. The N-dihydrocinnamoyl compound 4 showed the lowest ratio of sulfinamide to 
carboxamide hydrolysis (1: 1), consistent with the preference of the dihydrocinnamoyl 
group for the SI acyl poeket. Compounds 1 and 7-10 have similar smaIl acyl groups and 
show similar amounts of sulfinamide hydrolysis (from 4:1 to 2:1). Compounds 1 and 7 
contain e1ectron-withdrawing substituents, but these did not change the ratio of 
sulfinamide to carboxamide hydrolysis as compared to compound 8-10 without e1ectron-
withdrawing substÏtuents. Compounds 1 and 7 did react significantly faster than 
compounds 8-10. These experiments show that the ratio of sulfinamide to carboxamide 
hydrolysis does not vary upon adding electron-withdrawing substituents, but does vary 
upon addition of the 2-phenylethyl substituent. 
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The enantioselectivity was low for most sulfinamide hydrolyses, despite the fact 
that the reaction occurs at the sulfur stereocenter. One exception was 5, which had an 
enantioselectivity greater than 50 (see Table 1). 
o 0 
7R= ~OMe 9R= ~ 
o 
BR= ~ 
o 
10R= Y 
o 
Il 
0rS'oMe 
V11 
QIO Il ~ . S'OMe 
o 12 
Il 
~S'OMe V 13 
Figure 7: Substrates to test substrate reversaI hypothesis with subtilisin Carlsberg by 
measuring the S-N:C-N hydrolysis ration in N-acyl sulfinamides. Substituents that mimic 
the phenylalanine side chain (CH2CH2Ph) generally bind in the S} acyl site. Compounds 
1-6 are three pairs in which the acyl group is held constant while the sulfinyl group is 
varied. Compounds 7-10 expand the acyl group range in the N-acyl-p-
toluenesulfinamides. The sulfinates 11-13 were also tested for enzymatic hydrolysis. 
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Table 1: N-acyl sulfinamides: Total enzymatic hydrolysis and component S-N and C-N values 
Total Hydrolysis··b Sulfinamide Hydrolysis Carboxamide Hydrolysis Ratio 
Subtstrate Conv. %b rimel ees. %d %S-N' eep Cal! ES Fi' %C-N; eep• o/oi E' Fi' S-N:C-N 
rate' 
55 6. fast 85 (S) 44 (39) n(R) li 17 Il (9) 59 (R) 4 6 4:1 
2 2 53 6. fast 44(S) 43 (36) 29 (R) 2 2 10 (9) 80 (R) \0 18 4:1 
3 3 30 24.int. 37 23 (21) 7 (5) 4:1 
4 4 57 24. int. 83 (S) 30 69(R) 7 7 27 57 (R) NIA! 4 1 :1 
5 5 18 n. slow 17 18 (14) 9.3 >50 0 >\0:1 
6 6 55 n.slow 21 (S) 55 2 2 <3 >10:1 
7 7 49 24. fast 27 (S) 39 (19) 16(R) 1.5 2.2 \0 (9) 80 (R) 10 18 2:1 
8 8 21 n. slow 8 20 (10) <3 ~ 4:1 
9 9 40 n.slow 38 30 (18) 52 4 4 \0 71 NIA 6 2:1 
\0 10 23 n.slow \0 19 (13) 25 2 2 4 75 NIA 7 3:1 
a AU reactions performed at 25 oC in BES buffer (50 mM, pH 7.2), bTotal conversion determined from the disappearance of starting 
material using biphenyl as an internaI standard. Error ± ,..,2% conversion, based on standard deviation. C Approximate rate from 
conversion and time (h) and grouped into fast, intermediate, and slow categories. dees = enantiomeric excess of remaining starting 
material measured by HPLC. 'Calculated amount of the total conversion attributed to S-N bond hydrolysis, the value with the 
chemical reaction subtracted is in parenthesis. fCalculated enantiomeric excess from the portion of substrate that disappeared via the S-
N c1eavage path. gE = Observed enantioselectivity (uncorrected for spontaneous chemical hydrolysis) was calculated from 
conversion, c, and eep or ees according Sih.30 hE = enantioselectivity, corrected for spontaneous chemical hydrolysis using the program 
Selectivity K.reSH31 • i%C-N conversion - Percent age of C-N conversion based on formation of sulfinamide. iEnantiomeric excess of 
the C-N hydrolysis sulfinamide product, measured by HPLC. "Not applicable. 
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We tested several sulfinates (ester analogues), but only the aliphatic 
dihydrocinnamoyl analogue 13 gave enzymatic hydrolysis. Thus choosing a 
complementary acyl analogue to match the enzyme active site proved critical to enhance 
the promiscuous reaction. Subtilisin Carlsberg catalyzed hydrolysis of the 
dihydrocinnamoyl sulfinate, 13, with high enantioselectivity, E > 1 00, Table 2. The 
absolute configuration of the favored enantiomer was (R)-13, which has the same three-
dimensional arrangement as the N-acyl sulfinamide above. This is the fust ex ample of 
enzymatic sulfinate hydrolysis by a serine hydrolase, or by any hydrolase. The 
dihydrocinnamoyl group mimics phenylalanine and binds weIl to the SI acyl pocket. 
Subtilisin Carlsberg did not catalyze hydrolysis of the corresponding benzyl sulfinate 12 
or phenyl sulfinate 11. 
Table 2: Subtilisin Carlsberg catalyzed hydrolysis of sulfinates 11-13. 
Compound Time (h) % Chemicala % Enzymatic eesb 
11 72 26% <5% n.r.d 
12 72 6% None n.r. 
13 72 3% 34% 50% >100 
a) chemical (non-enzymatic) hydrolysis b) enantiomeric excess of the substrate 
determined using chiral HPLC. c) Enantioselectivity determined from conversion and ees, 
and corrected for spontaneous chemical hydrolysis using the program Selectivity 
KreSH.30,31 d) No reaction 
Site directed mutagenesis identified four key mutations that affect the amount of 
the sulfinamide vs. carboxarnide hydrolysis in subtilisin BPN. Mutations of subtilisin 
BPN' to introduce residues found in subtilisin Carlsberg increased the S-N bond 
hydrolysis. We selected residues dose to the active site for mutation because doser 
mutations usually have a larger effect on the reaction than more distant sites.32 The S}' 
leaving group pocket was mutated at residues 217, 209, and 63, while one position in the 
S) acyl binding poeket was mutated, position 156. The combined mutations increase by 
14-fold the amount of sulfinamide vs. carboxamide hydrolysis of 1 (Table 3). 
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The single mutant Y217L had the single biggest effect on the ratio of C-N vs. S-N 
reactivity - it Ïncreased 4-fold from wild-type BPN' (Table 3, entry 4). The other single 
mutants in the S)' poeket, L209Y and S63G, did not show a significant change in the 
selectivity ratio (lines 6 and 7). In the S) acyl poeket, the E156S single mutant also had 
little effect upon the chemoselectivity of the enzyme. This loeation is unique in that it is 
located in the acyl-binding poeket, not the leaving group poeket. 
Having determined position Y217L as an important position for S-N reactivity, 
we prepared multiple mutants to combine with this mutation. Positions that previously 
had little effect now increased the amount of S-N reaction indicating complementary, 
rather than additive, contributions. We made two double mutants. First, adding the 
E156S mutant to Y217L increased the S-N ratio 8-fold, to 40 % of the total enzymatic 
hydrolysis (entry 8, Table 3). Secondly, adding the L209Y mutant to Y217L increased 
the total S-N reactivity 6-fold (entry 9, Table 3). 
We made three triple mutants. The mutant Y217L, L209Y and S63G increased by 
15% to 45% over its double mutant (without mutation S63G, compare Iines 9 and 10). 
Adding either a S63G or a L209Y mutation to the Y217L/E156S mutant increase the S-N 
hydrolysis to 73% and 69%, respectively (compare lines 8, 11, and 12). Either ofthese 
mutants increase the amount of S-N reactivity in BPN' 14-fold, comparable to the 
preference in subtilisin Carlsberg. 
We expected the quadruple mutant to combine these successes. However, it only 
gave 46% S-N hydrolysis of the total enzymatic hydrolysis (9-fold increase). Evidently 
the many other ami no acid differences between the two enzymes are significant; in the 
case of the quadruple mutant these must affect the selectivity of the reaction. 
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Table 3: Mutations of Subtilisin BPN' alter the preference for S-N to C-N bond cleavage. 
Total Sulfinamide Hydrolysis Carboxamide Hydrolysis Normalized values 
Hydrolysis",b 
Subtilisin Conv. ees• %S-W eep FI %C- eep• %h El %S-N:%C-N Increase in %b %C Cal: Ng ~enz~matic~ %S-N 
None (chemical) 7 5 2 
2 Carlsbergl 55 85 44 72 17 II 59 6 79:21 
3 BPN' 49 85 3 46 93 64 <5:95 
4 Y217L 32 10 22 20:80 4-fold 
5 E156S 51 6 45 <5:95 
6 S63G 50 8 42 7:93 
7 L209Y 53 6 46 < 5:95 
8 Y217L + EI56S 47 21 26 40:60 8-fold 
9 Y217L+ +L290Y 50 18 32 30:70 6-fold 
10 Y217L + + S63G + L209Y 48 23 25 44:56 9-fold 
11 Y217L + E156S + S63G 50 81 36 88 25 14 60 4 72:28 14-fold 
12 Y217L + EI56S + L290Y 39 58 27 90 26 12 65 5 69:31 14-fold 
13 Y217L + EI56S + S63G + L290Y 51 25 26 46:54 9-fold 
aAll reactions peIformed at 25 oC in BES buffer (50 mM, pH 7.2), Reaction times 6 h. /Joyotal conversion determined from the 
disappearance of 1 using biphenyl as an internaI standard. Error ± -2% conversion, based on standard deviation. cees = enantiomeric 
excess of remaining starting material measured by HPLC. dCalculated amount of the total conversion attributed to S-N bond 
hydrolysis, the value with the chemical reaction subtracted is in parenthesis. eCalculated enantiomeric excess for the portion of 1 that 
disappeared via the S-N cleavage path. JE = Observed enantioselectivity (uncorrected for spontaneous chemical hydrolysis) was 
calculated from conversion, c, and eep or ees according Sih.30 8E = enantioselectivity, corrected for spontaneous chemical hydrolysis 
using the program Selectivity KreSH31. h%C-N conversion - Percentage of C-N conversion based on formation of p-
toluenesulfinamide. iEnantiomeric excess of the C-N hydrolysis product, p-toluenesulfinamide, measured by HPLC. 
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Discussion: 
The S-N hydrolysis by subtilisin Carlsberg is a clear ex ample of catalytic 
promiscuity. Catalytic promiscuity involves a switch in mechanism, or the type of bond 
broken/formed, or both. The protease hydrolyzes a completely different bond, a S-N 
sulfinamide bond, rather than C-N carboxyamide bond. It is an unusual example in that 
N-acyl sulfinamides contain both the natural amide and unnatural sulfinamide bond, yet 
the enzyme prefers the unnatural bond. Other examples of promiscuity do not present a 
choice between natural and promiscuous function for the enzyme witbin a substrate. 
There are several classes of enzymes that perform sulfate bond cleavage reactions. 
The S-N bond in N-sulfoglucosamine is cleaved to give sulfate by sulfamidase (E.C. 
3.10.1.1).38 The S-O bond in sulfamates also releases sulfate when cleaved by sulfatases 
(E.e. 3.1.6.x).39 However, the se reactions occur at a different functional group than the 
reaction reported here and involve a different intermediate. Sulfatases contain an (1-
formylglycine residue, not a serine, at the active site and react via a sulfate hemiacetal. 
Sulfonates are structurally similar to the sulfinyl compounds reported here. 
Sulfonates and sulfonyl fluorides inhibit many types of serine proteases because the 
sulfonyl enzyme does not turn over to regenerate the free enzyme.40 The sulfonyl 
inhibitor attaches to the catalytic serine, and X-ray crystal structures of a sulfonylated 
subtilisin are known.41 Similar N-acyl compounds, ~sultams (analoges to ~lactams), 
inactivate the serine protease elastase by opening a strained four membered ring to give a 
sulfonylated enzyme.42 While there is ample precedent for sulfonylation of serine 
hydrolases, de-sulfonylation does not occur. With the sulfinyl compounds in tbis work 
catalytic turnover does occur. Sulfinyl compounds may react because they are less 
hindered than sulfonyl compounds with one less oxygen and have an open site for attack 
of water. SuIf ur peptides containing sulfinamide functionality were proposed as protease 
inhibitors, but synthesis was unsuccessfuL43 
While sulfonyled enzymes are weIl known from inhibitors, the corresponding 
sulfinylated enzymes are unknown. The intermediate observed by mass spectrometry 
indicates that the hydrolysis of N-acyl sulfinamides proceeds through a sulfinyl enzyme 
intermediate. The sulfinyl group is most likely attached to the catalytic serine in an 
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analogous manner to acyl enzyme intermediates and to sulfonyl inhibitors. However. we 
do not have direct evidence for the location of the sulfinylated residue. Another possible 
nucIeophile is the imidizole of His64. A crystal structure of the Candida rugosa lipase 
revealed a sulfonylated histidine residue formed with excess sulfonyl chloride.44 but with 
sm aller amounts of sulfonyl chloride only the catalytic serine reacted. 
Subtilisin prefers large non-polar residues such as phenylalanine or tyrosine in the 
SI binding site.45 Boronic acids are competitive inhibitors of subtilisin Carlsberg and 
display a similar selectivity profile. The inhibition constant for methylboronic aeid is 13 
mM. while for 2-phenylethylboronic aeid it is 0.27 mM. a 46-fold difference.46 The 
dihydrocinnamoyl group also increased the reaetivity towards esters47 and N-aeyl 
sulfinamides.18 Substrates with the dihydrocinnamoyl mimie on the sulfrnyl portion 
provide strong evidence for the position of the substrate binding. Plaeing this group on 
the earboxyl portion of the moleeule favors the C-N reaetion. while plaeing the group on 
the sulfinyl portion favors the S-N reaction. This indieates a substrate reversal to place 
this group in the SI-aeyl binding poeket (see Figure 5). ln C-N hydrolysis. the aeyl group 
is positioned in the SI-aeyl binding poeket. while the leaving sulfinamide is located in the 
leaving group SI' poeket. For S-N sulfinamide hydrolysis. it is postulated that a reversal 
oeeurs to place the sulfinyl group in the SI aeyl poeket. and the leaving amide in the SI' 
poeket. Binding in this orientation would also be favored if the eatalytie histidine 
performs the analogous role of protonating the leaving group. as oeeurs in aeyl hydrolysis 
(Figure 2). Merely shifting the substrate. without a reversal. would place it in an 
unfavorable position to receive a proton from the eatalytic histidine. 
Further support for binding to enhance reaetivity cornes from a new cIass of 
substrates, sulfinates, made to reaet by adding the 2-phenylethane group. Subtilisin 
Carlsberg hydrolyzed only one of the three sulfinates tested. This is likely due to 
positioning of the substrate by the 2-phenylethyl sulfinyl group in 13. 
Remote binding effeets are often eited to enhance reaetivity and position the 
substrate for reaction and favor formation of the transition state.48 Binding orients the 
reaetive portion of the substrate into the correct distance. orientation and conformation 
for ehemieal transformation. similar to a near attack eomplex.49 These contributions may 
supplement the cIassie enzymatic eatalysis by stabilization of the transition state 
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geometry. However, dynamic effects in proteins make it difficult or impossible to dissect 
enzyme-substrate interaction into purely ground state binding vs. transition state binding 
contributions. 50 
Formation of the sulfinyl enzyme intermediate most likely involves nucleophilic 
substitution. Nucleophilic substitution of sulfinyl compounds proceeds by an associative 
mechanism from a four-coordinate sulfinyl geometry to a five-coordinate trigonal 
bipyramidal (sulfurane) geometry around the sulfur atom.51 The five-coordinate species 
may he either a transition state, in a concerted SN2-like process, or an intermediate, in a 
stepwise addition-elimination process. According to theoretical calculations, an 
intermediate is formed with an unsymmetrical trigonal bipyramidal structure and the 
leaving group and nucleophile in apical positions.52 There are also several examples of 
stable, isolated, trigonal biypyramidal sulfurane compounds.53 Reaction to form the 
sulfinyl-enzyme intermediate may in volve sulfurane (5-coordinate) transition state and a 
pseudorotation. 
In addition to reaction requirements, the enzyme also imposes limitations on the 
reaction. Nuc1eophilic attack occurs on the (R)-enantiomer of the sulfur stereocenter. The 
attacking nucleophile, most likely Ser221, will occupy an apical position in the trigonal 
bipyramidal structure, and the sulfinyl oxygen willlikely he placed in the oxyanion hole 
for stabilization of the buildup of charge in the transition state. The dihydrocinnamoyl 
portion of the molecule willlikely bind in the SI acyl site. This leaves the position of the 
leaving group, -NHR, and the lone pair. The stereochemistry requires that the lone pair 
he in the opposite apical position and the -NHR leaving group occupy the remaining 
equatorial position. Generally, the leaving group must occupy an apical position hefore 
departing. Pseudorotation to place the leaving group in an apical position may further the 
reaction (Sulfurane A to B, Figure 8), or may not he necessary. Pseudrotation is thought 
to occur in phosphoryl transfer reactions occurring with retenti on of configuration.54 Two 
diastereomers differing at the phosphorus center of a peptidic substrate gave the same 
stereochemistry for the resulting phosphorus intermediate.55 A pseudorotation was 
suggested to account for the alternate inversion or retention pathways. 
Pseudorotation may also account for the low enantioselectivity if both 
enantiomers can lead to the same intermediate. The stereochemistry of the resulting 
134 
Chapter 5 
sulfinylated enzyme fonned is unknown, and the overall retention or inversion is not 
known because the final product, sulfinic acid, is achiral. The feasibility of this 
mechanism is currently under investigation using QM/MM methods. 
o Ser221-0H 
s .. 
RHN/ ...... CH2CH2Ph 
Sulfurane A 
pseudorotation 1 ~R 
NHR Oxyanion 
1 'à~ Hole 
:-s<;' 
1 ~ser~l 
\ Acyl 
CH2CH2Ph: Pocket 
, , 
Sulfurane B 
Sulfinyl enzyme 
Figure 8: Fonnation of a possible sulfurane trigonal bipyramidal intennediate. The 
nucleophilic Ser22COH and the sulfur Ione pair occupy the apical positions in the trigional 
bipyramidal sulfurane A. Pseudorotation may occur to exchange apical and equatorial 
positions. 
A high enantioselectivity might be anticipated for sulfinamides reactions because 
hydrolysis occurs at the chiral center. Indeed, reaction with acety1cholinesterase with 
Soman (2-(3,3-dimethylbutyl)-methylphosphonofluoridate) occurs with high 
enantioselectivity and reacts exclusively (E> 104) with the P(S) configuration.56 
However, in other examples where reaction occurs at the organophosphorus stereocenter 
the enantioselectivity is not always high. Candida antarclÏca B lipase is inhibited by 
ethyl (-)-p-nitrophenyl hexylphosphonate onlyto times faster than the (+)-enantiomer, a 
moderate enantioselectivity.57 The enantiopreference for two diastereomers differing at 
the phosphorus center was only 2:1 for phosphonate inhibitors of several serine 
hydrolases, induding subtilisin.58 For the hydrolysis of phosphotriesters by the 
organophosphorus acid anhydrolase (OPAA), the enantioselectivity was substrate 
dependant from 3 to 36.59 Therefore reactions occurring directly at a stereocenter do not 
always have a high enantioselectivity. 
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Subtilisin Carlsberg and BPN' differ in 86 of 275 amino acids (69% identical) and 
have very similar crystal structures (see Figure 9) but hydrolyze peptides at different 
rates. For the synthetic peptide substrate succinyl-Ala-Ala-Pro-PHE-p-nitroanilide, 
Carlsberg had a 7-fold higher kca/KM value of 2500 sec-IM-I compared with the BPN' 
value of 360 sec-1M-1•60 Three mutations close to the active site of BPN' accounted for 
these kinetic differences. The E156S single mutant of BPN' increased the kca/KM value 
by 3-fold, attributed mainly to a lower KM value. The L217Y single mutant increased the 
~alKM value by 2-fold; both ~al and KM increased. A combination ofthese two 
mutations gave a combined 4-fold increase in the k.:a/KM of the resulting BPN' mutant for 
this synthetic peptide. A third mutation, G169A, which is not in direct contact with the 
substrate, gave a 3-fold increase. Combined into a triple mutant with 156/217 the G169A 
mutation raised the catalytic efficiency to match Carlsberg. The rate enhancement for 
peptide hydrolysis for residue 217 mutation suggested sm aller leucine being able to 
accommodate larger leaving groups, while other mutations were not rationalized.61 
In a similar way three mutations account for the increase in the promiscuous S-N 
reaction vs. the C-N reaction in subtilisins BPN' and Carlsberg. Two mutations sites were 
the same as the above study; positions 156 (SI acyl site) and 217 (SI' site) gave a 8-fold 
increase in the S-N reaction. Two other positions, 63 and 209, differ in BPN' and 
Carlsberg and were also chosen for mutation. Position 169 was not mutated, as it was 
forther from the active site. The above study examined rate changes resulting from 
mutation, while here the selectivity, not the rate, changed. The overall reaction rate was 
approximately the same for each mutant. 
AlI four mutations affected the amount of S-N hydrolysis, indicating that they are 
key residues near the active site that affect selectivity. The effect of mutations was not 
additive but complementary. For instance, single mutants of position 63, 156, and 209 
showed no change (Table 2, entries 5-7), but in combination each mutant contributed to 
an increase in S-N hydrolysis (entries 9-13). 
These mutations are in both the acyl and leaving group sites, and are consistent 
with a reversai of the substrate. One mutation (Glu156Ser) is loeated in the SI acyl-
binding poeket, while the other three of these mutations are loeated in the aIcohol-binding 
poeket (SI')' The changes in the enzyme are not obvious and it would be difficult to 
136 
Chapter 5 
predict or design this result based on simple modeling. In the SI acyl pocket, position 156 
is mutated from a charged glutamate residue to an uncharged serine residue. This results 
in a larger, less polar pocket. In the SI' leaving group poeket, tyrosine 217 is 8.4 Â from 
the catalytic serine (Ca), and is in direct contact with the substrate during C-N 
hydrolysis. Leucine is slightly wider than the aromatic tyrosine, but spatially they are 
quite sirnilar. Another possibility is a hydrogen bond between tyrosine and Ser63 which 
restricts movement in wild-type BPN'. The hydroxyl group of Tyr217 is 2.8 Â from 
Ser63, but this interaction is not possible in the mutated enzyme. Position 217 and 209 
are complementary in the two enzymes. In subtilisin BPN' these residues are tyrosine and 
leucine, while in subtilisin Carlsberg they are reversed, leucine and tyrosine. 
In addition to the substrate reversal hypothesis, an increased flexibility of the 
active site to accommodate an altemate reaction mechanism may also contribute to 
reactivity. Two of these mutations are located next to key residues: position 63 is 
adjacent to the catalytic His64, while position 156 is next to Asn155, an oxyanion-
stabilizing residue. In both cases, the mutations are to smaller residues that may allow 
more flexibility to accommodate an altemate mechanism. In particular, a pseudorotation 
of the intermediate may require addition al enzyme flexibility. 
Figure 9: Subtilisins BPN' (left), and Carlsberg (right). Catalytic residues Ser22 1 , His64 
and Glu156, the Slacyl site and the SI' leaving group site are shown. Residues differing 
between the two enzymes are 63, 209 and 217 in the SI' site, and 156 in the acyl site. 
There is no reason why these mutations should be the best for S-N hydrolysis. 
Because this is an example of catalytic plasticity, the natural enzyme (Carlsberg) is not 
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optimized for the reaction. Saturation mutagenesis on the positions identified, and others, 
should allow us to improve the reaction even more. The reaction rate was approximately 
the same for each mutant, and could he improved using mutagenesis and computation al 
results. Catalytic promiscuity is often introduced by a few mutations close to the active 
site.32,62 The residues responsible for the chemoselectivity here were all close to the active 
site. 
Enantiopure sulfinamides and sulfinates are valu able synthetic intermediates in 
the preparation of chiral amides and sulfoxides. The p-toluene and t-butyl sulfinamides 
are the most common due to their ease of preparation. Enantiopure p-toluene sulfinamide 
is prepared from the menthol sulfinate crystallization. This is limited to p-substituted 
aromatics, as the aliphatic equivalents are not crystalline and difficult to separate. Thus 
there are fewer methods to prepare the aliphatic sulfinyl compounds. While in the initial 
stages, the enzymatic hydrolysis reported here may provide a route to the less accessible 
aliphatic sulfinates, which are easily transformed to sulfinamides and sulfoxides. 
Experimental 
General methods. IH_ and I3C-NMR spectra were obtained as CDCI3 solutions at 300 
MHz and 75 MHz, respectively. Chemical shifts are expressed in ppm (ô) and are 
referenced to tetramethylsilane or solvent signal. Coupling constants are reported in Hertz 
(Hz). Flash chromatography with silica gel (35-75 mesh) was used to purify aIl 
intermediates and substrates. AlI reagents, buffers, starting materials and anhydrous 
solvents were purchased from Sigma-Aldrich (Milwaukee, USA) and used without 
purification. AlI air- and moisture-sensitive reactions were performed under Ar. Subtilisin 
Carlsherg (E.C. 3.4.21.62) was purchased from F1uka (St. Louis, USA). 
Enzymatic Reactions and Analysis 
Enzymatic reactions were preformed under the following conditions: BES buffer (250 
J-lL, 50 mM, pH 7.2), substrate (30 J-lL, 75 mM in MeCN containing biphenyl as an 
internal standard, and an enzyme solution (50 J!L, 10 mg/mL). The reaction was stirred 
at 25 oC quenched with acetonitrile (1.00 mL) to precipitate the enzyme, centrifuged, and 
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analyzed. Conversion was detennined by reverse phase chromatography of this solution 
on a Zorbax SB-CI8 column (4.6 mm x 250 mm, Agilent, Palo Alto, CA) with 
acetonitrile/water as the mobile phase. Biphenyl was used as an internaI standard and 
sulfmamide standards with biphenyl were used to determine C-N conversion. To 
detennine the enantiomeric excess the reaction was extracted with EtOAc (3 x 0.75 mL), 
dried with MgS04 and evaporated and analyzed using a chiral stationary phase: Chiralpak 
AD-H or Chiralcel on columns (4.6 mm x 25 cm, Chiral Technologies, West Chester, 
PA) at 230 nm. An achiral Discovery Cyano column (4.6 mm x 25 cm, Supelco, 
Bellefonte, PA) was placed before the chiral column in cases where the sulfinamide and 
N-acyl sulfinamide enantiomers overlapped. Retention times are given with compounds 
analyzed. Reactions for the pH dependence curve were prefonned on a Radiometer 
TitraLab 854 pH stat-titration apparatus, with a buffer of appropriate pKa (2.0 mM), and 
the pH held constant by titration with NaOH (0.1 mM). The reaction was stopped by 
addition of acetonitrile and analyzed as above. 
Mass Spectra: 
Enzyme mass spectra were obtained under the following conditions. Subtilisin Carlsberg 
(40 ~, 10 mg/mL in 10 mM BES, pH 7.2) and 1 (3 ~, 100 mM) were reacted for 30 
min. and acidified with fonnic acid (2%, 3 I-lL). The mixture was desalted using a porous 
C4 resin, diluted and analyzed by electrospray ionization mass spectrometry (Q Star, 
Applied Biosystems, Foster City, CA). Inhibited enzyme was prepared by treatment of 
an enzyme solution with PMSF (3 ~, 100 mM) and the above experiment replicated. A 
third experiment with N-chloroacetyl phenylsulfinamide 2, was also perfonned as a 
control. The molecular weight of the free enzyme shifted by 1-2 mass units depending on 
calibration, but the adducts were of consistently of expected mass. 
Synthesis of N-acyl-p-toluenesulrmamides. 
N-acyl-p-toluenesulfinamides63 were prepared by acylation of the corresponding p-
toluenesulfinamide with 2 equivalents of n-butyllithium and addition of the appropriate 
anhydride64 to give the N-acyl sulfinamide. N-acyl derivatives 1, 4, 6, and 7 were 
prepared and analyzed as described previously.22 
139 
Chapter 5 
N-(chloroacetyl)-benzenesulfinamide, 2, White solid, (580 mg, 
40%), mp 93-95 oC; IH NMR ô 4.15 (s, 2H), 7.59 (m, 3H), 7.75 (m, 
2H), 8.41 (s, IH); I3C NMR ô 42.4,124.9, 129.8, 132.7, 143.0, 
167.3; MS [M+Hr CgH9CIN02S Cal'd = 218.0043, found = 218.0054. Conversion: 50/50 
MeCNIH20, flow 0.6 mL/min for 9 min, then gradient to 80120 over 0.5 min; 
benzenesulfinamide: tR = 4.8 min; 2: tR = 6.1 min; biphenyl: tR = 15.7 min. Enantiomeric 
excess: 90/10 HexaneslEtOH, flow 0.5 mUmin, Cyano column and Chiralcel-OD. 
benzenesulfinamide, (R) tR = 33.4 min, (S) tR = 35.6 min; 2: (R) tR = 47.3 min, (S) tR = 
64.1 min. 
N-(acetyl)-p-toluene sulfinamide, 8, White solid, (560 mg, 22%), 
mp 124-126 oC (Lit 125-127 °CI8); IH NMR (300 MHz, CDCl3): ô 
2.19 (s, 3H), 2.44 (s, 2H), 7.35 (d, J = 8.1, 2H), 7.60 (d, J = 8.1, 
2H); I3C NMR (75 MHz, CDCI3): ô 21.8, 21.9, 124.8, 130.1, 140.2, 142.8, 171.3, HR-
EIMS m/z: M+ calcd for C9H12N02S 198.0588, found 198.0585. Conversion: 50/50 
MeCNIH20, flow 0.6 mL/min for 9 min, then gradient to 80120 over 0.5 min; p-
toluenesulfinamide: tR = 5.3 min; 8: tR = 5.5 min; biphenyl: tR = 15.7 min. Enantiomeric 
excess: 95/5 HexaneslEtOH, flow 0.75 ml/min, Cyano column and Chiralcel-OD. p-
toluenesulfinamide, (R) IR = 42.5 min, (S) tR = 52.0 min; 8: IR = 44.3 min, tR = 58.3 min. 
N-(propyl)-p-toluenesulfinamide, 9, White solid, (1.3 g, 65%); 
mp 108-110 oC; IH NMR (300 MHz, CDCl3): ô 1.23 (t, J = 7.5, 
3H), 2.44 (s (br), 4H), 7.35 (d, J = 7.8, 2H), 7.60 (m, 2H); 13C 
NMR (75 MHz, CDCI3): ô 8.8,21.5, 124.8,130.1,140.3,142.6,174.9; HR-EIMS m/z: 
M+ calcd for C)OHl4N02S 212.0745, found 212.0757. Conversion: 50/50 MeCNIH20, 
flow 0.6 mUmin for 9 min, then gradient to 80120 over 0.5 min; p-toluenesulfinamide: IR 
= 5.3 min; 9: IR = 6.4 min; biphenyI: tR = 15.7 min. Enantiomeric excess: 95/5 
HexaneslEtOH, flow 0.75 ml/min, Cyano column and Chiralcel-OD. p-
toluenesulfmamide, (R) tR = 42.5 min, (S) IR = 52.0 min; 9: (R) tR = 36.4 min, (S) IR = 
48.5 min. 
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N-(Isopropyl)-p-toluenesulfinamide, 10, White solid, (1.4 g 
,64%) mp 123-125 oC; IH NMR (300 MHz, CDCI3): ô 1.19 (d, J = 
7.0, 6H), 2.44 (s, 4H), 7.32 (d, J = 7.8, 2H), 7.53 (m, J = 7.0, 2H); 
13C NMR (75 MHz, CDCI3): Ô 18.9,19.2,21.5,124.7, l30.2, 140.7,142.8,177.8, MS 
[M+H] + CIIHI~02S Cal'd = 226.0901, found = 226.0903. Conversion: 50 MeCNIH20, 
flow 0.6 mUmin for 9 min, then gradient to 80/20 over 0.5 min; p-toluenesulfinamide: tR 
= 5.3 min; 10: tR = 7.7 min; biphenyl: IR = 15.7 min. Enantiomeric excess: 95/5 
Hexanes/EtOH, flow 0.60 mUmin, Cyano column and Chiralcel-OD. p-
toluenesulfinamide, (R) tR = 42.5 min, (S) tR = 52.0 min; 10: (R) tR = 30.9 min, (S) tR = 
39.7 min. 
Preparation of aliphatic sulfinamides and sulfinates: 
~SH 
V 
o--.s-srD 
o 
R"'-./Sto, 
---> If ~ 
2. phthINEt3 0 _ 
15 R =CH2Ph 
16 R= Ph 
m·CPBA 
1
1. RtCONH2. NaH 
2. m-CPBA 
o 0 
V S'NJlR 1 H t .ô 
Aliphatic N-acyl sulfinamides 
3 Rt = CH2CH2Ph 
5 R1 = p--tol 
17 R =CH2Ph 
18 R = Ph 
Aliphatic suHinates (X = 0) and 
sulfinamides(X = N) 
12R=Ph. R2=Me.X=0 
13R=CH2Ph, R2 =Me, x=o 
19 R = CH2Ph, X = NH2 
Scheme 1: General method for the preparation of aliphatic sulfinates and N-acyl 
sulfinamides (phth= phthalimide). 
Aliphatic sulfinamides were prepared from the corresponding thiols (or disulfides) by 
first making the N-thiophthalimide as a suIf ur transfer reagent.65 Thiophthalimides 15-16 
were synthesized by one of two methods: thiols were converted to the sulfinyl chloride 
followed by treatrnent with phthalimide in triethylamine.66 Altematively, disulfides were 
refluxed with N-bromopthtalimide in benzene. 61 Addition of the corresponding amide in 
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NaH provided N-acyl-sulfenarnides, and the resulting product oxidized with m-CPBA to 
give the N-acyl-sulfinamide (3, 5). This method was preferable to acylation of the 
sulfinarndie because of acidic alpha protons (oxidation is performed after the 
displacement). Sulfinates and sulfinamides were from the N-sulfenyl phthalimide to the 
N-sulfinylphthalimide with m-CPBA (17-18), followed by displacement with an aIcohol 
or amine (12-13, 19). 
N-(2-phenylethanethio)phthalimide, 15. A solution of 
benzeneethane thiol (10 g, 72 mmol) in n-heptane (75 mL) 
was cooled to 0 oC and sulfuryl chloride (9.7 g, 72 mmol) was 
added dropwise followed by stirring for 45 min. This solution was transferred to a second 
round-bottomed flask containing phthalimide (10.7 g, 72 mmol) and triethyl amine (10 
mL) in DMF (75 mL) at 0 oC and stirred for a further 2 hours. After 2 hours, the reaction 
was added to cold water (1 L) and the solid collected by suction filtration and dried under 
high vacuum. Beige solid, (16.9 g, 82%), mp 73-74 oC; IH NMR (300 MHz, CDCI3): Ô 
2.95 (t, J = 5.1, 2H), 3.18 (t, J = 5.1, 2H), 7.20 (m, J = 5H), 7.77 (m, 2H), 7.90 (m, 2H); 
BC NMR Ô 35.2, 39.6, 124.0, 126.5, 128.5, 128.6, 132.1, 134.7, 139.2, 168.6; HR-EIMS 
mlz: M+ calcd for Cl6Hl4N02S 284.0745, found 284.0739. 
~ 0 N-(benzylthio)phthalimide, 16.67 A solution ofbenzene 
~s'Fo disulfide (7.0 g, 28 mmol) and N-bromophthalimide (12.8 g, 56 
If ~ mmol) was placed in anhydrous benzene (75 mL) and refluxed 
o -
for 1 hour. After cooling to room temperature hexanes (75 mL) 
were added and the white precipitate collected by suction filtration. The crude product 
was recrystallized from ethanol to give a white solid (6.7 g, 88% yield), mp 163-165 (lit 
167-1680~7): rH NMR (300 MHz, CDCI3): Ô 4.12 (s, 2H), 7.24 (m, J = 5H), 7.75 (m, 
2H), 7.86 (m, 2H); BC NMR Ô 42.5, 123.9, 128.0,128.7,129.6, 131.9, 134.6, 135.3, 
168.0; HR-EIMS mlz: M+ calcd forC1SH12N02S 270.0588, found 270.0593. 
Formation of N-acyl sulfenamides from thiophthalimides 
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N -( dihydrocinnamoyl)-2-phenylethanesulfenamide, 
Dihydrocinnamide (1.05 g, 7.0 mmol) in anhydrous 
THF (50 mL) was cooled to 0 oC followed by addition 
of NaH (0.34 g, 8.5 mmol, dispersion in mineraI oil). Compound 15 (2.0 g, 7.0 mmol) 
was added and the reaction was stirred at room temperature for 3 hours. The reaction 
mixture was washed with saturated NH4CI (25 mL), water (2X25 mL), brine (25 mL), 
dried (MgS04). Purification by column chromatography on basic aIuminia activity 1 
(50:50 CH2CliHexanes to 50:50 EtOAclHexanes) gave a clear yellow oil, (1.33 g, 66%); 
IH NMR (300 MHz, CDCI3): Ô 2.46 (t, J = 7.5, 2H), 2.94 (m, 6H), 5.90 (s, IH), 7.26 (m. 
lOH); BC NMR Ô 31.6, 35.1, 38.6, 40.1, 126.5, 128.5, 128.6, 128.7, 140.1, 140.4,174.2; 
HR-EIMS m/z: M+ calcd forC17H2oNOS 286.1265, found 286.1260. 
N-(p-tolyl)-2-phenylethanesulfenamide, Purified by 
column chromatography (40% EtOAclHexanes) to give a 
white solid, (1.10 g, 57%), mp 90-94°C; tH NMR (300 
MHz, CDCh): Ô 2.40 (s, 3H), 2.95 (t, J= 7.0, 2H), 3.12 (t, J= 7.0, 2H), 6.62 (s, IH),7.26 
(m, 7H), 7.55 (m, 2H); l3C NMR Ô 21.6, 35.2, 40.2, 126.6, 127.5, 128.7, 129.3, 140.1, 
142.9,169.4; HR-EIMS m/z: M+ calcd for Cl6HlsNOS Cal'd = 272.1109, found = 
272.1113. 
Oxidation of Thiolphthalimides and N-acyl Sulfenamides to Sulfinyl phthalimides 
and N-acyl sulfinamides65 
N-(2-phenylethanesulfinyl) phthalimide, 17. A solution of 
m-chloroperbenzoic acid (4.4 g, 18 mmol, 70% purity) in 
chloroform (50 mL) was added dropwise over 0.5 hours to a 
solution of 15 (50 g, 18 mmol) in chloroform (7 5 mL) at 0 oC. The reaction mixture was 
stirred for 1 hour followed evaporation to give a solid that was triturated with ether (75 
mL) and filtered to give a white solid, (4.2 g. 79%), mp 120-122 oC; IH NMR Ô 3.03 (m, 
IH), 3.18 (m, IH), 4.09 (m, 2H), 7.21 (m, 5H), 7.82, (m, 2H), 7.91, .oo(m, 2H); BC NMR 
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Ô 29.6, 53.7, 124.4, 127.0, 128.6, 128.9, 131.6, 135.4, 137.5, 166.2; HR-EIMS m/z: 
[M+HJ + calcd for CI6HI4N03S 300.0694, found 300.0703. 
Q N-(benzylsulfinyl) phthalimide, 18, White solid, (3.0 g, 92%), '/" 0 0 ~ 1 ~';b mp 162-164 OC, Lit65b 154-155 oC; IHNMRô4.94(d,J= 12, 
N '1 ~ IH), 5.31 (d, J = 12, IH), 7.35 (m, 5H), 7.81, (m, 2H), 7.92, (m, 
o -- 13 2H); C NMR Ô 59.3, 124.5, 129.0,129.4, 130.1,131.7,135.4, 
135.8, 166.3; HR-EIMS m/z: [M+HV CI5H12N03S Cal'd = 286.0537, found = 286.0532. 
N-(dihydrocinnamoyl)-2-phenylethanesulfinamide, 
3, White soIid, (640 mg, 85%), mp 116-118 oC; IH 
NMR Ô 2.60 (s, broad, 2H), 2.94 (m, 4H), 3.14 (m, 2H), 
7.26 (m, 1OH), 8.57 (s, IH); 13C NMR Ô 28.4,30.8,56.2, 126.6, 127.2,128.5, 128.6, 
128.7,129.0, 137.9,140.0, 173.6; HR-EIMS m/z: M+ calcd for C17H2oN02S 302.1214, 
found 302.1241. Conversion: 40/60 MeCNIH20, flow 0.6 mL/min for 9 min, then 
gradient to 80/20 over 0.5 min; Sulfinamide, tR = 4.8 min; dihydrocinnamamide, tR = 4.9 
min; compound 3: tR = 7.9 min; biphenyl tR = 17.9 min. To separate the sulfinamide and 
dihydrocinnamide, 25/75 MeCN/H20, flow 0.6 mL/min, dihydrocinnamide, tR = 12.1 
min; sulfinamide, tR = 14.3 min. Enantiomeric Excess: 85/15 HexaneslEtOH, flow 0.75 
mL/min, Chiral cel OD. 3 Enantiomers tR = 20.7 and tR = 25.1 min; dihYdrocinnamide, tR 
= 9.7 min; sulfinamide enantiomers tR = 16.3 and tR = 22.2 min. 
N-(p-tolyl)-2-phenylethanesulfenamide, 10. A solution 
of m-chloroperbenzoic acid (910 mg, 3.7 mmol, 70% 
purity) in chloroform (20 mL) was added dropwise over 
0.5 hours to a solution of N-(p-tolyl)-2-phenylethanesulfenamide (1.0 g, 3.7 mmol) in 
chloroform (20 mL) at 0 oc. The reaction mixture was stirred for 1 hOUT followed 
washing with 5% sodium bicarbonate (3 X 20 mL) and dried (MgS04). Evaporation of 
the solvent gave a colorless oil, (980 mg, 92%), mp 132-135 oC; IH NMR Ô 2.37 (s, 3H), 
2.99 (m, 2H), 3.37 (m, 2H), 7.21 (m, 7H), 7.67, (m, 2H), 9.63 (s. 1H); BC NMR Ô 21.7, 
28.6,55.6,127.1,128.3,128.6,129.0, 129.5,138.2, 144.1,167.3; HR-EIMS mlz: M+ 
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calcd for Cl6Hl8N02S 288.1058, found 288.1045. Conversion: 40/60 MeCN/H20, flow 
0.6 mL/min for 9 min, then gradient to 80/20 over 0.5 min; Sulfinamide and p-
tolylamide, tR = 4.8 min; 10: tR = 7.9 min; biphenyl tR = 17.9 min). To separate the 
sulfinamide and p-tolylamide, 25/75 MeCN/H20, flow 0.6 mL/min, p-tolamide, 12.1 
min; sulfinamide, 14.3 min. Enantiomeric excess: 85/15 Hexanes/EtOH, flow 0.75 
mL/min, Chiralcel OD. 10 Enantiomers IR = 16.5 and tR = 20.8 min;p-tolylamide, tR = 8.7 
mm. 
Sulfinate esters65 
Cif Methyl phenylsulfinate, 11. Conversion: 80/20 MeCN/H20, flow 0.6 ('YS. 
COMe mL/min; 11, tR = 5.3 min; biphenyl tR = 9.8 min; Enantiomeric Excess: 
99: 1 Hexanes/Ethanol, flow 0.6 mL/min, Chiral cel OD. 11 Enantiomers tR 
= 13.3 and tR = 14.8 min. 
~~ ~S. OMe 
Methyl benzylsulfinate, 12, IH NMR (300 MHz, CDCh): Ô 3.75 (s, 
3H), 3.96 (d,J= 12.9, IH), 4.05 (d, J= 12.9, IH), 7.31 (m, 5H); BC 
NMR Ô 54.8,64.1, 128.4, 128.9, 130.5, 134.4; HR-EIMS m/z: M+ calcd for CgHl1 0 2S 
171.0479, found 171.0477. Conversion: 80/20 MeCN/H20, flow 0.6 mL/min; 12, tR = 5.0 
min; biphenyl tR = 9.7 min. 
o 
~M. 
COMe 
Methyl 2-phenylethanesulfinate, 13, Colorless oil, 440 mg (79%). 
IH NMR (300 MHz, CDCI3): Ô 3.00 (m, 4H), 3.76 (s, 3H), 7.26 (m, 
5H); BC NMR Ô 27.3, 54.7, 58.0, 126.8, 128.6 128.8, 138.8; HR-
EIMS m/z: ~ calcd for C9H130 2S 185.0636, found 185.0644. Conversion: 80/20 
MeCN/H20, flow 0.6 mL/min; 13, tR = 5.0 min; biphenyl tR = 9.7 min; Enantiomeric 
Excess: 85/15 Hexanes/Ethanol, flow 0.75 mL/min, Chiralcel OD.13 Enantiomers tR = 
8.5 and tR = 12.0 min. 
Absolute configuration of 13 
145 
Chapter 5 
The absolute configuration of the 13 was determined by conversion to a sulfoxide 
and chemical correlation. Treatment of the remaining enantioenriched starting material 
(39% ee) with p-toluenemangensium bromide proceeds with complete inversion of 
configuration to give the sulfoxide 14 (37% ee). This sulfoxide was enriched in the (R)-
enantiomer, as determined by comparison with a standard prepared from Anderson's 
reagent « -)-menthyl- (S)-p-toluenesulfinate) and a gringard to produce 14.68 Thus (R)-13 
was the fast reacting sulfinate enantiomer, consistent with the previous N-acyl 
sulfinamides. 
Anderson's 
Reagent 
-Q-MgBr 
o I~~S~ 
Sulfur ______ ~ ~
_______ 14 
~MgBr 
V 
Scheme 2: Absolute configuration of 13 by conversion to a sulfoxide of known 
configuration. 
A - Enzymatic reaction and derivatization 
The sulfinate 13 (20 mg, 0.11 mmol) in acetonitrile (2 mL) and BES buffer (20 mL, 2 
mM) and subtilisin Carlsberg (50 mg) were stirred at pH 7.2 using a pH stat to control pH 
for 2 days. The reaction was extracted with dicWoromethane (2 X 15 mL), dried, and 
evaporated. The enantiomeric excess of the remaining starting material was 39% 
(conditions as above). This compound was then placed in anhydrous ether (10 mL) and 
p-toluene magnesium bromide (0.16 mL of a 0.5 M solution in ether, 0.08 mmol) was 
added and the reaction stirred at room temperature. The reaction was stopped with the 
addition of saturated ammonium chloride, washed with water, dried, and evaporated. The 
resulting sulfoxide was analyzed by chrial HPLC and gave an enantiomieric excess of 
37%,95:5 hexane:ethanol, Chiracel OD, flow 0.75 mL/min, Enantiomers (S)-14: tR = 
17.3 (S) and (R)-14: tR = 18.7 min. 
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B - Standard of known configuration. (R)-(2-phenethyl)-p-toluene sulfoxide, 14 
To a solution of (IR. 2S. 5R)-(-)-menthyl-(S)-p-toluenesulfinamide (1.0 g, 3.4 mmol) and 
(IS. 2R. 5S)-(-)-menthyl- (R)-p-toluenesulfinamide (100 mg, 0.34 mmol) in ether (50 
mL) at 0 oC was added 2- phenylethyl magnesium bromide prepared from 2-
bromoethylbenene (2.0 g, Il mmol) and magnesium (270 mg, Il mmol) in ether (25 
mL). The reaction mixture was stirred for 2 hours and quenched with saturated 
ammonium chlrode (30 mL), washed with water, dried and Purified by column 
chromatography (40% Ethyl acetate/hexanes) to give a colorless oil (770 mg, 84%), 
enantiomieric excess, (R)-enriched, of 79%, HPLC as above. IH NMR (300 MHz, 
CDCI3): Ô 2.41 (s, 3H), 2.90 (m, 1H), 3.04 (m, 3H), 7.26 (m, 7H), 7.52 (m, 2H); BC NMR 
Ô 21.5, 28.3, 58.4, 124.1, 126.8, 128.6,128.8, 130.1, 138.9,40.4, 141.6; HR-EIMS mlz: 
[M+Hr calcd for C1sH I70S 245.1000, found 245.1003. 
o 
JI 
V SNH2 
2-phenylethylsulfinamide, 19, white solid (114 mg, 57%), mp 77-
78°C; IH NMR (300 MHz, CDC13): Ô 3.05 (m, 4H), 4.45 (s, 2H), 7.26 
(m, 5H); 13C NMR Ô 29.2, 58.0, 126.8, 128.6 128.8, 138.9; HR-EIMS 
m/z: M+ calcd for C8H12NOS 170.0639, found 170.0645. 
Mutations of Subtilisin BPN': 
Mutants of the template subtilisin BPN' vector pS4,69 which encodes for subtilisin BPN' 
and chloramphenicol resistance were prepared using the QuikChange Site Directed 
mutagenesis kit (Stratagene, La JoUa, CA), according to the manufacture's instructions. 
Primers used were as foUows: S63G (5'-
CCTITCCAAGACAACAACGGCCACGGAACTCACGTIGC-3'), cS63 (5'-
GCAACGTGAGTICCGTGGCCGTIGTIGTCTIGGAAAGG-3'); 
E156S (5'-GCGGCAGCCGGTAACTCTGGCACTTCCGGCAG-3'), cE156S (5'-
CTGCCGGAAGTGCCAGAGTTACCGGCTGCCGC-3'); L209Y (5'-
CGTATCTATCCAAAGCACGTACCCTGGAAACAAATACGGG-3'), 
cL209Y (5' -CCCGTATTIGTTICCAGGGTACGTGCTITGGATAGATACG-
3'); Y217L (5'-GGAAACAAATACGGGGCGCTTAACGGTACGTCAATGG-3') 
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c Y217L (5' -CCATTGACGT ACCGTT AAGCGCCCCGT ATTTGTTTCC-3'). After 
digestion with DPNI to remove template DNA, the resulting mutants were 
transformed into E. coli DH5a competent cells and plated on LB agar plates 
containing chloroamphenicol. Colonies were selected and grown in LB media for 
sequencing. BPN' mutants were expressed in protease deficient B. subtilis DB 10470 cells 
with the mutated DNA, and selected on LB plates containing chloroamphenicol. 
Subtilisin BPN' mutants were expressed in 2XSG7J media for 48 hours. The 
supematant after centrifugation was filtered through a 0.22 t!m membrane filter 
and then through a bead of Dowex DE-52 anion exchange resin at pH 7.2.22 The 
enzyme solution was then concentrated using an ultrafiltration 10 kDa cutoff 
membrane and used for enzymatic reactions with compound 1, as described 
previously. SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis) gave one band corresponding to the molecular weight of 
subtilisin. 
Acknowledgements: We thank the donors of the Petroleum Research Fund, administered 
by the American Chemical Society for partial financial support of this work. We thank 
Dr. Rick BoU (Genencor) for the gift of a plasmid encoding subtilisin BPN', Dr. S. L. 
Wong (University of Calgary, Canada) for the B. subtilis DB 10470 cells. 
148 
Chapter5 
References 
1 (a) Bomscheuer, D.T.; Kazlauskas, R. J. Angew. Chem. Int. Ed. 2004, 43, 6032-6040. 
(b) Copley, S. D. Curr. Opin. Chem. Biol. 2003, 7, 265 -272. (c)Yamell, A. Chem. Eng. 
News 2003,81,33-35; (d) O'Brian, P. J.; Herschlag, D. Chem. Biol. 1999,6,91-105. 
2 (a) Reid, T. W.; Stein, T. P.; Fahmey, D. J Am. Chem. Soc. 1967,89, 7125-7126; (b) 
Reid, T. W.; Fahmey, D. J. Am. Chem. Soc. 1967,89,3941-3943; (c) May, S. W.; Kaiser, 
E. T. Biochemistry 1972,11,592-600. 
3 Kiaser, E. T. Acc. Chem. Res. 1970,3, 145-15, a-Chymotrypsin can also hydrolyze 
certain phosphonates utilizing substrate-assisted catalysis: Zhao, Q.; Kovach, 1. M.; 
Benscura, A; Papathanassiu, A Biochemistry 1994, 33, 8128-8138. 
4 (a) Park, H. I.; Ming, L. Angew. Chem.1nt. Ed. 1999,38,2914-2916; (b) Ercan, A; 
Park, H.I.; Ming, L. Chem. Comm. 2000,2501-2502. 
5 (a) Jao, S.-C.; Huang, L.-F.; Tao, Y.-S.; Li, W.-s. J. Mol. Catal. B Enzym. 2004,27, 7-
12; (b) Hill, C. M.; Li, W.-S.; Cheng, T.-C.; DeFrand, J. 1.; Raushel, F. M. Bioorg. Chem. 
2001,29,27-35. 
6 Kovach, 1. M. J. Phys. Org. Chem. 2004, 17,602-614. 
7 (a) Famey, D. M.; Gold, A M. J. Am. Chem. Soc. 1963,85,997-1009; (b) James, G.T. 
Anal. Biochem. 1978. 86, 574-579. 
8 Hinchliffe, P.S.; Wood, J. M.; Davis, A. M.; Austin, R. P.; Beckett, R. P.; Page, M. 1. 
Org. Biomol. Chem. 2003, 1, 67-80. 
9 Jensen, R. A. Ann. Rev. Microbiol. 1976, 30, 409-425. 
10 Ward, O. P.; Singh, A Curr. Opin. Biotechnol. 2000, Il, 520-526. 
11 Seffemick, 1. L.; Wackett, L. P. Biochemistry, 2001, 40, 12747-12750. 
12 (a) Broun, P.; Shanklin, J.; Whittle, E.; Somerville, C. Science, 1998, 282, 1315-1317; 
(b) Broadwater, J. A.; Whittle, E.; Shanklin, J. J. Biol. Chem. 2002,277,15613-15620. 
13 Nixon, A. E.; Firestine, S. M.; Salinas, F. G; Benkovic, S. 1. Proc. Nat!. Acad. Sei. 
1999,96,3568-3571. 
14 Femandex, I.; Khiar, N. Chem. Rev. 2005, 103, 3651-3705. 
15 (a) Zhou, P.; Chen, B.-C.; Davis, F. A Tetrahedron 2004,60,8003-8030; (b) Ellman, 
J. Pure Appl. Chem. 2003, 75, 39-46; (c) Davis, F. A.; Zhou, P.; Chen, B. C. Chem. Soc. 
Rev. 1998,27, 13-18; (d) Carreno, M. C. Chem. Rev. 1995,95,1717-1760; (e)Tillett, J. 
149 
Chapter 5 
G. In Chem. Sulphinic Acids, Esters Their Derivatives,· Patai, S., Ed.; Wiley: Chichester, 
u. K., 1990; pp 603-622. 
16 Carreno, M. C. Chem. Rev. 1995,95, 1717-1760. 
17 Colonna, S.; Gaggero, N.; Carrea, G.; Pasta, P.; Alphand, V.; Furstoss, R Chirality, 
2001, 13, 40-42 
18 Savile, C. K; Magloire, V., P.; Kazlauskas, R 1. J. Am Chem. Soc. 2005, 127, 2104-
2113. 
19 (a) McPhalen, C. A.; Janes, M. N. G. Biochemistry, 1988,27,6582-6598; (b) Bode, W. 
Papamokos, E. Musil, D. Seemuller, U. Fritz, H, EMBO J., 1986, 5, 813-818. 
20 (a) Siezen, R. J.; Leunissen, J. A. M. Protein Sei. 1997,6,501-523; (b) Gupta, R.; Beg, 
Q. K.; Lorenz, P. Appl. Microbiol. Biotechnol. 2002, 59, 15-32; (c) Bordusa, F. Chem. 
Rev. 2002,102,4817-1867. 
21 Bryan, P. N.; Biochem. Biophys. Acta. 2000, 1543,203-222 
22 Mugford, P. F.; Maglorie, V. P.; Kazlauskas, R J. J. Am. Chem. Soc. 2005, 127, 6536-
6537. 
D . . Ashton, D. S.; Beddel, C. R; Cooper, D. J.; Green, B. N.; OlIver, RW. A.; Welham, 
K. J. FEBS 1991,292,201-204. 
24 Aplin, R T.; Baldwin, 1. E.; Schofield, C. 1.; Waley, S. G. FEBS lett. 1990,277,212-
214. 
25 Wilmouth, R c.; Clifton, 1. J.; Robinson, C. V., Roach, P. L.; Aplin, R T.; Westwood, 
N. J.; Hajdu, J.; Schofield, C. J. Nat. StTUct. Biol. 1997, 4, 456-463. 
26 Goodall, J. J.; Booth, V. K.; Ashcroft, A. E.; Wharton, C. W. ChemBiochem, 2002, 3, 
68-75. 
27 Gold, A, Methods in Enzymology, 1967, Il, 706-711. 
28 Thomas, P. G.; Russell, A. J.; Fersht, A. R Nature 1985, 318,375-376. 
29 Schechter, 1.; Berger, A. Biochem biophys. Res. Commun. 1968,27, 157-162. 
30 Chen, c.-S.; Fujimoto, Y.; Girdaukas, G.; Sih, C. J. J Am. Chem. Soc. 1982, 104, 7294-
7299. 
150 
Chapter5 
31 Faber, K.; Hônig, H.; Kleewein, A in Preparative Biotransformations, Roberts, S. M. 
(ed.), John Wiley and Sons: New York, 1995, pp 0.079-0.084. See also 
http://borgc185.kfunigraz.ac.atlscience.htm (accessed Jan 2005). 
32 Morley, K. L.; Kazlauskas, R J. Trends Biotechnol. 2005,23,231-237. 
38 Anson, D. S.; Bielicki, J. Int. J. Biochem. Cell Biol. 1999, 31,363-367. 
39 . Hanson, S. R; Best, M. D.; Wong, C.-H. Angew. Chem., Int. Ed. Engl. 2004,43, 5736-
5763. 
40 (a) Fahrney, D. E.; Gold, A M. J. Am. Chem. Soc. 1963,85,997-999; (b) Gold, A. M.; 
Fahrney, D. E. Biochemistry, 1966,5,2911-2918. 
41 (a) Gallagher, T.; Oliver, J.; BoU, R; Betzel, c.; Gilliland, G. L. Acta Cryst., 1996, 
D52, 1125-1135; (b) Chu, N.-M., Chao, Y.; Bi, R-C. Protein Eng. 1995,8,211-215. 
42 P.S. Hinchliffe, J.M. Wood, A M. Davis, R P Austin, RP. Beckett, M.l Page, Org. 
Biomol. Chem, 2003, 1,67-80. 
43 (a) Merricks, D.; Sammes, P. G.; Ealker, E. RH.; Henrick, K.; McPartlin, M. M. J. 
Chem Soc, Perkin Trans 1 1991,32,2169-2176; (b) Moree, W. J.; van der Marel, G. A; 
Liskamp, R J. J. Org. Chem. 1995,60,5157-5169; (c) Moree, W. J.; van Gent, L. c.; 
van der Marel, G. A.; Liskamp, R J. Tetrahedron 1993,49, 1133-1150; (d) Moree, W. J.; 
van der Marel, G. A; Liskamp, R J. Tetrahedron Lett. 1992,42,6389-6392; (e) Moree, 
W. J.; van der Marel, G. A; Liskamp, R J. Tetrahedron Lett. 1991,32,409-412. 
44 Grochulski, P.; Bouthillier, E; Kazlauskas, R 1.; Serreqi, AN.; Schrag, J. D.; Ziomek, 
E.; Cygler, M. Biochemistry 1994, 33, 3494-500. 
45 (a) Wells, J. A; Powers, D. R; BoU, R. R; Graycar, T. P.; Esteil, D. A Proc. Natl. 
Acad. Sei. USA, 1987,84,1219-1223; (b) Esteil, D. A; Graycar, T. P.; Miller, J. V.; 
Powers, D. R; Bumier, J. P.; Ng, P. G.; Wells, J. A Science 1986,233,659-663. 
46 Keller, T. H.; Seufer-Wasserthal, P.; Jones, R J. Biochem. Biophys. Res. Comm., 1991, 
176,401-405. 
47 Lin, Y. Y.; Palmer, D. N.; Jones, J. R Cano J. Chem.I974, 52, 469-76. 
48 (a) Menger, E M. Biochemistry 1992, 31, 5368-5373; (b) Jencks, W. P. Adv. Enzymol. 
Relat. Areas Mol. Biol. 1975, 43,219-410. 
151 
Chapter 5 
49 (a) Bruice, T. C. Ace. Chem. Res. 2002, 35,139-149; (b) Hur, S.; Bruice, T. C. Proc. 
Nat!. Acad. Sei., 2003,100, 12015-12020. 
50 (a) Cannon, W. R.; Singleton, S. E; Benkovie, S. J. Nature Struct. Biol. 1996,3,821-
833; (b) Garcia, M.; Gao.J.; Karplus, M. Truhlar, D. G. Science, 2004, 303,186-195. 
51 (a) Femandex, I.; Khiar, N.; Liera, J. M.; Alcudia, F. J. Org. Chem., 1992,87,6789-
6796; (b) Mikolajczyk, M.; Drabowicz, J.; Bujnicki, B Tetrahedron LeU. 1985,26,5699-
5702. 
52 Norton, S. N.; Bachrack, S. M.; Hayes, J. M. J. Org, Chem. 2005, 70, 5896-5902. 
53 Perkins, C W.; Wilson, S. R.; Martin, J. C; J. Am. Chem. Soc. 1985,107,3209-3218. 
54 Holmes, R. A. Acc. Chem. Res. 2004, 37, 746-753. 
55 Sampson, N. S.; Bartlett, P. S. Biochemistry, 1991,30,2255-2263. 
56 Kovach, I. M. J. Phys. Org. Chem. 2004, 17, 602-614. 
57 Bjorkling, F. Dahl, A. Patkar, S. Zundel, M. Bioorg. Med Chem. 1994,2,697-705. 
58 Sampson, N. S.; Bartlett, P. S. Biochemistry, 1991,30,2255-2263. 
59 Hill, C. M.; Wu, F.; Cheng, T.C; DeFrank, J.; Raushel, F. M. Bioorg. Med Chem. 
Lett. 2000, 10, 1285-1288. 
60 Wells. J.; Cunningham, B. C; Graycar, T. P. EsteIl, D. A. Proc. Natl. Acad. Sei., 1987, 
84,5167-5171. 
61 Bonneau, P. R.; Graycar, T. P.; Esteil, D. A.; Jones, J. B. J. Am. Chem. Soc. 1991,113, 
1026-4030. 
62 Aharoni,A.; Gaidukov, L. Khersonsky, O.; Gould, S. M.; Roodveldt, C.; TawfIk, D. S. 
Nat. Genet. 2005, 37, 73-76. 
63 Backes, B. J.; Dragoli, D. R.; Ellman, J. A. 1. Org. Chem. 1999, 64,5472-5478. 
64 Chen, F. M. F.; Kuroda, K.; Benoiton, N. L. Synthesis 1978, 928-929. 
65 (a) Harpp, D. N.; Bacle, T. G. 1. Org. Chem. 1973,38,4328-4334; (b) Harpp, D. N.; 
Back, T. G. Tetrahedron Lett. 1972, 52, 5313-5316. 
66 Behforuz, M.; Kerwood, J. E. J. Org. Chem., 1969,34,51-55. 
67 Bûchel, K.H.; Conte, A. Chem. Ber. 1967, 100, 1248-1251. 
68 (a) Anderson, K. K.; Gaffield, W.; Papanikolaou, N. E.; Foley, J. W.; Perkins, R. I.; 1. 
Am. Chem. Soc., 1958, 87, 5736-5742; (b) Anderson, K. K. J. Org. Chem. 1964,29, 
152 
Chapter 5 
1953-1956; (c) Mislow, K.; Green, M. M.; Laur, P.; MelIilo, 1. T.; Simmons, T. Ternay, 
A. L. J. Am. Chem. Soc. 1965,87, 1958-1961, 
69WeIls, J. A.; Ferrari, E.; Henner, D. J.; EsteIl, D. A.; Chen, E. Y. Nuc. Acids Res. 1983, 
11, 7911-7925. 
70 Kawamura, F.; Doi, R. H. J. Bacterio/. 1984, 160,442-444. 
71 Harwood, C. R.; Cutting, S. M. Mo/ecu/ar Bi%gica/ Methods for Bacillus, John Wiley 
& Sons, England, 1990, pp 33-35, 391-402. 
153 
Summary, Conclusions and Future Work 
We have expanded the application of subtilisin to hydrolyze unnatural substrates 
and perfonn unnatural reactions. The open active site of subtilisin allows it hydrolyze 
sterically hindered substrates such as a bulky auxiliary and tertiary alcohol esters. A new 
catalytic promiscuous reaction of subtilisin Carlsberg was discovered where a 
sulfinamide (S-N) bond is hydrolyzed rather than the expected amide (C-N) bond in N-
acyl sulfinamides. The active site also catalyzes unnatural reaction using a similar 
mechanism to the natural hydrolysis. 
We identified two enantiocomplementary enzymes, subtilisin and cholesterol 
esterase, which can resolve a Diels-Alder chiral auxiliary. Both enzymes displayed high 
enantioselectivity (E >200) and gram quantities were resolved with subtilisin Carlsberg. 
The molecular basis of subtilisin' s high enantioselectivity was determined using 
molecular modeling. The slow reacting enantiomer disrupted key hydrogen bonds with 
the enzyme due to steric clashes. 
We also performed the [lfst study on the protease catalyzed resolution of tertiary 
alcohol esters. In general proteases showed good reactivity but low enantioselectivity. 
Substrate studies determined that internai substrate strain limited the reaction to tertiary 
alcohols with a methyl or smaller small substituent because this substituent must adopt an 
unfavorable syn-pentane-like orientation with the oxyanion of the first tetrahedral 
intermediate. This work demonstrates that proteases such a subtilisin can hydrolyze 
challenging tertiary alcohol esters. Protein engineering may further improve the 
resolution oftertiary alcohols by increasing the enantioselectivity. Using a 
complementary acyl group (such as dihydrocinnamoyl for subtilisin and a-chymotrpysin) 
may enhance the reactivity of challenging substrates even further. 
Finally, we discovered a new reaction of subtilisin Carlsberg, the hydrolysis of N-
acyl sulfinamides by cleavage of the S-N bond. We examined the substrate range of the 
reaction and proved the reaction proceeds tbrough a sulfinyl enzyme intermediate. This is 
one of the few examples where the molecular basis for the promiscuity was examined. 
Only a few amino acid substitutions of subtilisin BPN' changed its selectivity to favour 
the S-N reaction. Catalytic promiscuity may expand the application of enzymes to 
organic synthe sis by allowing new transformations. Directed evolution may improve the 
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reaction further by increasing activity and enantioseIectivity. QMIMM of the transition 
state should reveal the exact mechanism in the formation of the sulfinyl enzyme 
intermediate. The reaction could be applied in the transfer of a sulfinyl group to other 
amine and alcohol nucleophiles, rather than water. 
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Contributions to knowledge 
1. We established that subtilisin is an excellent catalyst for the resolution of sterically 
hindered substrates. The bulky secondary alcohol spiro substituent (chapter 2) was 
resolved with high enantioselctivity. This example should allow further resolutions of 
sterically hindered substrates with subtilisin. 
2. Molecular modeling of the spiro secondary alcohol showed no evidence for the 
stereoelectronic effect contributing to the enantioselectivity of subtilisin. This was 
suggested as an important factor in lipase and protease enantioselectivity, but in this 
example it does not contribute. 
3. We performed the tIfSt investigation ofprotease catalyzed hydrolysis oftertiary 
alcohol esters. This is an important first step in developing efficient methods to produce 
enantiopure tertiary alcohols using proteases. Currently there are only a few synthetic and 
biocatalytic methods to prepare enantiopure tertiary alcohols. 
4. We examined a new reaction that can be used in the synthesis of important 
enantiopure sulfinyl compounds, such as sulfinamides and sulfinates. This could 
eventually be used to transfer sulfinyI groups to other amines and alcohols instead of 
water. 
5. Substrate studies on N-acyl sulfinamides and sulfinates indicate that binding in the 
acyl group portion can switch type of reaction between sultmamide and carboxyamide 
hydrolysis. Introducing the dihydrocinnamoyl group tumed the substrate around to 
increase the amount of sulfinamide hydrolysis. Thus the catalytic promiscuity arose from 
a re-orientation of the substrate rather than an introduction of new catalytic residues. 
6. We demonstrated that catalytic promiscuity required only a few mutations to 
dramatically alter activity. Catalytic promiscuity is an emerging field ofbiocatalysts, 
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which should widen the number of functional group transformations available to organic 
chemists. It will also aid in understanding how enzymes acquire new functions. 
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